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RESUME 
The thesis describes the work related to synthesis, structure elucidation, 
stereochemistry and biological assay grouped in six chapters as Chapter-1 
(2,2-disubstituted-thiazolidin-4-ones), Chapter-2 (3,5-disubstituted-2-
pyrazoiinyl-thiocarboxamides), Chapter-3 (2-[3,5-disubstituted-2-
pyrazolinyl]thiazolin-4-ones), Chapter-4 (l,3,3-tris(/7-chlorophenyl) 
propene), Chapter-5 (4'-chloroflavone) and Chapter-6 (Biological screening : 
study for anticancer and antibacterial activity). 
The techniques used for structure elucidation are 'H-NMR, '^C-NMR, 
DEPT, 2-DNMR (COSY, HETCOR, Long-range HETCOR) including DCI-MS, 
EI-MS, FAB-MS, HRMS, IR and FTIR. 
CHAPTER - 1 
2,2-Disubstituted-Thiazolidin-4-ones from 6):,/^Unsaturated Enones 
In recent years, it has been found that the interest in thiazolidin-4-ones 
for medical application is increasing strongly. The thiazolidin-4-ones, their 
derivatives and analogues have exhibited unusually high in vitro activity 
against Mycobacterium tuberculosis, highly potent and selective anti-Platelet 
Activiting Factor activity and broad spectrum activity against various 
diseases. Because thiazolidin-4-ones were proven to be highly potent and 
selective and as part of our aim in search of biologically active compounds 
with sulphur and nitrogen containing heterocycles, we have undertaken the 
synthesis of these four novel compounds, 2-[2,2-bis(4-chlorophenyl)ethyl]-
2-(4-chlorophenyl)thiazolidin-4-one (3), 2,2-di[2-(4-chlorophenyl)-2-(3,4-
dimethoxyphenyl)ethyl]thiazolidin-4-one (6), 2,2-dif2-(4-chlorophenyl)-2-
3,4-dimethoxyphenyl)ethylJ-5-(methyl)thiazolidin-4-one (7) and 2,2-
di[2,2-bis(4-chlorophenyl)ethyl]-5-(methyl)thiazolidin-4-one (10). The 
compound (3) has been obtained from 4,4'-dichlorochalcone (1) via 1,3,3-
tris(4-chlorophenyl)propan-l-one (2) using mercaptoacetic acid. Compound 
(6) and (7) both from l,5-bis(3,4-dimethoxyphenyl)pent-l,4-dien-3-one (4) 
via l,5-bis(4-chlorophenyl)-l,5-bis(3,4-dimethoxyphenyl)pentan-3-one (5) 
using mercapto acetic acid in the former and a-mercaptopropionic acid in the 
latter and the compound (10) from l,5-bis(4-chlorphenyl)pent-l-4-dien-3-
one (8) via l,l,5,5-tetra(4-chIorophenyl)pentan-3-one (9) using a-
mercaptopropionic acid, all in the presence of ammonium carbonate as a 
source of ammonia (SCHEME-I). 
The synthesis of target compounds (3), (6), (7) and (10) were performed in 
two steps (SCHEME-I). 
(i) The adducts (2), (5) and (9) were first prepared by the reaction of the 
corresponding enones (1), (4) and (8) with dry chlorobenzene in the presence 
of anhydrous aluminium chloride at room temperature, in good yields. 
(ii) The adducts (2), (5) and (9) were then condensed with a -
mercaptoalkanoic acids and ammonium carbonate furnished four novel 
compounds, 2-[2,2-bis(4-chlorophenyl) ethyl]-2-(4-chlorophenyl) thiazolidin 
-4-one (3), 2,2-di[2-(4-chlorophenyl)-2-(3,4-dimethoxyphenyl)ethyl] thiazolidin-
4-one (6), 2,2-di[2-(4-chlorophenyl-2-(3-4-dimethoxyphenyl)ethyl]-5-(methyl) 
thiazlidin-4-one (7) and 2,2-di[2,2-bis(4-chlorophenl) ethyl]-5-(methyl) 
thiazolidin-4-one (10). 
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The structures ^ stereochemistry of compound (3) (FIG. 1) was 
established on the basis of spectral studies such as IR, DCI-MS, HRMS, 
'H-NMR, '3C-NMR, NOE-experiments, COSY, HETCOR and Long-range 
HETCOR. 
FIG. - 1 
CHAPTER - 2 
3,5-Disubstituted-2-pyrazolinyl-Thiacarboxamides from Dienones 
Pyrazoline derivatives are associated with a wide range of biological 
activities such as antibacterial, antifungal, antiinflammatory, analgesic, 
antitumor and anti-HIV activity. Keeping in view of the clinical importance of 
pyrazolines and as part of our work in search of biologically active sulphur 
and nitrogen containing heterocycles, here we report the synthesis of 3,5-
disubstituted-2-pyrazolinyl-thiocarboxamides (12) and (14) from dienones 
(4) and (8) using thiosemicarbazide in ethanol (SCHEME-III). 
It consists of the reactions of dienones, l,5-bis(3,4-
dimethoxyphenyl)pent-l,4-dien-3-one (4) and l,5-bis(4-chlorophenyl) pent-
l,4-dien-3-one (8) with thiosemicarbazide in the presence of hydrochloric 
o 
(4)R,=R2 = OMe 
(8)Ri=aR2 = H 
(12)R,=R2 = OMe 
S<^NH2 (14)Ri=aR2=H 
SCHEME - III 
acid which yielded two novel compounds, 2-[3-{2-(3,4-
dimethoxyphenyl)ethenyl}-S-{3,4-dimethoxyphenyl}-2-pyrazolin-l' 
yljthiocarboxamide (12) and 2-[3-{2-(4-chlorophenyl)ethenyl}-5-{(4-
chlorophenyl)}-2-pyrazolin-l-yl]thiocarboxamide (14). In the former, the 
thiosemicarbazone (11) formed as intermediate being minor could not be 
isolated while in the latter, the thiosemicarbazone, N*[lgS-bis(4-
chlorophenyl)pent-l,4-dien-3-ylidene]thiosemicarbazide (13) was isolated 
in poor yield (SCHEME-III). 
The structures of these compounds were established by IR, DCI-MS, 
•H-NMR and ^^C-NMR spectral studies. 
CHAPTER - 3 
2-f3,5-Disuhstituted-2-Pyrazolinyl]thiazolin-4-ones from Chalcones 
The compounds containing thiazolinone moiety are associated with 
diverse biological activities and were found to be very potent against a 
number of diseases such as antiulcer, antiinflammatory, anti-AIDS and 
antitubercular acitivity. In recent past, reactions of thiosemicarbazones of 
various aldehydes and ketones with a-chloroacetic acid and its functional 
derivatives in the presence of sodium acetate have been investigated and 
found to give the corresponding hydrazono-thiazolin-4-ones. However, the 
analogous reactions of 3,5-disubstituted-2-pyrazolinyl-thiocarboxamides 
with chloroacetic acid have not been described. Keeping in view of the 
importance of pharmaceutical applications and as part of our programme in 
search of biologically active compounds with sulphur and nitrogen containing 
heterocycles we have undertaken this problem. 
In continuation of our previous work described in CHAPTER-2 on the 
reactions of thiosemicarbazide with different a,y9-unsaturated dienones to 
form novel compounds, 3,5-disubstituted-2-pyrazolin-l-yl-thiocarboxamides, 
we have extended the above reactions employing the 2-thienylchalcone and 
4,4'-bromomethyl chalcone in place of dienones and condensing the 
thiocarboxamides moeity of 2-pyrazolinyl thiocarboxamides with 
chloroacetic acid in the presence of sodium acetate which yielded rwo novel 
compounds, 2-[3,5-bis(2-thienyl)-2-pyrazolin-l-yl]thiazolin-4-one (20) and 
2-(3'(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-yl]thiazolin-
4-one (24), 
The reactions of these chalcones possessing a,p-unsaturated function 
were carried out in two steps. 
Step 1 : The chalcone (17) and (21) were first reacted with thiosemicarbazide 
in the presence of conc. hydrochloric acid to yield N'-[l,3-bis(2-thienyl) 
-2-propen-l-ylidene]thiosemicarbazide (18) and 2-[3,5-bis(2-thienyl) 
-2-pyrazolin-l-yl]thiocarboxamide in the former while N'-[l-(4-
bromophenyl)-3-(4-methylphenyl)-2-propen-l-ylidene]thiosemicarbazide 
(22) and 2-[3-(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-yl]thiocar-
boxamide (23) in the latter (SCHEME-V). 
Step 2 : The pyrazolinyl thiocarboxamides (19) and (23) were then treated 
with chloroacetic acid in the presence of sodium acetate to yield two novel 
compounds, 2-[3,5-bis(2-thienyl)-2-pyrazolin-l-yl]thiazolin-4-one (20) and 
2-(3-(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-yl]thiazolin-4-one 
(24) respectively. 
The structures of these products were established on the basis of 
spectral studies of FT-IR, DCI-MS, EI-MS, FAB-MS, 'H-NMR and '^C-NMR, 
spectral studies. 
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CHAPTER - 4 
l,3,3-Tris(p-chlorophenyl)propene from Chalcone 
The toxicity of hydrocarbons is in general increased when the following 
elements or radicals are introduced into molecule, CI, Br, I, OH, SH, SO2, 
NO2 and NH2. Some of organochlorine compounds are reported potent 
insecticidal, antitumor, antimalarial and acaricidal. Keeping in view of the 
importance of organochlorine compounds, effort has been made for search of 
some new or improved organochlorine compounds as derivatives of 
chalcones. We report here the synthesis of l,3,3-tris(4-
chlorophenyl)propan-l-ol (25) and l,3,3-iris(4-chlorophenyl)prop-l-ene 
(26) from 4,4'-dichlorochalcone (1) (SCHEME-VII). The reaction were 
carried out in three steps. 
Pha/anhydAlOj 
(molar ratio, 1: large e>cess: 3), 
stirred, 2 h 
NaBH4 (molar ratio, 1:14.3), 
THF,stiired, reflux, 4 h 
a 
Etehydration in presence of 
p-TsC»i diy ben2Ene, relufif, 8 h 
SCHEME-VII 
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Step 1 : The adduct (2) was prepared from chalcone (1) using chlorobenzene 
in presence of anhydrous aluminium chloride exactly as described in 
CHAPTER-1. 
Step 2 : The carbonyl group of the l,3,3-tris(4-chlorophenyl)propan-l-one 
(2) was reduced with sodium borohydride in THF provided l,3,3-tris(4-
chlorophenyl)propan-l-ol (25). 
Step 3 : The dehydration of l,3,3-tris(4-chlorophenyl)propan-l-ol (25) was 
carried out by refluxing it in dry benzene in the presence of a catalytic amount 
of /7-toluenesulphonic acid furnished l,3,3-tris(4-chlorophenyl)prop-
1-ene (26). 
The structures of these compounds were established by IR, DCI-MS, 
FAB-MS, ^H-NMR, '^C-NMR spectral studies. 
CHAPTER - 5 
A Flavone from 1,3-Diketone (Baker-Venkataraman 
Transformation of 2-Benzolyloxyacetophenone) as an Undesired 
product in the Synthesis of Dithiazolidin-4-one 
Flavonoids are widely distributed plant secondary metabolites and the 
field of flavonoids is one of the most fascinating area of plant chemistry. 
Their occurrence in nature, the chemical and biological relationship between 
them and the chemistry of their derivatives have been the subject of intensive 
study in recent past. These natural heterocyclic compounds possess a wide 
range of physiological and pharmacological properties, such as heart 
stimulant, antiviral, antihaemolytic activity, anthelmintic activity. In previous 
chapters we have synthesized 2-substituted-4-thiazolidinones as novel 
compounds from chalcones via their monoketo adduct using thioglycollic 
acid in the presence of ammonium carbonate in dry benzene. 
11 
The aim of the present problem was to synthesize dithiazolidin-4-ones 
from 1,3-diketones using the same reagent. For this purpose, the precursor, 
1,3-diketone (28) was reacted with thioglycollic acid and ammonium 
carbonate in dry benzene which afforded a 4-chloroflavone (29) instead of 
the target compound, dithiazolidin-4-one. The ring closure of 1,3-diketone in 
acid medium to form flavone molecule is a well known reaction. From 'H-
NMR spectrum, it is found that the 1,3-diketone exists in the equilibrium 
mixture of keto-enol tautomeric forms (SCHEME-VIII). 
The reaction was carried out in two steps. 
(i) The 1,3-diketone, 2-hydroxy-4'-chlorodibenzoyl methane (28) was first 
prepared by Baker-Venkataraman transformation of 2-(4'-chlorobenzoyloxy) 
acetophenone condensing o-hydroxyacetophenone with p-chlorobenzoic acid 
in the presence of a catalytic amount of POCI3. 
(ii) The 2-hydroxy-4'-chlorodibenzoyl methane (28) was then condensed 
with thioglycollic acid and ammonium carbonate in dry benzene afforded an 
undesired product, 4'-chloroflavone (29). The target compound dithiazolidin-
4-one could not be obtained in the reaction. The 1,3-diketone did not react 
with thioglycollic acid and ammonium carbonate, it simply cyclized to give a 
flavone which is a well known cyclization reaction in acetic medium 
(SCHEME-VIII). 
The structures of these compounds were established by DCI-MS, 'H-
NMR and '^C-NMR spectral studies. 
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CHATPER - 6 
Biological Screening : Study for Anticancer and Antibacterial 
Activities 
A. ANTICANCER ACTIVITY 
The compounds (2), (3), (9), (10), (12), (14), (19), (20) and (25) have 
been evaluated for anticancer activity first in the 3-cell lines of three types 
of human cancers : breast (MCF7), Lung (NCI-H460) and CNS (SF-268) at 
one concentration as the one dose primary anticancer assay. The two 
compounds (3) and (25) out of these nine compounds tested have been found 
to be active in 3-cell line screening against breast (MCF7), Lung (NCI-
M460) and CNS (SF-268) (Table-23). These two compounds were then tested 
against 60-cell lines of nine types of human cancers : leukemia, lung, colon, 
CNS, melanoma, ovarian, renal, prostate and breast at five different 
concentrations. The compounds showed anticancer activity only at the higher 
conentration, 1 x lO'^ ^M. However, the compounds (3) has shown some 
activity in renal cancer even at lower concentration, 1 x lO'^M, The 
compound (2) has shown significant anticancer activity in melanoma, colon 
and renal cancers, where the maximum reduction in growth is observed as 52, 
80 and 91 % respectively. The compound (25) has shown anticancer activity in 
melanoma and colon cancers, where the maximum reduction in growth is 48 
and 83% respectively. 
(B) ANTIBACTERIAL ACTIVITY 
A total of five compounds were tested against three Gram +ve bacteria 
{Streptococcus viridans. Staphylococcus epidermatis and Bacillus subtilis 
and one Gram -ve bacteria {Escherichia coli). The varying level of 
14 
antibactrial activity was detected against one or more test organisms. Solvent 
control (DMSO) showed non-significant inhibition to test microorganisms. 
All the five compounds demonstrated activity against both Gram +ve and 
Gram -ve bacteria. The compounds exhibited antibacterial activity in the 
concentration range 200 |ag to 400 ^ig/100 |j,l. Overall broad spectrum 
antibacterial activity i.e. active against Gram +ve and Gram -ve was deduced 
in five compounds. These compounds may be directly explored in the 
preparation of topical antiinfective agents. However, further exploration 
requires detailed study on exact MIC values and least toxicity to host cell and 
system. 
DESIGN AND SYNTHESIS OF BIOLOGICALLY 
ACTIVE COMPOUNDS WITH SULPHUR AND 
NITROGEN CONTAINING HETEROCYCLES 
AND RELATED COMPOUNDS 
T H E S I S 
SUBMITTED FOR THE DEGREE OF 
fioctor o f 
IN 
CHEMISTRY 
ev 
SHISHUPAL SINGH 
DEPARTMENT OF CHEMISTRY 
FACULTY OF SCIENCE 
AUGARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
2003 
T6087 
mr »mmKmf$ 
DEPARTMENT OF CHEMISTRY 
ALIGARH MUSLIM UNIVERSITY 
A L I G A R H — 2 0 2 0 0 2 
(U. P.) I N D I A 
Phones 
Dated. 
Ext.(0571)7 0 3 5 1 5 
Int. 317, 318 
tdttixfitiitt 
I certify that the work presented in this thesis entitled '^Design 
and Synthesis of Biologically Active Compounds with Sulphur 
and Nitrogen Containing Heterocycles and Related Compounds" 
has been carried out by Mr. Shishupal Singh under my supervision. 
It is original in nature and has not been submitted for any other degree. 
(Prof. W.H. Ansari] 
unen. 
an 
(yicknowUdgetnents 
Low mij Lead with aii kumiiitij and reverence to tk for tL 
camp ietion of tk ii taiL. 
lA/ordd faii to expredd mt^ indeitedneid tkat ^ owe to mi^ erudite reiearck 
guide, ]Prof. lA^aJid ^Jduiain .^niari, wko inipired 
to take up tkii taik. J wUl 
ckeriik tkrougkout m^ iife tke uaiuakie duggeitioni, conitructit/e criticiim and 
ding Support tkat S received from kim tkrougkout tke course oftk ii itudi^. 
J wisk to place on record tke k ind keip received from. jProf. ^kafiuHak 
d Prof W. Ji^as, who as a airmen of tke 'department provided a a tke 
necessary facilities for undertaking tkii reiearck proLiem. 
J would like to tk 
ank all tke faculti^ memkers of tke department, specially, 
Prof J.P jeawat. Prof U Wuskfi^ue and U^r. J . f^auf for tkeir constant Support and encouragement. 
^ uviik to express m^ veneration to Prof. <jCemiere, tjniveriiti^ of 
Jntwerp ( m C J ) , 
iSelgium and Prof. ^ L a d , Universitif of XJalenecia, 
.Spain, wko ai our collakorators carried out tke Spectral itudiei of our compoundi. 
IZ)r. ^aza, ^^efence Reiearck '^development Organiiation, ^walior, 
^ndia are also acknowledged deeply for tkeir kind cooperation in providing Some 
Spectra, ^ke kelp recieved from Yjational C^ancr .3nstitute, l^ari^land, l^etkesda, US.A 
in camming out tke anti-cancer activiti^ of our compounds is also truel^ 
acknowledged. ^ wisk to expreii m^ kenevolence to 2)r. ^tk ar Malik 
.Siddie^ui, ^department of i3iockemistri^, ^aculti^ of rJlife .Sciences, U., 
.^ligark, ^ndia for tkii kelp in tke determination of anti-kacterial activiti^ of 
Some novel compounds. 
.3 would like to express m^ profound sense of gratitude and felicitation to 
Jmir J k med. 2)r. Salman .^Jdaikmi, ..^min-ul-^ilam, 
eik -J^umar, ^^umar, 2)r. I^itu ^in^li, H^r. 
Qamaruddin, l^anidL ^^^rawa L ZIL I eauti^nt and nice moment ipent 
with -Jdemraj ^in^L, l^ajLum,ar ^in^L, ^urjan ^in^k, XJijai^ Sin^li, PkoJ 
PraL a6k ^ingk uuiii Le ckerisked tkrou^kout m(j life. .Jdeartfui tkanks are due 
to l^r. II)ineik .J^umar, ..J^m, ^utueik, .J^m. Yjirueik, ^^m. \Jeeruati, ^'Cm. 
yifjeena, ^J^m. I^ekka, l^rs. ^eema \/erma ^or tkeir pieaiant companiondkip. 
J owe a Lt to Wii6 Tifjonika and ^^m. Pooja for Leing a conitant ioarce of 
indpiration and moral Support. 
DL 
ere are no wor ds to tkank Wn. Skakia ^facj, and mij iaL coiiea^uei 
Wr. Wak Skak ana J k mad, (^uirana .J^kuwaja, Sauitri Uerma, 
.Jduma ^amai, ^^rti Wjakeskwari, meena ^^smat, Jak an, 
^Jdumaira Parueen and 6peciaiitj 2)/*. ^a^eed ^^ukktar an d n)r. Wujeekur 
man for tkeir amicakie and cooperation tkrou^kout mt^ staij in tke iak. 
3 find no wordd to expreii m^ feeiin^d for m^ dear parents. tke arc kitects 
of m^ carrier ivkose kiessin^s and prai^erS, enakied me to reack, wkere .S am 
todai^. Uke genuine and unceasing Support from mij krotkerS WL Ckattarpai 
.Sin^k, ^amesk (Lkandra ^ingk, Param .Sin^k, i^adam .Sin^k an d Jskok ^J^umar for prouidin^ me witk a a tke entkusiasm for carrying out tkis work. 
(^cj^uaiit^ .3 express mij profound and SenSe of gratefulness to mtj sister 
Wrs. Skakuntaia, k rotker-in-iaw l^r. Pooran .Singk, mij nepkews Sk 
11/ 
^^umar, l^atendra _J^umar and m^ nieces .^^m. ^^auita .Singk an d J(m. 
^J^aipana .Singk for tkeir extraordinari^ cooperation and consistent inspirations. % anks are due to Y^jr. I^ifa<^uat, Ifl^jr. ..Jdafeez an d Wr. Qutuk 
-uddin 
for ait tke assistance prouided k^ tkem. YYjr. Pradeep ^J'Cumar .Skarma deserues 
a word of praise for tke excellent ti^pin^ of tke manuscript. 
C O N T E N T S 
[Synthesis, Structure Elucidation and Biological Screening] 
CHAPTERS CONTENTS PAGES 
General Introduction (i-ii) 
CHAPTER - 1 2,2-Disubstituted Thiazolidin-4-ones from 
a,P-Unsaturated Enones 1-107 
THEORETICAL 1-10 
DISCUSSION 11-85 
EXPERIMENTAL 86-96 
REFERENCES 97-107 
CHAPTER- 2 3,5-Disubstituted-2-Pyrazolinyl-
Thiocarboxamides 
THEORETICAL 
DISCUSSION 
EXPERIMENTAL 
REFERENCES 
108-181 
108-123 
124-161 
162-168 
169-181 
CHAPTER - 3 2-[3,5-Di-aryl substituted-2-Pyrazolinyl] 
Thiazolin-4-ones from Chalcones 182-252 
THEORETICAL 182-187 
DISCUSSION 188-238 
EXPERIMENTAL 239-247 
REFERENCES 248-252 
CHAPTER - 4 l,3,3-Tris(p-chlorophenyl)propene 
from Chalcone 
THEORETICAL 
DISCUSSION 
EXPERIMENTAL 
REFERENCES 
253-285 
253-260 
261-278 
279-281 
282-285 
CHAPTER- 5 A Flavone from 1,3-Diketone (Baker-
Venkataraman Transformation of 
2-Benzoyloxyacetophenone) as an 
Undesired product in the Synthesis of 
Dithiazolidin-4-one 
THEORETICAL 
DISCUSSION 
EXPERIMENTAL 
REFERENCES 
286-315 
286-291 
292-308 
309-311 
312-315 
CHAPTER-6 Biological Screening 316-334 
LIST OF PUBLICATIONS 
e r r a t a 
335 
5 3 6 
(i) 
GENERAL INTRODUCTION 
Heterocyclic compounds are very widely distributed in nature and are 
essential to life as they play a vital role in the metabolism of all living cells. 
Thus, for example, the following are heterocyclic compounds : the pyrimidine 
and purine bases of the genetic material DNA; the essential amino acids 
proline, histidine and tryptophan; the vitamins and coenzyme precursors 
thiamine, riboflavine, pyridoxine, folic acid and biotin; the B,2 and E families 
of vitamin; the photosynthesizing pigment chlorophyll; the oxygen 
transporting pigment haemoglobin, and its breakdown products^ the bile 
pigments; the hormones kinetin, heteroauxin, serotonin and histamine, 
together with most of the sugars. There are a vast number of 
pharmacologically active heterocyclic compounds, many of which are in 
regular clinical use. Some of these are natural products, for example 
antibiotics such as penicillin and cephalosporin, alkaloids such as vinblastine, 
ellipticine, morphine and reserpine and cardiac glycosides such as those of 
digitalis. However, the large majority are synthetic heterocyclics which have 
found widespread use, for example as anticancer agents, analeptics, 
analgesics, hypnotics and vasopressor modifiers, and as pesticides, 
insecticides, weedkillers and rodenticides. 
There is also a large number of synthetic heterocyclic compounds with 
other important practical applications, as dyestuffs, copolymers, solvents, 
photographic sensitizers and developers, as antioxidant and vulcanization 
accelerators in the rubber industry and many are valuable intermediates in 
synthesis. 
The broad spectrum of biological activities associated with these 
compounds and the multiplicity of action displayed by certain individual 
(ii) 
members make them one of most interesting class of compounds. The current 
research in organic chemistry and closely allied branches of biology is 
characterized by extensive investigation of physiologically active compounds 
encountered in the plant and animal world. The search for these active 
constituents which control the biological process of various systems have 
acted as a powerful stimulus to the further development of the chemistry of 
heterocyclic compounds. Synthesizing any useful organic compound is easier 
than to isolate the same from natural resources. Therefore, in recent years 
much effort are being applied by chemists in synthesizing such organic 
compounds which possess high degree of biological activities. Innumerable 
heterocyclic compounds have been prepared across the world for better 
therapeutics, particularly the compounds having hetero atoms such as 0 , S 
andN. 
A study on the influence of structure on activity shows that sometimes a 
minor change in heterocyclic nuclei enhances the pharmacological profile 
many folds than the parent nuclei. The search for new efficient and safe nuclei 
leads to an improvement in the existing drugs by increasing their potency, 
duration of action and decreasing side effects as well as creating new 
biologically active agents by molecular modification. 
The successful application of heterocyclic compounds in these and many 
other ways and their appeal as materials in applied chemistry and in more and 
fundamental and theoretical studies ensures virtually limitless series of 
structurally novel heterocyclic compounds with wide range of physical, 
chemical and biological properties. 
Keeping in view of the importance of heterocyclic compounds, we have 
undertaken this problem on "Design and Synthesis of Biologically Active 
Compounds with Sulphur and Nitrogen Containing Heterocyles". 
Chapter -1 
2y2-Disubstituted Thiazolidin-4-ones 
from a,^Unsaturated Enones 
l[keorctical 
THEORETICAL 
Heterocyclic compounds are those which have a cyclic structure with 
two, or more, different kinds of atoms in the ring. Since the ring can be of 
any size, from three-membered upwards, and since the heteroatoms can be 
drawn in ahnost any combination from a large number of the elements (though 
nitrogen, oxygen and sulfur are the most common), the number of possible 
heterocyclic systems is almost limitless. The search for physiologically 
active compounds which control the biochemical process of different 
systems have acted as a powerful stimulant for the development of the 
chemistry of heterocyclic compounds. Compounds with sulphur and nitrogen 
containing heterocycles form an important and fascinating group of 
heterocyclic compounds of diverse biological activities. 
4-Thiazolidinones belong to an important class of biologically active 
five membered sulphur and nitrogen containing heterocyclic compounds with 
a carbonyl group in the 4-position(II). These are the derivatives of 
thiazolidine(I). 
II IV 
Rj/R2=alkyyaiyl IVA, X = 0 (2,4-thiazoUdin-(lione) 
rVB, X = S (2-thiono-4-thiazolidinone or rhodanine) 
IVC, X = MR (2-imino-4-thiazolidinone or pseudothiohydantoin) 
IVD, X = N-N =C (hydra2dno as 4-oxo-2-thiazolin-2-ylhydrazone 
of the carbonyl compound). 
Substituents in the 2, 3 and 5-positions may be varied, but the greatest 
difference in structures and properties is exerted by the group attached to the 
carbon atom in the 2-position (R^ and R^ in formula III and X in formula IV). 
Variations in the substituents attached to the nitrogen atom and the methylene 
carbon atom are possible for the structures represented by formulas HI and IV. 
4-Thiazolidinones have been the subject of extensive study in the recent 
past. Numerous reports in the form of chemical r e v i e w s ^ a n d review 
articles '^"* have appeared in the literature which highlight their chemistry and 
use, especially syntheses, reactions and biological activity. 4-Thiazolidinone 
derivatives have been found to be associated with diverse biological activities 
such as bactericidal^"^®, fungicidar"^'^\ insecticidaP^-'"', pesticidaP^ 
herbicidaP^-^^, amoebicidal^^ antitubercular^®-^^ antiinflammatory^^'^^, 
antitumor^'^"^^ antipsychotic^^'^^ antiviraP^"^'^, anti-convulsant^^'^^'^^, 
anthelmintic^^-^° respiratory activity^^-'*' antidiarrhoeal''^ and antiarthritic''^ A 
number of thiazolidinone derivatives has also been found to exhibit highly 
potent anti-PAF'*'*"''^ , anti-histaminic'^^"'^^, antidiabetic'^ ^"^®, oxygenase 
inhibitory^^ calcium antagonist^^, potassium inhibitory" PPAR agonist^" ,^ 
cardioprotective^^ antiischemic activity^^'^^ and a promising agent for 
treating Alzheimer disease^®, cancer^^ and viral diseases like AIDS^^" '^''^ ^ and 
hepatitis-B^l 
Several methods for the preparation of 4-thiazolidinones have been 
reported in the literature^which are based mainly on the reaction of:-
1. a-mercaptoalkanoic acids with 
(a) Schiff bases 
(b) isothiocynates 
(c) isocynates 
(d) cyanamide 
2. a-halo- or a-hydroxyalkanoic acids, a, ^-unsaturated acids or their 
derivatives with 
(a) dithiocarbamates 
(b) thiocarbamates 
(c) thioureas 
(d) thiosemicarbazones 
(e) alkali thiocynates 
a-Mercaptoalkanoic acids have been extensively used for the synthesis 
of 4-thiazolidinones. The substituted and unsubstituted a-mercapto alkanoic 
acids react conveniently with Schiff bases of aromatic or heterocyclic 
aldehydes or ketones and aliphatic or aromatic amines in different solvents to 
give a variety of 2-substituted-4-thiazolidinones(V)^'^0'^^>'^^'5^-^^ 
R - N = ( i - R 2 + H S - C - C O O H • V ^i. 
R = alkyl, aryl or heterocyclic group R, = alkyl, aryl or heterocyclic 
Rj = H, a l^ lorary l Rj = H, a l ^ l , aryl 
R, = H, alkyl 
Hydrazones of aldehydes or ketones react with substituted or 
unsubstituted a-mercapto alkanoic acids to form 2-substituted or 
2,2-disubstituted 4-thiazolidinones(VI)5'67-73 
R_NH_N=C( ^ H S - C H - c o o h ^ 
R2 
VI 
R = alkyl, aryl or heterocyclic R, = H, alkyl, aryl or heterocyclic 
Rj = allq^l, aiyl or heterocyclic R3 = H, alkyl 
a-Mercaptoacetic acid reacts with the aldehyde or ketone in the 
presence of ammonium salts such as ammonium carbonate or acetate in inert 
solvent. The reaction seems to proceed by the formation of an aldimine or a 
ketimine intermediate followed by the cyclisation with a-mercaptoacetic 
acid to form 2,2-disubstituted-4-thiazolidinones(VII)^3'''''-'^^. 
R H N ^ 
\ = 0 + N H j + H S - C H 2 - C O O H > ^ 
r / Ri 
R=H or allcyl Rj=alkyl or aiyl 
a-Mercaptoacetamide reacts with the carbonyl function of aldehydes in 
the presence of catalytic amounts of p-toluenesulphonic acid or boron 
trifluoride ethereate in inert solvent to give 2-substituted-4-
thiazolidinones(VIII)20.78.79 
HN 
H 
I Q 
R —C = 0 +HS - C H 2 - C O N H 2 — ^ R 
R=alkyl or aryl VIII 
a-Mercaptothiocarboxylic acids can also be used for the synthesis of 
4-thiazolidinones(IX) by the reaction with different Schiff bases^°. 
R - N = C + H S - C H 2 - C O S H 
R2 
R=alkyl or aryl Rj=H or alkyl R2=alkyl or aryl 
A number of spiro-4-thiazolidinones(X, XI) has been prepared by the 
reaction of cyclic ketones with a-mercaptoacetic acid in the presence of 
ammonium carbonate or substituted 
'(CH2)„-s 
HS.CHj.COOH 
N — R 
0 
XI 
R = Alkyl or aiyl 
Substituted and unsubstituted a-mercaptoacetic acid, esters react 
smoothly with the compounds containing activated nitrile groups in 
the presence of an equivalent amount of alcoholate to give 
4-thiazolidinones(XII)^5. 
R4R3HC 
OR 
R4R3HC 
R=CH3 or C2H5 Ri=H or C j H j R2 = H, CjHj^ Ph or 0-CH3CgH4 
R3=Hor Ph R4= - COOEt, - CONHj, - CN. Pyiidyl, Indoyl or Ph 
Monforte et al.®"^  have synthesized 4-thiazolidinones by reacting 
carbodiimides with a-mercaptopropanoic acid. The acid reacts with one of the 
two carbodiimidic C=N groups to give 3-substituted-2-imino-5-methyl-4-
thiazolidinones(XIII). 
R' 
/ » 
R -
XIII 
R=alkyl or aryl 
Substituted 2-imino-4-thiazolidinones(XIV) are obtained in good yields 
by the reaction of symmetrical and unsymmetrical thioureas with various 
substituted and unsubstituted a-haloalkanoic acids, their esters, acid 
chlorides, amides and carbamates. The reaction proceeds via the intermediate 
isothiourea which cyclise in the presence of sodium acetate or pyridine^^"^^. 
i f ^^  
RNH-C-NHRi ^ RNH-C=NRi+ X-C-COY 
R3 
- H Y 
R=alkyl, aryl or hetwocyclic Rl=alkyl, aiyl or heterocyclic 
R2=Horalkyl R3=Horalkyl 
A number of fused thiazolidin-4-ones(XV) has been prepared by the 
reaction of cyclic thioureas with various substituted a-haloalkalnoic acids 
and their derivatives®'*'^ ®®. 
-(CHA R 
I 
+ X — C H — C O Y 
R = H o r alkyl 
X = Halo-
Y = Clor OR 
\ 
XV 
2-Iinino-4-oxo-5-thiazolidinone acetic acid(XVI) can be conveniently 
prepared from dicarboxylic acids^®^ a-Bromosuccinic acid on treatment with 
thioureas in the presence of sodium acetate in methanol gives 2-imino-4-
oxo-5-thiazolidinone acetic acid. 
S SH 
II I 
R N H - C - N H 2 R N = C - N H 2 + H 0 0 C - C - C H 2 C O O H 
Br 
- H B r 
CH2COOH 
R=H, alkyloraryl 
Recently, Madhukar S. Chande et have synthesized 3-amino-2-
alkyl/arylimino-5-carbethoxy methyl thiazolidin-4-one (XXII) by the reaction 
of diethyl bromomalonate (DBM) with 4-aryl substituted thiosemicarbazide 
in ethanol in the presence of pyridine. 
S SH H 
II I I 
R N H - C - N H N H 2 R N = C - N H N H 2 + H 5 C 2 0 0 C - C - C H 2 C O O C 2 H 5 
Br 
- H j O 
CH2COOC2H5 
XVII 
R=H or aiyl 
Thioureas add to the unsaturated carbon-carbon linkage of maleic, 
fumaric, citraconic acids, their esters and imides probably by a Michael
reaction and cyclisation gives a 2-imino-4-oxo-5-thiazolidineacetic 
acid(XVIII)^03,i04 
S SH 
II I 
RNH-C-NHz ^ ^ RN=C-NH2 + H00C-CH=CH-COOH 
- H j O 
O 
HN 
R=H,alkyl oraryl 
RN/ X g X C^HjCOOH 
XVIII 
2-Imino-4-oxo-5-thiazolidineacetic acid (XIX) can also be synthesized 
in good yields by refluxing equimolar amounts of substituted and 
unsubstituted thioureas and maleic anhydride in acetone 
o 
s f RNH-C-NHRi z ^ RNH-C=NRi + O 
O 
-HjO 
,0 N-
RlN''^  X g X C^HjCOOH 
XK 
R=H, alkyl or aryl R p H , alkyl or aryl 
Dimethyl acetylenedicarboxylate (DMAD) reacts readily with 
substituted thioureas, thiosemicarbazides and thiosemicarbazones to give 
4-thiazolidinones(XX)i°7 
RNH— C — NHR+H3 OOOC— C ^ C — COOCH3 
^CHaxxus 
S' 
R=H,CH3.C6H5CH2 or Q H j 
XX 
As with thioureas, thiosemicarbazones of aldehydes or ketones react 
with maleic anhydride in refluxing benzene or toluene and form the 
5-carboxy-methyl-4-oxo-2-thiazolin-2-ylhydrazone (XXI) of the carbonyl 
compounds^ 
/ ' f /• A 
RNHCSNHN=C 
\ \ 
( 
/ 
C=N-N CHjCOOH 
XXI 
R=H or aiyl RpH, alkyl, aiyl or Heterocyclic 
R^=alkyl or aryl 
When the thiosemicarbazone of aldehyde or ketone is allowed to react 
with substituted and unsubstituted a-haloalkanoic acids, their esters, amides 
in the presence of sodium ethoxide or sodium acetate, the product formed is 
aldehyde or ketone derivative of 2-hydrazino-4-thiazolidinones 
RNHCSNHN=C 
\ R, 
R,\ 
C=N-N-
/ 
xxn 
SH R3 
RNH-C=N-N=C + X-CH-COY 
\ 
R2 
- H X 
- H Y R 
R, 
C = N -
R=H or aryl Ri=H, alkyl or aryl 
R2=alkyl or aryl R3=H, alkyl or aryl 
1 0 
A number of extranuclear thiazolidin-4-ones(XXIII) has been prepared 
by the reaction of thiosemicarbazones of cyclic ketones with substituted and 
unsubstituted a-haloalkanoic acids in the presence of sodium acetate or 
sodium ethoxide^^®'^ ^ .^ 
S R2 
(CH2)„]=N—NH—C—NH—NH—Ri •+] ' X—CH—COY 
(CHA 
Ri = H,Aiyl, alkyl 
R2 = H,alkyl,aryl 
Recently, W.H. Ansari and co-workers^have synthesized a novel 
compound 2-[2-carboxymethylthio-2-(4-chlorophenyl)ethyl]-2-(4-chloro-
phenyl)-4-thiazolidinone (XXIV) from p,p'-dichlorochalcone. 
CL ^ ^ 
1. HSCH2COOH 
2. (NH4)2C03/ diy benzene 
XXIV 
discussion 
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DISCUSSION 
SUMMARY 
The work included in this chapter deals with the synthesis of 
following four novel compounds -
i) 2-[2,2-Bis(4-chlorophenyl)ethyl]-2-(4-chlorophenyl) thjazolidin-4-one(3), from 
4,4'-dichlorochalcone(l) via l,2,3-tris(4-chlorophenyl) propan-1-
one(2) using mercaptoacetic acid. 
a) 2,2-Di[2-(4-chlorophenyl)-2-(3,4-dimethoxyphenyl)ethyl]thiazolidin-
4-one(6), from l,5-bis(2,4-dimethoxyphenyl)pent-l,4-dien-3-one (4) 
via l,5-bis(4-chlorophenyl)-l,5-bis(3,4-dimethoxyphenyl)pentan-3-
one (5) using mercaptoacetic acid. 
Hi) 2,2-Di[2-(4-chlorophenyl)-2-(3,4-dimethoxyphenyl)ethyl]-5-(methyl) 
thiazolidin-4-one(7), from (4) via (5) using a-mercaptopropionic acid 
and 
iv) 2,2-Di[2,2-bis(4-chlorophenyl)ethyl]-5-(methyl)thiazolidin-4-one(10) 
from l,5-bis(4-chlorophenyl) pent-l,4-dien-3-one(8) via 1,1,5,5-tetra 
(4-chlorophenyl) pentan-3-one(9) using a-mercaptopropionic acid, 
all in the presence of ammonium carbonate as a source of ammonia. 
Structures are established on the basis of IR, Mass, 'H-NMR, ^^C-NMR 
and 2D-NMR (COSY, HETCOR, LONG RANGE HETCOR, APT) spectral 
studies. The compounds (2), (3), (9) and (10) have been evaluated for 
anticancer activity and compound (3) and (10) for antibacterial activity. 
INTRODUCTION 
In recent years, it has been found that the interest in thiazolidin-4-ones 
for medical applications is increasing strongly. Thiazolidin-4-ones substituted 
in the 2-position, viz (-)2-(5-carboxypentyl)-4-thiazolidinone (originally 
isolated^® from the culture broth of a strain of streptomyces and used as a 
new antibiotic in the name of actithiazic acid), its derivatives and analogues^® 
have exhibited unusually high in vitro acitvity against Mycobacterium 
tuberculosis. In their syntheses^®, a-mercaptoacetamide was used instead of 
1 2 
a-mercaptoacetic acid for the reaction with carbonyl compounds in the 
presence of a catalytic amount of /?-toluenesulphonic acid in refluxing 
benzene or toluene with azeotropic removal of water. A number of 2-pyridyl 
substituted 4-thiazolidinones has been synthesized by Tanabe et al.'^^ in 1995 
following the method of Surrey^'', condensing a-mercaptoalkanoic acids with 
aldehydes and primary amines or with corresponding Schiff bases and found 
to exhibit highly potent and selective anti-Platelet Activating Factor 
activity'^ '^ "'*^ both in vitro and in vivo. During the past few years, some 
biologically potential thiazolidin-4-ones have been synthesized and found to 
possess anticonvulsant^®'^^'^^, antidiarrhoeal''^, antihistaminic"*^"^^, 
antimicrobial^"^®, oxygenase inhibitory^^ and calcium antagonist activity^^. 
Because 4-thiazolidinones substituted in the 2-position were proven to be 
biologically very potent and selective and as part of our programme in search 
of biologically active compounds with nitrogen and sulphur containing 
heterocycles, we have undertaken this problem. It deals with the synthesis of 
four novel compounds, 2-[2,2-bis(4-chlorophenyl)ethyl]-2-(4-chloro-
phenyl) thiazolidin-4-one (3), 2,2-di[2-(4-chlorophenyl)-2-(S,4-dimethoxy-
phenyl)ethyl]thiazolidin-4-one (6), 2,2-di[2-(4-chlorophenyl)-2-(3,4-dimethoxy-
phenyl)ethyl]-5-(methyl)thiazolidin-4-one (7) and 2,2-di[2,2-bis(4-
chlorophenyl)ethyl]-5-(methyl)thiazolidin-4-one (10). The compound (3) 
has been obtained from 4,4'-dichlorochalcone (1) via l,3,3-tris(4-
chlorophenyl)propan-l-one (2) using mercaptoacetic acid. Compounds (6) 
and (7) both from l,5-bis(3,4-dimethoxyphenyl)pent-l,4-dien-3-one (4) via 
l,5-bis(4-chlorophenyl)-l,5-bis(3,4-dimethoxyphenyl)pentan-3-one (5) 
using mercaptoacetic acid in the former and a-mercaptopropionic acid in the 
latter and the compound (10) from l,5-bis(4-chlorophenyl)pent-l,4-
dien-3-one (8) via 1, l,5,5-tetra(4-chlorophenyl)pentan-3-one (9) using 
1 3 
a-mercaptopropionic acid, all in the presence of ammonium carbonate as a 
source of ammonia. 
Structural assignments, stereochemistry and biological assay are 
discussed. Screening results of compounds (2), (3), (9) and (10) are 
summarized for anticancer activity against 3-cell lines of three types of 
human cancers : lung, breast and CNS and the results of (3) are also 
summarized for anticancer activity against 60-cell lines of nine types of 
human cancers : leukemia, lung, colon, CNS, melanoma, ovarian, renal, 
prostate and breast. Screening results of (3) and (10) are also summarized for 
antibacterial activity against four bacteria Escherichia coli. Bacillus subtilis. 
Staphylococcus epidermatis and Streptococcus viridans (DETAILS IN 
CHAPTER-6). 
a 
(10) 
1 4 
(3) 
MeO- -OMe 
MeO OMe 
(4) 
OMe 
OMe 
(5) 
OMe 
OMe 
(10) 
1 5 
OMe 
OMe 
(7) 
0 
(8) 
(9) 
(10) 
1 6 
RESULTS AND DISCUSSION 
The syntheses of target compounds (3), (6), (7) and (10) were performed 
in two steps (SCHEME-I). 
Step 1 : The adducts (2), (5) and (9) were first prepared following a literature 
procedure^^^ by the reaction of the corresponding enones (1), (4) and (8) with 
dry chlorobenzene in the presence of anhydrous aluminium chloride (molar 
ratio, 1 :large excess^^ :^3) at room temperature, in good yields (-66%, 70%, 76%). 
Step 2 : The adducts (2), (5) and (9) were then condensed with 
a-mercaptoalkanoic acids and ammonium carbonate (molar ratio, 
1:1.30:5.25) by refluxing in dry benzene for 40-45 h with azeotropic removal 
of water and the products purified by column chromatography over silica gel 
using pet. ether-diethylether as eluent and then crystallized to yield the 
desired products (~58% yields). The compounds (6) and (7) both were 
obtained from the same adduct (5) by condensing with mercaptoacetic acid 
and a-mercaptopropionic acid while (3) and (10) from the adducts (2) and (9) 
by condensing with mercaptoacetic acid and a-mercaptopropionic acid 
respectively. 
1 7 
n = 0 
n = l 
n = l 0. w 
So 
anhydAlC^ (molar ratio, 1: large e jcess '^: 3), 
stirred at r.t, 3-8 h. 
2 ) R , = H,R2 = C1, n i = 0 
5 )Ri = R2 = 0Me, n , = l fS 
ft. 
9 ) R , = H,R2 = C1, n, = l & •i-t 
CO 
R3—CH.COOH/(NH4)2a:b (molarratio, 1:1.30:5.25), 
SH 
diy benzene, refluj; 40-45h. 
(R3 = H, mercaptoacetic acid or thiogfycollic acid 
Rg = CH3, a-mercaptopropionic acid) 
3)Ri=H,R2 = aR3 = H ni=0 
6) Ri=R2 = OMe,R3 = H ni=l 
7) R, = R2 = 0Me,I^ = Me ni = l 
10) R,=H,R2 = aR3 = Me n, = 1 SCHEME-I 
1 8 
Mechanism of the above reaction 
A plausible mechanism for the above reaction may be offered 
(SCHEME-II). It is believed that the adduct first formed by the nucleophilic 
addition of chlorobenzene to a, P-unsaturated enone function, reacts with 
ammonia from ammonium carbonate to give the ketimine intermediate^'^. The 
reaction then proceeds by the neucleophilic attack of thiol group of 
HS-CHCOOH upon > C=N, adding to the carbon atom followed by capture 
R3 
of a proton by nitrogen atom and subsequent cyclization with the elimination 
of a water molecule. The proposed mechanism is depicted taking an example, 
the enone (1) as shown in SCHEME-II. 
n 
-CI 
1 9 
CI CI 
SCHEME-II 
2 0 
Synthesis of 2-[2,2-bis(4-chlorophenyl)ethyl]-2-(4-chlorophenyl)-
thiazolidin-4-one from 4,4'-dichlorochalcone (1) via 1,3,3-
tris(4-chlorophenyl)propan-l-one P (2) using thioglycollic acid in 
the presence of ammonium carbonate in dry benzene. 
The compound (2) was first prepared by adding an excess of 
chlorobenzene to a suspension of 4,4'-dichlorochalcone(l) and anhydrous 
aluminium chloride (molar ratio, 1:3) in chlorobenzene, stirring the reaction 
mixture for 2.5 h at room temperature. After the reaction was over, the 
reaction mixture on TLC examination (silica gel 'G', pet. ether (40-60°)-
benzene, 9:1 v/v) showed the presence of only one spot, labelled as P. On 
usual work up and crystallisation from benzene, it yielded P as white 
crystalline needles in 66% yield. The adduct (2) was then condensed with 
mercaptoacetic acid and ammonium carbonate (molar ratio, 1:1.30 : 5.25). 
The cyclocondensation was carried out by refluxing the reaction mixture in 
dry benzene for 40 h with azeotropic removal of water. TLC examination 
(silica gel 'G', pet. ether (40-60°) - diethylether, 7:3 v/v) of the reaction 
mixture showed the presence of one spot, labelled as Ei^. After usual work 
up and purification of the products by column chromatography over silica gel 
using pet. ether-diethyl ether (7:3 v/v) as eluent followed by crystallisation 
(benzene-acetone, 9:1 v/v) afforded Eia (3) as white crystalline globules in 
58.6% yield. 
2 1 
The outline of synthesis is given below : 
(1) 
PhCl/anhydrous AICI3 (molar ratio, 
l-.large excess'^^ : 3), stirred at r.t., 
2.5 h. 
a 
P(2) 
HSCH2C00H/(NH4)2C03 (molar ratio, 
1:1.30:5.25), diy benzene, reflux, 40 h. 
a 
2 2 
Structure Elucidation of P (2) 
It is a white needles shaped crystalline solid, m.p. 155°C and appears 
light brown on exposure to iodine vapours (TLC). The structure of P has been 
established by FT-IR, DCI-MS, HRMS, 'H-NMR and ^^C-NMR spectra. IR 
spectrum (KBr pellets) of P showed characteristic signals at 1677 (C=0), 
2927 (CH), 1590 (Phenyl), 1485, 1400, 1264, 1209, 1090, 1013, 838, 
774 cm-^ The DCI-MS (NH3 as reagent gas) spectrum (FIG. 1) of P (2) 
showed a set of [M+NH4]^ peaks at m/z 406/408/410/412 (93.4/97.1/37.5/ 
6.8) and an another set of [M+Hf peaks at m/z 389/391/393/395 (34.2/35.2/ 
14.0/2.5), confirming its molecular weight as 388/390/392/394. This is equal 
to the sum of the molecular weights of 4,4'-dichlorochalcone (276) and 
chlorobenzene (112) indicating that the formation of adduct P (2) has 
occurred by the addition of chlorobenzene to a, P-unsaturated enone of the 
chalcone. The set of peaks at m/z 139/141 (100.0/38.0) appeared as base peak 
was arised by the cleavage of 1-2 bond while the other set of peaks at 
m/z 235/237/239 (81.6/605/124) was obtained by the cleavage of 2-3 bond 
of the adduct molecule as shown in CHART-1. The HRMS (ESI) spectrum 
showed peaks corresponding with C21H15OCI3 [M+Na], which has been 
calculated as 411.0086 and found to be 411.0089, further confirming its 
molecular weight 388/390/392/394. The 'H-NMR (FIG. 2) and '^C-NMR 
(FIG. 3a, 3b) spectra of P dissolved in acetone-^/^ showed signals as assigned 
(TABLE-1). The assignments of all 'H-NMR and ^^C-NMR signals to 
individual H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity and relative integrations. The 'H-NMR 
spectrum of P showed a doublet at 83.92 (J=7.32Hz) and a triplet at 54.78 
(J=7.32Hz) which were attributed to two methylene protons at C-2 and a 
methine proton at C-3. The signals for aromatic protons appeared as 
2 3 
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1,2-cleavage 
[M+Hl'm/z 389/391/393/395 (34.2/35.2/14.0/2.5) 
CI 
e r r : C = 0 
m/z 139/141 (100.0/38.0) 
2,3-cleavage 
H 
/ / W Z' ^ 
CI CI 
m/z 235/237/239 (81.6/60.5/12.4) 
CHART - 1 
A2B2 pattern and were assigned for three aromatic rings as shown in 
TABLE-1. The ^^C-NMR spectrum also showed signals which support the 
adduct structure. 
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On the basis of these facts, the structure of P was formulated as 1,3,3-
tris(4-chlorophenyl)propan-l-one(2). 
Structure Elucidation of Eia (3) 
It is a white crystalline globules solid, m.p. 170 °C and appears reddish 
brown on exposure to iodine vapours (TLC). The structure of Eia has been 
established by FT-IR, DCI-MS, ^H-NMR and '^C-NMR, INEPT, COSY, 
HETCOR, LONG RANGE HETCOR and NOE spectra. IR spectrum (KBr) of 
Eia showed characteristic absorption bands at 3380 (NH), 1665 (-CONH), 
1600, 1590 (phenyl), 1470(S-CH2), 1405(C-H), 1250, 1080, 1010, 825 cm-'. 
The DCI-MS (NH3 as reagent gas) spectrum (FIG. 4) of Eia showed a set of 
[M+NH4]+peaks at m/z 479/481/483/485 (21.0/22.7/10.0/4.4) and an another 
set of [M+Hf peaks at m/z 462/464/466/468 (89.6/100.0/44.8/8.8) as the 
base peak, confirming its molecular weight 461/463/465/467. This is equal 
to the sum of the molecular weights of P (2) (388), thioglycollic acid (92) 
and ammonia (17) minus two molecules of water (36) which indicated the 
formation of thiazolidinone ring by the cyclocondensation of P (2) with 
thioglycollic acid and ammonia. The HRMS (ESI) spectrum showed molecular 
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ion which is corresponding with the molecular formula C23HigCl3NOS 
[M+H]^ calculated 462.0253 and found 462.0264; further confirming its 
molecular weight 461/463/465/467. The main fragment ion peaks observed at 
m/z 212/214 (50.6/23.1) [p-ClC6H4C3H30NS]'- was arised by the cleavage at 
a-position to the heterocyclic ring on the alkyl chain side, showing the 
location of the ring. The mode of fragmentations is shown in CHART - 2. The 
'H-NMR (FIG. 5) and ^^C-NMR (FIG. 6a, 6b) spectra of Eja dissolved in 
acetone-t/5 showed signals as assigned (TABLES-2 and 3). The assignments 
of all ^H-NMR and ^^C-NMR signals to specific H- and C-atoms have been 
performed on the basis of typical chemical shift values, multiplicity and 
relative integrations. The 'H-NMR spectrum showed a singlet at 58.04 for 
NH proton and two geminal doublets at 53.45, 3.56 (J= 15.42) for the ring 
methylene protons (-CH2-S-), suggesting the formation of thiazolidinone 
ring. The formation of thiazolidinone ring was also supported by a shift of 
C-2 proton of P (2) to higher field from 53.92 to 3.05-3.16 (position 1' in 
Eja). The '^C-NMR spectrum is also in agreement with thiazolidinone ring as 
C-1 signal of the compound P(2) has shifted to higher field from 5196.95 to 
570.84 in Eja due to disappearance of C=0 group and formation of the ring. 
The aromatic protons signals appeared as A2B2 system as in compound P (2). 
On the basis of these evidence, the structure of Ej^. has been formulated as 2-
[2,2-bis(4-chlorophenyl)ethyl]-2-(4-chlorophenyl)thiazolidin-4-one (3). 
The structure and stereochemistry of compound Ei^ (3) have further been 
confirmed by additional NMR techniques such as COSY, INEPT, HETCOR, 
LONG RANGE HETCOR and 2D-N0E spectra (FIGS. 7a-c, 8a-b, 9a-c and 
lOa-d). These spectra suggested that the relative configuration of the product 
(3) is most probably \x ( u n l i k e ^ a n d partial conformation of both central 
bonds C-2-C-r and C-V-C-T as antiperiplanar (FIG. I)"9,i20 Especially, 
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according to Karplus'^', the coupling constants Ji.up2' and Ji^ dn,!' indicated an 
antiperiplanar torsion angle for Hdn-T and H-2', and a synclinal torsion angle 
for Hup.r and H-2' i.e. the coupling constant, revealed a synclinal position of 
H-2' relative to the diastereotopic hydrogen atoms H-l'up and H-l'dn. This 
was further confirmed by a NOE-correlation of H-2' with both H-l'up and H-
I'dn (TABLES 2 and 3). Thus, the most preferred conformation of (3) 
deduced on the basis of above spectral techniques, is presented in FIG. 1. 
FIG. - 1 
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Synthesis of 2,2-di[2-(4-chlorophenyl)-2-(3,4-dimethoxyphenyl) 
ethyl]thiazolidin-4-one SFDic (6) from l,5-bis(3,4-dimethoxyphenyl) 
pent-l,4-dien-3-one(4) via l ,5-bis(4-chlorophenyl)- l ,5-bis(3 ,4-
dimethoxyphenyl)pentan-3-one SFD (5) using thioglycolUc acid in the 
presence of ammonium carbonate. 
The compound SFDjc (6) was prepared as mentioned above. The adduct 
SFD (5) was first prepared by treating the dienone (4) (prepared according to 
published procedure)^^^ with excess of chlorobenzene and anhydrous 
aluminium chloride as yellow semi-solid mass in 70% yield. It was then 
reacted with thioglycollic acid and ammonium carbonate (molar ratio, 
1:1.30:5.25) in refluxing benzene for 40 h. The products on purification by 
column chromatography (silica gel, pet. ether-diethyl ether, 7:3 v/v) followed 
by crystallization (benzene-acetone, 9:1 v/v) afforded SFDic (6) as white 
crystalline globules in 55% yield. 
The outline of synthesis is presented below. 
a 
MeO. 
a 
PhO/anhyd. AICI3 (nclarratio, 1: large ewess'^' : 3), 
stirred at r.t., 3-8h. 
OMe 
OMe 
O 
Sn)(5) 
SH a 
aiaX)H/(NH4)2a:^ (molar ratio, 1:1.30:5.25), 
dry benzene, reftu!^ 40-50 h. 
OMe 
"OMe 
SBD,C(6) 
a 
52 
Structure Elucidation of SFD (5) 
It is a yellow semi solid mass and appears brown on exposure to iodine 
vapours (TLC). The constitution of SFD has been established by FT-IR, FAB-
MS, ^H-NMR and ^^C-NMR spectra. The IR spectrum (KBr) displayed 
characteristic absorption bands at 2928 (CH), 1711 (C=0), 1595, 1476 
(phenyl), 1356, 1090, 1016, 759, 603 cm-K In FAB-MS spectrum of SFD 
(FIG. 11) the molecular ion peak [M]"^  was absent but sets of peaks at m/z 
541/543, 529/531, 491/493/495, 235/237, 165/167, 149/151, 125/127 etc. 
arised mostly by demethoxylation/dechlorination confirmed that its 
molecular weight was 578/580/582 (CHART-3). The ^H- and '^C-NMR 
spectra of SFD dissolved in C D C I 3 showed signals as assigned in TABLE 4. 
The assignments of all ^H- and ^^C-NMR signals to individual H- and C-atoms 
have been performed on the basis of typical chemical shift values, 
multiplicity, relative integrations and also by comparison with the spectral 
data of P(2) (TABLE-1). The ^H-NMR spectrum (FIG. 12) showed a double 
doublet at 54.43 (J=13.20Hz and 6.60Hz) and an another double doublet at 
54.47 (J=13.20Hz and 6.30Hz) which were attributed to H2up/4up and H2dn/4dn-
A double doublet at 54.99 (J=6.60Hz and 6.30Hz) was assigned to H-1/5. 
Thus, the coupling constants suggested that the two diastereotopic hydrogens 
at C-2/C-4 are antiperiplanar and synperiplanar with the hydrogen at C-l/C-5. 
The singlet at 53.13 was accounted for four methoxy groups. The aromatic 
protons signals for four benzene ri t i^ consiting of fourteen protons were 
also attributed as shown in TABLE-4. The ^^C-NMR spectrum (FIG. 13) 
showed a signal at 5205.1 for carbonyl carbon and the signals at 541.30 and 
548.90 were assigned to C-2/4 and C-l/5.The signal at 544.5 was attributed 
to methoxycarbons. The aromatic carbons signals were assigned as shown in 
the TABLE-4. 
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On the basis of these facts, SFD was characterised as 1,5-bis 
(4-chlorophenyl)-l,5-bis(3,4-dimethoxyphenyl)pentan-3-one (5). 
MeO. 
MeO 
OMe 
OMe 
Structure Elucidation of SFDic (6) 
It is a white globules shaped crystalline solid, m.p 204 °C and appears 
light brown on exposure to iodine vapours (TLC). The constitution of SFDic 
has been fully established by FT-IR, EI-MS, ^H-NMR and '^C-NMR spectra. 
The IR spectrum (KBr) showed characteristic absorption bands at 3400 (NH), 
2912 (CH), 1674 (-CONH), 1594 (Phenyl), 1485 (S-CHj), 1410 (C-N), 
1366, 1239, 1208, 1092, 1012, 818, 780 cm"'. The El-MS spectrum 
(FIG. 14) of SFDic showed no molecular ion peak but the peaks observed at 
m/z 528, 352, 236, 203, 165 obtained by fragmentations of [M+1]^ as shown 
in CHART-4, confirmed its molecular weight to be 651. This is equal to the 
sum of the molecular weights of the adduct (5) (578), thioglycollic acid (92) 
and ammonia (17) minus two molecules of water (36). This indicated that the 
formation of thiazolidinone ring has occurred by the cyclocondensation of 
the adduct SFD (5) with thioglycollic acid and ammonia. The base peak at 
m/z 236/238 (100/12.88) corresponding with the fragment ion 
[/7-C1C6H4C5H30NS]-' indicated the location of ring. The 'H-NMR (FIG. 15) 
and i^C-NMR (FIG. 16) spectra of SFDic dissolved in C D C I 3 showed signals 
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as assigned ( T A B L E - 5 ) . The assignments of all ^H-NMR and ^^C-NMR 
signals to specific H- and C-atoms have been performed on the basis of their 
typical chemical shift values, their coupling constants, relative integrations 
and by comparison with ^H-NMR and ^^C-NMR spectral data of the adduct 
S F D (5) ( T A B L E - 4 ) and the 4-thiazolidinone E ia (3) ( T A B L E - 2 and 3). The 
^H-NMR spectrum of SFDic showed a singlet at 67.70 for NH proton. The 
chemical shifts of C-2/C-4 protons of the adduct S F D (5) ( T A B L E - 4 ) were 
shifted to higher fields from 54.43-4.47 to 52.35-2.58 (C-lVC-l" proton) in 
the product SFDjc (6). This indicated the formation of thiazolidinone ring. 
The disappearance of chemical shift at 5205.1 for carbonyl group carbon and 
appearance of the signal at higher field at 570.40 and an additional signal at 
54.22 for methylene proton further supported the formation of the 
thiazolidinone ring. The other signals were found comparable with that of the 
adduct (5). 
On the basis these spectral evidence, the structure of SFDjc was 
formulated as 2,2-di[2-(4-chlorophenyl)-2-(3,4-dimethoxyphenyl)]ethyl] 
thiazolidin-4-one (6). 
OMe 
OMe 
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Synthesis of 2,2-di[2-(4-chlorophenyl)-2-(3,4-dimethoxyphenyl) 
ethyll-5-(methyl)thiazolidin-4-one SFDie (7) from l,5-bis(3,4-
dimethoxyphenyl)pent-l,4-dien-3-one (4) via l,5-bis(4-chlorophenyl)-
l ,5-bis (3 ,4-dimethoxyphenyl)pentan-3-one SFD (5) using 
2-mercaptopropionic acid in the presence of ammonium carbonate. 
The synthesis of compound S F D i e ( 7 ) has been carried out as described 
above. 
The adduct S F D ( 5 ) already prepared in S F D I C ( 6 ) was treated with 
2-mercaptopropionic acid and ammonium carbonate in dry benzene refluxing 
the reaction mixture for 40h with azeotropic removal of water. The products 
on purification over a silica gel column (pet. ether (40-60°)-diethyl ether, 7:3 
v/v) and crystallisation (benzene-acetone, 8:2 v/v) yielded SFDje as white 
crystalline globules in 57% yield. 
The outline of synthesis is presented below. 
MeO- / / \ 
MeO 
O 
(4) 
-OMe 
OMe 
MeO. 
MeO 
PhCVanhyd.AlCaS (molar ratio, 1: large excess 122:3), 
stirred at r.t., 3-8h. 
OMe 
"OMe 
SI® (5) 
CI CI 
MeO. 
MeO" 
S H 
I 
CHJCHC00H/(NH4)2C0J (molar raUo, 1:1.30:5.25), 
dry benzene, reflux, 40-50 h. 
, O M e 
"OMe 
6 6 
Structure Elucidation of SFDie (7) 
It is a white crystalline globules solid, m.p. 208 °C and appears as light 
brown on exposure to iodine vapours (TLC). The structure of SFDJE has been 
fully established by FT-IR, EI-MS, ^H-NMR and by comparison with the 
spectral data of previously described similar compound SFD^c (6). The IR 
spectrum (KBr) showed characteristic absorption bands at 3453 (NH), 2900 
(CH), 1681 (-CONH), 1593, 1485 (phenyl), 1435 ( S - C H - C H 3 ) , 1371, 1242, 
1197, 1092, 1012, 810, cm'^ In El-MS spectrum of SFDie (FIG. 17) the 
molecular ion peak was absent but the fragment ions obtained (CHART-5), 
confirmed its molecular weight 665/667/669 which is equal to the sum of the 
molecular weights of the adduct (5) (578), 2-mercaptopropionic acid (106) 
and ammonia (17) minus two molecules of water (36). This indicated that the 
formation of thiazolidinone ring has occurred by the cyclocondensation of 
the adduct SFD (5) with 2-mercaptopropionic acid and ammonia. The base 
peak at m/z 235/237 (100/68.18) with fragment ion [p-C\ C6H4C5H20NS]^ 
arised due to the cleavage of a - to the heterocyclic ring on the alkyl chain 
side of ring, indicated the location of ring. The mode of fragmentation is 
presented in CHART-5. The ^H-NMR spectrum (FIG. 18) of SFDie (7) 
dissolved in C D C I 3 showed signals as assigned in TABLE-6. The assignments 
of all ^H-NMR signals have been performed on the basis of typical chemical 
shift values, multiplicity and relative integrations and by comparison with 'H-
NMR spectrum of a previously described compound SFD^c (6) (TABLE-5). 
The three doublets at 52.29 (J=14.70 Hz, 4.50Hz), 2.46 (J=14.70Hz, 6.30Hz) 
and 4.72 (J=4.50Hz, 6.30Hz) were attributed to Hup-lVHup-1", Hdn-lVHdn-1" 
and H-27H-2" respectively. The signals at 54.12-4.15 were accounted for four 
methoxyprotons. A doublet at 51.54 (J=6.90Hz) was assigned to the methyl 
protons at C-5 of thiazolidinone ring and a quartet at 53.83 (J=6.90Hz) for a 
proton of the same position. The proton signal were also found identical with 
that of SFDic-
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Based on the above facts, SFDie was characterized as 2,2-di[2-(4-
chlorophenyl)-2-(3,4-dimethoxyphenyl)-ethyl]-5-(methyl)thiazolidin-
4-one (7). 
MeO 
3 H M e O 5 
(7) 
4 
a 
OMe 
OMe 
Synthesis of 2 ,2-di [2 ,2-bis(4-chlorophenyl)ethyl) -5-(methyl) 
thiazolidin-4-one ClFDjc (10) from, l,5-bis(4-chlorophenyl) 
pent-l,4-dien-3-one(8) via, l,l,5,5-tetra(4-chlorophenyl)pentan-
3-one CIFD (9) using 2-mercapto propionic acid in the presence 
of ammonium carbonate 
The synthesis of CIFDjc (10) was carried out as described above. 
The adduct CIFD (9) was first prepared by treating a solution of 1,5-
bis(4-chlorophenyl)pent-l,4-dien-3-one (8) with anhydrous aluminium 
chloride (molar ratio, 1:3) in excess chlorobenzene as yellow semi solid 
mass in 76% yield. The adduct CIFD (9) in dry benzene was then reacted with 
2-mercaptopropionic acid and ammonium carbonate. The products on 
purification over a silica gel column (pet. ether (40-60°)-diethyl ether, 7:3 
v/v) and crystallization (benzene-acetone, 8:2 v/v) afforded ClFDic(lO) as 
white crystalline globules in 56% yield. 
7 2 
The outline of synthesis is given below. 
Cl- / V a 
o 
(8) 
PhCl/anhyd. AlQa (molar ratio, 1 : large exsess: 3), 
stirred at r.t., 3-8h. Cl 
aFD(9) 
Cl a 
CH3CHC00H/(NH4)2C03 (molar ratio, 1:1.30:5.25), 
SH diy benzene, teflu^  40-50 h. 
Cl 
H Me O 
aFDic(lO) a 
Structure Elucidation of CIFD (9) 
It is a yellow semi-solid mass and appears light brown on exposure to 
iodine vapours (TLC). The structure of CIFD has been established by FT-IR, 
FAB-MS, 'H-NMR and '^C-NMR spectra. The IR spectrum (KBr) displayed 
characteristic bands at 2924 (C-H), 1710 (C=0), 1592, 1572, 1490 (phenyl), 
1408, 1095, 1059, 1008, 819, 747 cm'V The FAB-MS spectrum (FIG. 19) of 
CIFD (9) showed a set of [M+Hf peaks at m/z 527/529/531/533/535, 
confirming its molecular weight 526/528/530/532/534 [C29H22OCI4] which is 
equal to the sum of the molecular weights of l,5-bis(4-chlorophenyl)pent-
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l,4-dien-3-one (302) and two molecules of chloro- benzene (224). This 
indicated that the formation of the adduct has occurred by the addition of two 
molecules of chlorobenzene to the diene. The base peak at m/z 235/237/239 
(100.0/64.58/11.45) and other significant peaks at m/z 249/251/253 (3.7/2.4/ 
2.08), 165/167 (29.16/10.41) were shown in the fragmentations (CHART-6). 
The 'H-NMR (FIG. 20) and ^^C-NMR (FIG. 21) spectra of CIFD dissolved 
in C D C I 3 showed signals as assinged in TABLE-7. The assignments of all 'H-
and ^^C-NMR signals to individual H- and C-atoms have been performed on 
the basis of typical chemical shift values, multiplicity, relative integrations 
and also by comparison with the spectra of previously described adduct 
SFD (5). The two double doublets at 53.02 (J=17.10 Hz,J=9.90 Hz) and 63.14 
(J=17.10 Hz, J=4.80 Hz) were attributed to H-2up/H-4up and H-2dn/H-4dn. 
A double doublet at 64.49 (J=9.90 Hz, J=4.80 Hz) was assigned to H-1/5 
proton. Thus, the coupling constants showed that two diastereotopic 
hydrogens at C-2/C-4 are anti- and synperiplanars with C-l/C-5 hydrogen. 
The aromatic protons signals were accounted for sixteen protons of four 
benzene rings. The ^^C-NMR spectrum showed signals as assigned (TABLE-7). 
A signal at 643.98 was assigned to C-2/C-4 and at 647.21 to C-l/C-5 
carbons. The peak at 6205.67 was attributed to carbonyl carbon and the 
signals for the aromatic carbons were observed at 6128.29-142.83. 
On the basis of above facts, the structure of CIFD was formulated as 
1,1,5,5-tetra(4-chlorophenyl)pentan-S-one(9). 
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Structue Elucidation of ClFDic (10) 
It is a white globules shaped crystalline solid, m.p 168°C and appears 
brown on exposure to iodine vapours (TLC). The constitution of CIFDjc has 
been established by FT-IR, FAB-MS, ^H-NMR and ^^C-NMR spectra. The IR 
spectrum (KBr) showed characteristic absorption band at 3425 (NH), 2909 
(CH), 1680 (-CONH), 1591, 1484 (phenyl) 1450 ( S - C H - C H 3 ) , 1435 (C-N) 
cm-^ The FAB mass spectrum (Argon/Xenon as the FAB gas) (FIG. 22) of 
CiFDic showed a set of [M+lf peaks at m/z 614/616/618/620/622, 
comfirming its molecular weights 613/615/617/619/621 which is consistent 
with the molecular formula C 3 2 H 2 7 O N S C I 4 . The other significant peaks were 
observed at m/z 364/366/368 and 235/237/239 (CHART-7). The 'H-NMR 
(FIG. 23) and ^^C-NMR (FIG. 24) spectra of ClFDjc dissolved in C D C I 3 
showed signals as assigned in TABLE-8. The assignments of all ^H- and 
^^C-NMR signals to individual H- and C-atoms have been performed on the 
basis of their typical chemical shift values, their multiplicities, relative 
integrations and by comparison with the ^H- and ^^C-NMR spectra of 
previously described similar compounds (3) and (6) (TABLES 2, 3, 5 and 6). 
The ^H-NMR spectrum is in agreement with the formation of thiozolidinone 
ring as the chemical shift of C-2/C-4 protons in CIFD has shifted upfiled 
from 53.02-3.14 to 52.30-2.42 (1* and 1" in CIFDic) due to the ring 
formation. A quartet at 53.81 (J=6.6Hz) and a doublet at 61.56 (J=6.6 Hz) 
were attributed to a proton and a methyl group protons at C-5 of 
thiazolidinone ring. The '^C-NMR spectrum showed a signal at 549.50 which 
was assigned to C-lVC-l" carbon and an another signal at 546.62 to C-2VC-2" 
carbon. The ^^C-NMR spectrum is also in agreement with a thiazolidinon-e 
ring as C-3 signalof carbonyl carbon has shifted to higher field from 5205.67 
to 5175.29 due to disappearance of C=0 group and formation of ring. A signal 
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at 519.58 was assigned to methyl carbon and the signals for aromatic carbons 
were observed at 5125.80-143.97.The ^H- and ^^C-NMR signals were found 
comparable with that of similar compounds (3) and (6). 
Based on the above spectral evidence compound CIFDic was 
characterised as 2,2-di[2,2-bis(4-chlorophenyl)ethyl]-5-(methyl)thiazolidm-4-
one (10). 
Cxyerimcntal 
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EXPERIMENTAL 
Reagents and solvents were of commercial grade and were used without 
further purification. All melting points were determined on a Koffler hot-
plate apparatus and are uncorrected. IR spectra were recorded on Perkin-
Elmer 621 spectrophotometer in KBr-pellets. FTIR were recorded on Perkin-
Elmer spectrophotometer RXi and wave numbers (Umax) were recorded in cm"'. 
'H-NMR spectra were recorded in Brucker Ac300, Brucker DRX 300 and 
Varian Unity 400 in C D C I 3 , DMSO-de and acetone-dg, with TMS as the 
internal standard . The abbreviations s, d, t, m, dd, ddd, brp, dt denote singlet, 
doublet, triplet, multiplet, double doublet, triple doublet, broad pentet and 
double triplet. ^^C-NMR were recorded on a Varian Unity 75 and 100 
spectrometers. EIMS were recorded on V.G. Micromass model ZAB-IF 
apparatus at 70ev ionisation voltage. DCI-Mass spectra were recorded on a 
Ribermag R10-1 OB quadrupole mass spectrometer, using ammonia as reagent 
gas. The FAB mass spectra were recorded on a JEOL SX 102/DA-6000 Mass 
spectrometer/Data system using Argon/Xenon (6KV, 10mA) as the FAB gas. 
The accelerating voltage was lOKV and the spectra were recorded at room 
temperature, w-nitrobenzyl alcohol (NBA) was used as the matrix. HUMS 
values were recorded in quadrupole-time of flight mass spectrometer (Qtof2, 
Micromass, Manchester, UK) equipped with a standard electrospray 
ionisation (ESI) interface. Samples were dissolved in acetone (p.a.) P (2) 
1.2 mg mL-\ EIA(3), 1.0 mg mL"') and diluted 1/10 in methanol (HPLC 
grade) containing 0.1% of acetic acid. Using a Hardvard syringe pump (model 
22) these solutions were infused at flow rate of l|iL min"^ To enhance the 
[M+Na]+ signals of P (2) 10 of Nal solution (2^g/)iL in 50:50 isopropyl 
alcohol/H20) was added. Thin layer chromatography (TLC) was carried out on 
8 7 
0.25 mm layer plates with silica gel 'G' (Merck). Spots were visualised on 
exposure to iodine vapours using iodine chamber. The column 
chromatography was performed on silica gel [Merck (60-120) mesh] using 
25-30 g per g. of material to be separated and purified. Solvents were dried 
according to standard procedures. 
4,4'-Dichlorochalcone (1) 
4,4'-Dichlorochalcone (1) was prepared following a published but 
slightly modified procedure^^^ by condensing p-chloroacetophenone with 
;7-chlorobenzylidene diacetate (both prepared according to reported 
procedures^^^) in equimolar ratio in the presence of 2.5 equivalents of 
sodium hydroxide. A mixture of p-chloroacetophenone (4.13g, 0.0268 mol) 
and ;7-chorobenzylidene diacetate (6.5g 0.0268 mol) in ethanol (21 ml) was 
kept on an ice bath in a 500 ml flask. To this was added sodium hydroxide 
(2.68g, 0.0671 mol, 10%) dropwise with stirring. After complete addition, the 
reaction mixture was furhter stirred for 3 h, then diluted with 300 ml of ice 
cold water and kept in refrigerator overnight. The precipitate formed was 
filtered and washed successively with water to make it neutral. It was finally 
washed with 10 ml of cold alcohol and the yellow solid mass thus obtained 
was crystallised from acetone-benzene to give (1) as light yellow crystalline 
needles, 6.29 g (85%), m.p. 156°C, Rf 0.72 (pet. ether (40-60°)-benzene, 
1:1 v/v). 
l,3,3-Tris(4-chlorophenyl)propan-l-one P (2) 
It was prepared following a reported method^^^. To a suspension of 4,4'-
dichlorochalcone (1) (990 mg, 3.57 mmol) and anhydrous aluminium chloride 
(1450 mg, 10.9 mmol) in chlorobenzene (8 ml), chlorobenzene (25 ml) was 
added slowly with stirring at room temperature. After complete addition, the 
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reactio,n mixture was stirred for 2 h. The resulting yellow solution was 
extracted with ethyl acetate, washed several times with water, dried over 
anhydrous Na2S04 and the solvent was evaporated under reduced pressure. The 
products on crystallization from benzene yielded P (2) as white crystalline 
needles, 920 mg (66%), m.p. 155°C, Rf 0.58 (pet. ether (40-60°)-benzene, 
9:1 v/v). 
Spectral data of P (2) : 
IR (KBr pellet) : u^ax cm'^  1677 (C=0), 2927 (CH), 1590 (phenyl), 1485, 
1400, 1264, 1209, 1090, 1013, 838, 774. 
ifl-NMR (acetone-dfi, 400 MHz, temp. 30°C) : 5h 8.04 (2H, d, J=8.69Hz, 
Ar-H-2,6), 7.51 (2H, d, J=8.69 Hz, Ar-H-3,5), 7.39 (4H,d,J=8.69Hz, ArVAr'-
H-3,5), 7.28(4H, d, J=8.69Hz, ArVAr'-H-2,6), 4.78 (IH, t, J=7.32 Hz, H-3), 
3.92 (2H, d, J=7.32 Hz, H-2). 
^^C-NMR (100 MHz, acetone-dg, temp. 30°C) : 6c 196.95 (C-1), 144.09 
(C-ArVAr'-l), 139.68 (C-Ar-4), 136.66 (C-Ar-1), 132.56 (C-ArVAr'-4), 
130.68 (C-Ar-2,6), 130.47 (C-ArVAr'-2,6), 129.64 (C-Ar-3,5), 129.32 (C-
AryAr'-3,5), 45.77 (C-3), 44.58 (C-2). 
DCI-MS (NH3) : m/z 406/408/4120/412 (93.4/97.1/37.5/6.8) [M+NH4J+, 
389/391/393/395 (34.2/35.2/14.0/2.5) [M+Hf, 235/237/239 (81.6/60.5/ 
12.4) [(p-ClC6H4)2CHr, 139/141 (100.0/38.0) {p-ClCell^COr, 94 (8.9), 93 
(21.5). HRMS (ESI) for C21H15CI3O [M+Naf : Calc. 411.0086. Found 
411.0089. 
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2-[2,2-Bis(4-chlorophenyl)ethyll-2-(4-chlorophenyl)-thiozolidin-4-
one Eia (3) 
A mixture of the adduct l,3,3-tris(4-chlorophenyl)propan-l-one P (2), 
(890 mg, 2.3 mmol), thioglycollic acid (280mg, 3.0 mmol) and ammonium 
carbonate (1160 mg, 12.1 mmol) in dry benzene (20 ml) was refluxed for 40h 
with stirring at 80°C on an oil bath, collecting the generated water in an 
azeotropic collector. The progress of the reaction was monitored by TLC at 
every 30 min. After the reaction was over, the reaction mixture was 
concentrated under reduced pressure, extracted with diethyl ether and washed 
with water until the solution became neutral. The ethereal solution was dried 
over Na2S04 and the solvent evaporated under reduced pressure. The orange-
coloured oily residue left was finally examined by TLC (silica gel 'G', pet.-
ether (40-60°C)-diethyl ether, 7:3 v/v) which showed only one component, 
labelled as Eia- The oily residuce was chromatographed over a silical gel 
column using pet ether (40-60°)-diethyl ether (3:7 v/v) as an eluent. Elution 
of the column furnished a light yellow-coloured solid which on 
crystallisation from benzene-acetone (9:1 v/v) afforded Ej^ (3) as white 
crystalline globules, 615 mg. (58.6%). m.p. 170°C, Rf 0.85 (pet. ether (40-
60°)-diethyl ether, 1:1 v/v). 
Spectral data of Eia (3) 
IR (KBr pellet) : u^ax cm'^  : 3380 (NH), 1665 (-CONH), 1600, 1590 
(phenyl), 1470 (S-CHj), 1405 (C-H), 1250, 1080, 1010, 825. 
^H-NMR (acetone-dfi, 400 MHz, temp. 30°C) : 5h 3.45 (IH, d, J=15.42Hz, 
H-5up), 3.56 (IH, d, J=15.42Hz, H-5dn), 8.04 (IH, brs, NH), 3.05 (IH, dd, 
J=14.80Hz, J=5.03Hz, H-l'up), 3.16 (IH, dd, J=14.80Hz, 7.78 Hz, H-1'dn), 
4.33 (IH, dd, J=5.03Hz, J=7.78Hz, H-2'), 7.46 (2H, d, J=8.86Hz, H-Ar-2,6), 
7.31 (2H, d, J=8.86Hz, H-Ar-3,5), 7.30 (2H, d, J=8.40Hz, H-Ar'-2,6), 
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7.20(2H,d,J=8.40Hz, H-Ar'-3,5), 7.36 (2H, d, J=8.55Hz, H-Ar"-2,6). 7.28 
(2H, d, J=8.55Hz, H-Ar"-3,5). 
i^C-NMR (lOOMHz, acetone-c?6, temp. 30°C) : 5c 70.84 (C-2), 173.58 
(C-4), 33.51 (C-5), 49.91 (C-1'), 47.89 (C-2'), 145.21 (C-Ar-1), 127.91 
(C-Ar-2,6), 129.10 (C-Ar-3,5), 133.69^ (C-Ar-4). 144.90^ (C-Ar'-l), 130.52 
(C-Ar'-2,6), 129.32 (C-Ar'-3,5), 132.55« (C-Ar'-4) 144.25^ (C-Ar"-1), 130.26 
(C-Ar"-2,6), 129.44 (C-Ar"-3,5), 132.40^ (C-Ar"-4) ["Assignment may be 
reversed, ''Assignment may be reversed]. 
DCI-MS (NH3) : m/z 479/481/483/485 (21.0/22.7/10.0/4.4), [M+NH4]+, 
m/z 462/464/466/468 (89.6/100.0/44.8/8.8) [M+1], 238(8.2), 237(21.3), 
236(11.7), 235(28.9), 228(6.8), 226 (10.3), 215 (7.9), 215 (7.9), 214 (23.1), 
213(20.0), 212 (50.6) 165(12.4), 134(6.5), 117 (7.2). HRMS (ESI) for 
C23H18CI3NOS [M+Hf : Calculated 462.0253. Found 462.0264. 
l ,5-Bis(3,4-dimethoxyphenyl)pent-l,4-dien-3-one (4) 
It was prepared following a literature procedure^^^ by condensing 
acetone with 3,4-dimethoxybenzaldehyde (molar ratio, 1:2) in the presence of 
2.5 equivalents of sodium hydroxide. A mixture of 3,4-dimethoxybenzaldeyde 
(5 gm, 0.0301 mol) dissolved in ethanol (20 ml) and acetone (0.873 gm, 
0.0151 mol) was kept stirring on an ice bath and to this was added sodium 
hydroxide (1.51 gm, 0.038 mol, 10%) dropwise. A flocculent precipitate was 
formed during addition within 5 mintues. After complete addition, it was 
stirred further for 1 h, then filtered and the precipitate washed several times 
with cold water and finally with alcohol. The yellow solid mass thus obtained 
was crystallised from benzene to give (4) as yellow crystalline needles 
3.720 gm (65%), m.p. 125 °C, Rf 0.67 (pet. ether-EtOAc, 8:2 v/v). 
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l ,5-Bis(4-chlorophenyl)- l ,5-bis(3,4-dimethoxyphenyl)pentan-3-
one SFD (5) 
To a suspension of 1,5-bis (3,4-dimethoxyphenyl) pent-l,4-dien-3-one (4) 
(1.5 g, 0.0042 mol) and anhydrous aluminium chloride (1.69 g, 0.0126mol) 
in chlorobenzene (10 ml), was added dry chlorobenzene (60 ml) slowly with 
stirring at room temperature. After complete addition, the reaction mixture 
was further stirred for 8 h and worked up as usual. The products on 
purification by column chromatography over silica gel using pet. ether 
(40-60°)-benzene (7.3 v/v) as eluent yielded SFD (5) as yellow semi solid 
mass, 2.13 g (70%)^Rf 0.60 (pet. ether (40-60°)-benzene 8:2 v/v). 
Spectral data of SFD (5) 
IR (KBr pellet) : u^ax cm'^  2928 (CH), 1711 (C=0), 1595, 1476 (phenyl), 
1356, 1090, 1016, 759, 603. 
iH-NMR ( C D C I 3 , 300 MHz, temp. 27°C) : 8h 4.43 (2H, dd, JzupMup, 2(in/4dn = 
13.20Hz, JjupMup, 1/5 = 6.60 Hz, H-2up/4up), 4.47 (2H, dd, J2up/4up. 2dn/4dn = 
13.20Hz, J2dn/4dn, 1 / 5 = 6.30 Hz, H-2dn/4dn), 4.99 (IH, dd, JjupMup. 1 /5 , = 6 . 6 0 
Hz, J2dn/4dn . i/5=6.30 Hz, H-1/5), 3.13 (12H, s, 4 x O C H 3 ) , 6.84-7.31 (14H, 
brm, H-Ar). 
i^C-NMR ( C D C I 3 , 75 MHz, temp. ITC) : 6c 41.30 (C-2/C-4), 48.90 (C-1/ 
C-5), 44.50 (4 X O C H 3 ) , 205.1 (C-3), 125.70-141.45 (4 x Ar - C). 
FAB-Mass (JEOL SX 102/DA-6000) : m/z 545 (12.49), 543 (8.33), 541 
(6.0), 529/531 (54.16/29.16), 495 (5.20), 493 (8.33), 491 (9.37), 391 
(16.66), 392 (4.0), 293 (4.16), 291 (16.20), 289 (3.0), 279 (2.80), 277 
(4.99), 253 (2.0), 251 (10.41), 249 (14.16), 239 (14.58), 237 (85.41), 235 
(100.0), 203 (3.74), 201 (10.84), 199 (20.84), 178 (14.16), 167 (4.16), 165 
(47.91), 154 (20.84), 151/149 (12.49/4.16), 138 (7.91), 137 (14.16), 136 
(16.66), 127/125 (4.16/8.33), 107 (6.24). 
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2 , 2 - D i [ 2 - ( 4 - c h l o r o p h e n y l ) - 2 - ( 3 , 4 - d i m e t h o x y p h e n y l ) e t h y l ] 
thiazolidin-4-one SFDic (6) 
To a solution of the adduct SFD (5) (900mg, 1.557 mmol) in dry 
benzene (25 ml), thioglycollic acid (186 mg, 2.024 mmol) and ammonium 
carbonate (785 mg, 8.17 mmol) were added. The reaction mixture was 
refluxed for 40 h with stirring, collecting the generated water in azeotropic 
collector and then worked up as usual. The products on purification over a 
silica gel column (pet. ether (40-60°) - diethyl ether, 7:3 v/v as eluent) and 
crystallization (benzene-acetone, 9:1 v/v) yielded SFDjc (6) as white 
crystalline globules, 557 mg (55%), m.p 204°C, Rf 0.62 (benzene - EtOAc, 
7:3 v/v). 
Spectral data of SFDic (6) 
IR (KBr pellet) : Un^ ax cm"' 3400 (NH), 2912 (C-H), 1674 (-CONH), 1594 
(phenyl), 1485 (-S-CHj), 1410 (C-N), 1366, 1239, 1208, 1092, 1012, 
818, 780. 
iR-NMR ( C D C I 3 , 300 MHz, temp. 25°C) : 5h 2.35 (2H, dd, Jrup/i"up, rdn/i"dn 
= 14.70Hz, J i - u p / i " u p . 2 / 2 " = 4.80Hz, H-lVr'up), 2.58 (2H, dd, Jyup/Vup, rdn/i"dn 
= 14.70Hz, Ji.dn/rdn.272" = 6.90Hz, H-l'dn/l"dn), 3.43 (12H, s, 4 x O C H 3 ) , 
4.22 (2H, s, H-5), 4.7(1H, s, H-2V2"), 7.70 (IH, s, NH), 7.04-7.37 (14H, 
brm, H-Ar). 
i^C-NMR ( C D C I 3 , 75MHz, temp. 30°C) : 5c 33.50 (C-5), 42.20 (C-2VC-2"), 
46.34 (4 X O C H 3 ) , 48.70 (C-lVC-1"), 70.40 (C-2), 172.1 (C-4), 125.3-143.0 
(4xAr-C). 
EI-MS : m/z 528 (85.60), 526(50.75), 366(10.0), 364(3.03), 352(59.09), 
332(3.03), 322(1.51), 292 (0.75), 290 (9.85), 276 (3.79), 274 (25.0), 260 
(1.52), 238 (12.88), 236 (100.0), 234 (12.12), 203 (6.06), 165 (55.30), 92 
(2.27), 86(6.06). 
9 3 
2 , 2 - D i [ 2 - ( 4 - c h l o r o p h e n y l ) - 2 - ( 3 , 4 - d i m e t h o x y p h e n y l ) e t h y l ] - 5 -
(methyl)thiazolidiii-4-one SFDje (7) 
To a solution of the adduct SFD (5) (900 mg, 1.557 mmol) in dry 
benzene (25 ml), 2-mercaptopropionic acid (214 mg, 2.024 mmol) and 
ammonium carbonate (785mg, 8.17 mmol) were added. The reaction mixture 
was refluxed for 45 h with stirring and collecting the generated water in an 
azeotropic collector and then worked up as usual. The products on 
purification over a silica gel column (pet. ether (40-60°)-diethyl ether, 7:3 v/v 
as eluent) and crystallization (benzene-acetone, 8:2 v/v) afforded SFDJE (7) 
as white crystalline globules, 590 mg (57%), m.p 208°C, Rf 0.73 (benzene-
EtOAc, 7:3 v/v). 
Spectral data of SFDig (7) 
IR (KBr pellet) : u^ax cm"' 3453 (NH), 2900 (CH), 1681 (CONH), 1593, 
1485 (phenyl), 1435 ( S - C H - C H 3 ) 1371, 1242, 1197, 1092, 1012, 810. 
iR-NMR (CDCI3, 300 MHz, temp. 25°C) : 5H 2.29 (2H, dd, Jrup/i"up, rdn/i"dn 
= 14.70Hz, Ji-up/i"up.2V2" = 4.50Hz, H-rup/l"up), 2.46 (2H, dd, J rup/ i -up . rdn/ 
= 14.70Hz, Ji-dnyr-dn. 272" = 6.30Hz, H-rdn/l"dn), 4.72 (IH, dd, J,.up/i"up.2V 
2"=4.50 Hz, Jrdn/i"dn.2V2"=6.30 Hz, H-2V2"), 4.12-4.15 (12H, s, 4 x O C H 3 ) , 
3.83 (IH, q, J=6.90Hz, H-5), 1.54 (3H, d, J = 6.90Hz, H - 5 - C H 3 ) , 6.98-7.29 
(14H, brm, H-Ar). 
EI-MS : m/z 616 (9.84), 614 (3.78), 582 (1.52), 580 (2.27), 491 (2.27), 380 
(3.79), 378 (10.60), 366 (55.30), 364 (46.21), 336 (2.65), 290 (2.27), 275 
(32.58), 273 (22.72), 249 (2.27), 239 (17.42), 238 (18.18), 237 (68.18), 
236 (23.48), 235 (100.0), 201 (1.52), 199 (0.75), 165 (9.84), 106 (9.84), 86 
(2.27). 
9 4 
l ,5-Bis(4-chlorophenyl)pent-l,4-dien-3-one(8) 
It was prepared as described above by condensing acetone with 
p-chlorobenzaldehyde (molar ratio, 1:2) in the presence of 2.5 equivalents of 
sodium hydroxide. To a solution of p-chlorobenzaldehyde (6.84 gm, 0.049 
mol) dissolved in ethanol (20 ml) was added acetone (1.42 gm, 0.0244 mol) 
dropwise and the solution was kept on an ice bath in a 500 ml flask. To this 
was added sodium hydroxide solution (4.8 gm, 0.123 mol^lO%) slowly and 
was kept stirring for 2.5 h. The yellow precipitate formed was filtered and 
washed successively with water and finally with alcohol and then crystallized 
from benzene to give (8) as yellow crystalline needles, 6.30 gm (79%), 
m.p. 176 °C, Rf 0.72 (pet. ether-EtOAc, 8:2 v/v). 
iR-NMR (acetone-rffi 400MHz,): 5h 7.28 (2 x IH, d, J=16.0, H-2), 7.70 (2 
X IH, d, J=16.0, H-3), 7.73 (2 x 2H, d, J=8.50, 2xAr-2,6), 7.45 (2 x 2H, d, 
J=8.50, Ar-3,5). 
l,l,5,5-Tetra(4-chlorophenyl)pentaii-3-one CIFD (9) 
To a suspension of l,5-bis(4-chlorophenyl) pent-l,4-dien-3-one (8) (2g, 
0.0066 mol) and anhydrous aluminium chloride (2.692 gm, 0.0199 mol) in 
chlorobenzene (10 ml) was added chlorobenzene (90 ml) slowly with stirring 
at room temperature. After complete addition, the reaction mixture was 
stirred for 10 h. and worked up as usual. The product on column 
chromatography over silica gel using pet. ether (40-60°)-benzene, 7:3 v/v as 
an eluent afforded CIFD (9) as light yellow-coloured semi solid mass, 3.35 g 
(76%), Rf 0.62 (pet. ether (40-60°)-benzene, 8:2 v/v). 
Spectral data of CIFD (9) 
IR (KBr pellet) : u^ax cm"' 2924 (CH), 1710 (C=0), 1592, 1572, 1490 
(Phenyl), 1408, 1095, 1059, 1008, 819, 747 (C-Cl), 686. 
9 5 
^H-NMR ( C D C I 3 , 300 MHz, temp. 20°C) : 5 h 3.02 (2H, dd, J2up/4up,2dn/4dn = 
17.10Hz, J2up./4up, 1/5 = 9.90 Hz, H-2up/4up), 3.14 (2H, dd, J2up/4up, 2dn/4dn = 
17.10Hz, J2dn/4dn. 1/5 = 4.80 Hz, H-2dn/4dn), 4.49 (2H, dd, J2up/4up,i/5 = 9.90 
Hz, J2dn/4dn,i/5 = 4.80Hz, H-1/5), 6.95-7.36 (16H, brm, H-Ar). 
i^C-NMR (DMSO, 75 MHz, temp. 27°C) : 6c 43.98 (C-2/C-4), 47.21 (C-1/ 
C-5), 205.67 (C-3), 128.29-142.83 (4 x Ar-C). 
FAB-Mass (Argon/Xenon, 6KV, 10mA, as the FAB gas) : m/z 535 (2.50), 
533 (2.60), 531 (5.72), 529 (9.80), 527 (6.77), 497 (1.00), 495 (1.60), 493 
(2.00), 491 (2.08), 295 (1.04), 293 (2.29), 291 (4.16), 281 (1.0), 279 (3.8), 
277 (4.0), 253 (2.08), 252 (1.60), 251 (2.40), 250 (1.80), 249 (3.70), 248 
(2.0), 239 (11.45), 237 (64.50), 235 (100.0), 201 (10.41), r 9 9 (12.49), 180 
(2.0), 178 (8.0), 167 (10.41), 165 (29.16), 151 (4.4), 149 (41.66), 139 
(6.0), 137 (8.0), 113 (12.49), 111 (9.37). 
2,2-Di[2,2-bis(4-chlorophenyl)ethyl]-5-(methyl)thiazolidin-4-one 
ClFDic (10) 
A mixture of l,l,5,5-tetra(4-chlorophenyl)pentan-3-one (9) (950 mg, 
1.80 mmol), 2-mercaptopropionic acid (248 mg, 2.34 mmol) and ammonium 
carbonate (910 mg, 9.48 mmol) in dry benzene (50 ml) was refluxed for 45 h 
with stirring at 80°C on an oil bath using an azeotropic collector. The progress 
of the reaction was monitored by TLC at every 30 min. The reaction mixture 
was then concentrated under reduced pressure, extracted with diethyl ether 
and washed with water until the solution was neutral. The ethereal solution 
was dried over Na2S04 and the solvent evaporated under reduced pressure. The 
orange-coloured oily residue left was purified by passing over a silica gel 
column (using pet. ether (40-60°)-diethyl ether, 7:3 v/v as an eluent) and then 
crystallized (benzene-acetone, 8:2 v/v) to give ClFDic (10) as white 
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crystalline globules, 620 mg (56.00%), m.p 168°C, Rf 0.65 (benzene EtOAc, 
7:3 v/v). 
Spectral data of CiFDic (10) 
IR (KBr pellete) : u^ax cm"' 3425 (NH), 2909 (CH), 1680 (-CONH), 1591, 
1484 (phenyl), 1450 (S-CH-), 1435 (C-N), 1357, 1243, 1193, 1091, 1010, 
949, 869, 813, 777. 
iH-NMR ( C D C I 3 , 300 MHz, temp. 25°C) : 6h 1.56 (IH, s, 5 - C H 3 ) , 2.30 
(2H, dd, Jrup/i"up. rdn/i"dn= 16.20Hz, Jrup/i-up. 272" = 4.20Hz, H-l'up/r'up), 
2.42 (2H, dd, h'up/vnp, rdn/i-dn = 16.20Hz, Ji-dn/i-dn, 272" = 7.20Hz, H-l'dn/ 
l"dn), 4.16 (IH, dd Ji-up/i-up, 272" = 4.20Hz, Jrdn/i"dn272" = 7.20Hz, H-2V2"), 
3.81 (IH, q, J=6.60Hz, H-5), 7.29 (IH, s, NH), 6.98-7.22 (16H, brm, H-Ar). 
i^C-NMR ( C D C I 3 , 75 MHz, temp. 30°C) : 5c 19.58 ( 5 - C H 3 ) , 42.21 (C-5), 
49.50 (C-lVC-1"), 46.62 (C-2VC-2"), 68.32 (C-2), 175.29 (C-4), 125.80-
142.97 (4 xAr-C). 
FAB-MASS (Agron/Xenon (6KV, 10mA, as the FAB gas) : m/z 622(2.20), 
620 (7.29), 619 (8.33), 618 (22.92), 617 (18.75), 616 (43.74), 615 (17.70), 
614 (32.29), 613 (4.0), 392(2.0), 391 (9.37), 368 (4.0), 366 (12.50), 364 
(14.58), 239 (10.41), 238 (8.0), 237 (62.49), 236 (14.0), 235 (100.0), 201 
(6.66), 200 (4.0), 199 (8.33), 167 (2.0), 166 (7.92), 165 (25.0), 155 (8.0), 
154 (37.50), 149 (12.49), 139 (4.0), 138 (10.0), 137 (17.70), 136 (27.08), 
107 (6.0). 
erences 
97 
REFERENCES 
1. F. C. Brown Chemical Review, 1961,464-511. 
2. S.P. Singh, S.S. Parmar, K. Raman and V.I. Stenberg, Chemical Review, 
1981, 175-203. 
3. K.A. Zolotoreva and L.A. Pugacheva, Voronezh 1964, 5. Chem. Abstr. 
1966,65, 18765. 
4. (a) G.Danila, Review Chim. (Bucharest), 1978, 29, 820; Chem. Abstr., 
1979, 90, 72086 p.; (b) ibid, 1978, 29, 1152; Chem. Abstr, 1979, 90, 
152037 p. 
5. N.C. Desai, Dipika Dave, M.D. Shah and G.D. \^as, Indian. J. Chem., 
2000, 39B, 277-282. 
6. (a) J. Mohan; V.K. Chada; H.S. Chaudhry; B.D. Sharma and H.K. Pujari 
et al., Indian J. Exp. Biol, 1972, 10, 37. (b) H.Y. Hassan; N. El-Koussi 
andZ.S. Farghaly, Chem. Pharm. Bull. 1998, 46, 863. 
7. S.B. Desai, RB. Desai, K.R Desai, Asian. J. Chem. 1999,15(2), 363-365. 
8. R.C. Sharma and D. Kumar. J. Indian. Chem. Soc., 2000, 77, 492-493 . 
9. E. Piscapo, M.V. Diumo, R. Gagliardi and 0 . Mazzoni, Boll. Soc. Ital. 
Biol Sper, 1989, 65 (9), 853-859. 
10. (a) K.J. Mehta, A.C. Chawda and A.R. Parikh, J. Indian Chem. Soc., 
0 
1979; LVI, 173. (b) C.D. Daulatbad, G.G. Bhat, Indian J. Heterocycl 
Chem., 1999, 9(2), 157. 
11. L. Hui-Ling; L. Zong Cheng; A. Thorleif, Molecules, 2000, 5(9), 1055-
1061, http://www.mdpi.org/molecule/papers/50901055.pdf. 
98 
12. C.R. Harris and S.A. Tumbull Can. Entomol., 1977, 109, 1109. 
13. D'Silva and D.J. Themistocles, U.S. Patent 760629 (1976); Chem. 
Abstn, 1977, 86, 29794y . 
14. T.Z. Salnai, Acta Phytopathol. Acad. Sci. Hung., 9, 125 (1974); Chem. 
Abstr., 1975, 83, 23396m. 
15. (a) T. Takematsu, M. Furushima, Y. Hasegawa et al., Japanese Patent 
7243812 (1972); Chem. Abstr., 1973, 79, 143522 p. (b) T. Takematsu, 
K. Yokoyama, K. Ikeda, Y. Hayashi et al., Japenese Patent 75121431 
(1975); Chem. Abstr., 1976, 84, 26880 w. 
16. E.A.S. Lacroix, British Patent 1 3 9 0 5 5 0 ( 1 9 7 5 ) ; Chem. Abstr., 1 9 7 5 , 
8 3 , 9 2 3 9 5 X . 
17. J. M. Cox, J. M. Clongh, N.J. Barnes, D.P.J. Pearson, I.R. Mathews, 
S.K. vohra, S.C. Smith, G. Mitchell and R.A. Barbe, PCTInt. Appl. WO 
9533, 719 (1995); Chem. Abstr, 1995, 124, 261022w. 
18. M. Takano, M. Enomoto, K. Saito and S. Kizawa, Japanese Patent 
07,304,759 (1995). Chem. Abstr, 1997, 124, 202239z. 
19. a) R.C. Gupta, R. Nath, K. Shanker, K.R Bhargava and K. Kishor, J. 
Indian Chem. Soc., 1978, LV, 832; b) RA. Ragab, N.M. Bid, H.A. El-
Tawab, Pharmazie 1997, 52, 926. 
20. (a) W.M. McLamore, W.D. Celmer, V.V. Bogert, RC. Pennington, I.A. 
Solomons, J Am. Chem. Soc., 1952, 74, 2946. (b) W.M. McLamore, 
W.D. Celmer, V.V. Bogert, RC. Pennington, B.A. Sobin, I.A. Solomons, 
J Am. Chem. Soc., 1953, 75, 105. (c) W.M. McLamore, W.D. Celmer, 
V.V. Bogert, RC. Pennington, and I.A. Solomons, J. Am. Chem. Soc., 
1953, 75, 109. 
99 
21. H. Oza, D. Joshi and H. Parekh, Indian J. Chem., 1998, 37B, 822-824. 
22. K. Raman, B. R. Pandey, J.R Barthwal and K.R Bhargava, Res. 
Commun. Chem. Path. Pharmacol., 1977, 18, 765. 
23. (a) M.M. Hansen, A.R. Harkness, V.V. Khan and M.J. Martinelli, PCT 
Int. Appl. W09619466 (1996) Chem. Abstr., 125, I42717n (1996). 
(b) M.M. Hansen, A.R. Harkness, and S.M. Rentzel, Eur. Patent 
EP761656 (1995), Chem. Abstr., 1997, 126, lllAlOi. 
24. A. Kumar, T. Ram, R. Tyagi, B. Goel, E. Bansal and V.K. Srivastava, 
Boll. Chem. Farm., 1998, 137(5), 152-156. 
25. T. Previtera, M.G. Vigorita, G. French and C. Zappala, Farmco., 1994, 
49(10), 33-40. 
26. J. Kropcho, U.S. 4, 053471 (Cl.544-133; C070295/14), 11 Oct 1977, 
Appl. 740, 705, 11 Nov 1976; 4pp. Chem. Abstr., 1977, 88, 22888q. 
27. M. Kakakami, K. Koya, T. Ykai, N. Tatsuta, A. Ikegawa, K. Ogawa, T. 
Shishido and L.B. Chen, J. Med. Chem., 1997, 40(20), 3151-3160. 
28. P. Monforte, S. Grasso, A. Chimirri, G. Fench, Fharmaco, Ed. Sci. 
1981, 36(2), 109. 
29. M. Chaudhry, S.S. Parmar, S.K. Chaudhry, A.K. Chaturvedi and B.V. 
Ramasastry, J. Pharm. ScL, 1976, 65, 443. 
30. (a) N.J. Hrib and J.G. Jurcak, J. Med Chem., 35(14), 2712-2715 
(1992); (b) N.J. Hrib and J.G. Jurcak, US Patent 5,229,388 (1993), 
Chem. Abstr., 1994, 120, 270452f. 
31. N.J. Hrib, J.G. Jurcak, D.E. Bregna, K.L. Burgher, H.B. Hartman, 
S.Kafka, L.L. Kerman, S. Kongsamat and J.E. Roehr, J. Med. Chem., 
1996, 39(20), 4044-4057. 
100 
32. A. Grafe, H. Leibig and G. Dransch, German Patent 2,151,229 (1973); 
Chem. Abstr, 1993, 79, 9921q. 
33. J.L. Krans, J.C. Graciet and M. Gamberono, PCT Int. Appl. 
W09734891 (1996), Chem. Abstr., 1997, 127, 307620g. 
34. J.C. Graciet, V. Niddam, M. Gamberoni, C. Tarabans, J. Dessolin, M. 
Medon, N. Mourier, F. Zonlim and C. Borel, Bioorganic. Med. Chem. 
Lett., 1996, 6(15), 1775-1780. 
35. R. Shyam and I.C. Tiwari, Bull. Chem. Soc. Jpn., 1977, 50, 514. 
36. A.K. Dimri and S.S. Parmar, J. Heterocycl. Chem., 1978, 15, 335. 
37. S. Nagar, H.H. Singh, J.N. Sinha and S.S. Parmar, J. Med. Chem., 1973, 
16, 178. 
38. N.Ergene and G. Capan, Farmaco., 1994, 49(6), 449-451. 
39. R. Girandon, French Patent 2,108834 (1972); Chem. Abstr., 1973, 79, 
32040K. 
40. R. Aries, French Patent 2,186,245 (1974); Chem. Abstr, 1974, 81, 
140869n. 
41. S.S. Parmar, C.Duivedi, A. Chaudhry and T.K. Gupta, J. Med. Chem., 
1972, 15, 99. 
42. M.V. Diurno, O. Mazzoni, A.A. Izzo and A. Bolognese. II Farmaco, 
1997, 52, 237. 
43. M. Missbach, Eur Pat. Appl., 1993, EP 548,017 (CI. 07D417/12). 
44. Y. Natsume, N. Imanishi, H. Koike and S. Morooka, Arzneium-Forsch, 
1994, 44(11), 1208-1213. 
101 
45. (a) Y. Tanabe, H. Yamamoto, M. Murakami, K. Yanagi, Y. Kubota, H. 
Okumura, Y. Sanemitsu and G. Suzukamo, J. Chem. Soc. Perkin Trans 
I, 1995, 7, 935. (b) Y Tanabe, Y Komuro, N. Imanishi, S. Morooka, M. 
Enomoto, A. Kojima, Y. Sanemitsu and M. Mizutani, Tetrahedron. 
Lett., 1991, 32, 379-382. 
46. M.V. Diurno, 0 . Mazzoni, G. Correale and I.G. Monterry, Farmaco., 
1994, 54(9), 579-583. 
47. T. Previtera, M.G. Vigorita, M. Bisila, F. Orsini, F. Benetolla, G. 
Bombieri, Eur. J. Med. Chem., 1994, 2 9 ( 4 ) , 317-324. 
48. Y. Tagami, T. Yamaguchi, J. Kubo, J. Shimozono, K. Yonemuna and M. 
Mukai, Japanese Patent 0 9 , 0 3 , 0 6 7 ( 1 9 9 7 ) , Chem. Abstr., 1 9 9 7 , 1 2 6 , 
1 7 1 5 9 2 U . 
49. H. Ueno, T. Oe, I. Snehiro and Nakamura, US. Patent 5594116 (1997), 
Chem. Abstr, 1977, 126, 157507p. 
50. B. Valleskey, M. Juliana, D.C. Hunder, C.D. John. J.A. Panetta and W.N. 
Shaw, Eur Patent 587377 (1994), Chem. Abstr, 1994, 121, 35596t. 
51. D.A. Walsh and I.M. Uwaydah, US Patent 5061720 1991; Chem. 
Abstr, 1992, 116, 59362m. 
52. T. Kato; T. Ozaki and K. Tamura, J. Med Chem., 1999, 42, 3134. 
53. N.A. Castle M. Gross and J.S. Mendoz, PCT Int. Appl. WO 99 62891 
(C1.C07D277/14) US. Appl., 1999, 307, 708. 
54. S.P. Sahoo, C. Santini; J.K. Bouers, K. Julia; J.V. Heck E. Metzger and 
V.K. Lobardo, PCT Int. Appl. WO 0078, 312 (CI.A61K31/421), 28 
Dec. 2000, US. Appl. PV 139, 953, 18 June 1999; 140 pp. Chem. 
Abstr, 2001, 134, 71589V. 
102 
55. T. Kato, T. Ozaki, K. Tsuzuki and N. Ohi. Org. Process Res. Dev., 2001, 
5(2), 122-126. 
56. S.K. Chugai, K. Tamura, Y. Suzuki and M. Akima, PCT Int. Appl. WO 
96, 19, 210, 1996, Chem. Ahstr., 1996, 125, 142718. 
57. T. Kato and T. Ozaki, PCT Int. Appl. WO 95,00,471 (1995); Chem. 
Abstr., 1995, 122, 29084j. 
58. M.Y. Ebeid, O.A. Fathallah, M.I. El-Zaher, M.M. Kamel, W.A.M. Abdon 
and M.M. Anwar, Bull. Fac. Pharm., 34(2), 125-135 (1996), Chem. 
Abstr., 1997, 126, 180829d. 
59. A.K. Padhy, V.L. Nag and C.S. Panda, Indian J. Chem., 1999, 38B(8), 
998-1001. 
60. M.G. Vigorita, S. Grasso, M. Zappala, R. Ottana, M.T. Monforte, R. 
Barbara, A. Trovato, Farmaco., 1994, 49(4), 271-276. 
61. K. Mogilaiah; R R. Reddy; R.B. Rao; Indian J. Chem., 1999, 38B, 495-500. 
62. S. B. Kalaiya and A.R. Parikh, J. Indian Chem. Soc., 1987, LXIV, 172-
175, 1987. 
63. R.R. Astik, G.B. Joshi and K.A. Thaker, J. Indian. Chem. Soc., 1975, 
52, 1071. 
64. S.R. Maynard, J. Heterocycl. Chem., 1974, 587-593. 
65. T. Kato, T. Ozaki, K. Tsuzuki, PCT Int. Appl. WO 02 08,208 (CI. 
C07D277/14), 31 Jan 2002, JP Appl. 2000/225, 686, 26 Jul 2000; 36 
pp. (Japan). Chem. Abstr., 2002, 136, 134756m. 
66. Asini, Abdullah Mohaned, Molecular 2001, 6(6), M213 http:// 
www.indpi.org/M0/bank/M0213 .htm. 
103 
67. M. Kidwai, N. Negi and P. Misra, J. Indian. Chem. Soc., 2000, 77, 46-47. 
68. Y. Tanabe, M. Nagoasa, Y. Nishii, Heterocycl, 1995, 41(9), 2033-2042. 
69. H. Oza, D. Joshi, H. Parekh, Indian J. Chem., 1998, 37B, 822-24. 
70. R.S. Lodhi, S.D. Srivastava, S.K. Srivastava, Indian J. Chem., 1998, 
37B, 899-903. 
71. H.D. Joshi; P.S. Upadhyay and A.J. Baxi, Indian J. Chem., 2000, 
39B(12) 967-970. 
72. K. Mogilaiah, R.B. Rao and G.R. Sudhakar, Indian J. Chem., 2001, 
40B(4); 336-338. 
73. E. Bansal, J. Ram, S. Sharma, M. Tyagi and A.P. Rani, Indian J. Chem., 
2001, 40B, 307. 
74. (a) A.R. Surrey, J. Am. Chem. Soc., 1947, 69, 2911; (b) ibid. 70, 4262 
(1948); (c) ibid, 71, 3105, 3354 (1949); (d) A.R. Surrey and R.A. 
Cutler; (e) ibid, 1954, 578. 
75. F.A. Nasirullah, S.M. Osman and W. Pimlott, J. Am. Oil. Chem. Soc., 
1982, 59, 411-414. 
76. Nasirullah, F. Ahmad and S.M. Osman, J. Am. Oil Chem. Soc., 1982, 
59(10), 411-414. 
77. A.N. Dzhan e/z hapanyan; A.A. Avetisyan; A.A. Ogonesyan; M.T. 
Dagyan, Khim. Geterosikl. Soedin., 1981 (4), 75-6, 95. 
78. K. Pilgrim and G.E. Pollard, J. Heterocycl. Chem., 1977, 14, 1029. 
79. Osaka, Yoshiaki, Bern. Offen 3,026, 053 C( CI. C07D277/14), 05 Feb 
1981, Japan: Appl 79/87, 056, 09 Jul 1979; 25 pp. Vol. 16, 2002. 
104 
80. S. Satsumabayashi, S. Moroki, BC. Murata and A. Takahashi, Synthesis, 
1977, 881. 
81. (a) K.C. Joshi, A. Dandia and N. Ahmed, Indian J. Chem., 1989, 28B, 
639-641; (b) K.C. Joshi, R. Patni and P. Chand, Heterocycles, 1981, 
16, 1551. 
82. Z. Paryzek and M. Kielczewski, Bull. Acad Polon. Sci. Sen Sci. Chim., 
1975,23,9. 
83. Shafiullah and H. Ali, J. Steroid Biochem., 1980, 13, 467. 
84. M.S. Al-Thebeiti and M.F. El-Zohry, Indian J. Chem., 1998, 37(B), 
804-809. 
85. G. Satzunger, Leibigs An. Chem., 1963, 665, 150. 
86. P. Monforte, G. Fennech, M. Basil, P. Ficarra and A. Silvestro, J. 
Heterocycl. Chem., 1979, 16, 341. 
87. P.S. Upadhyay, R.N. Vansdadia and A.J. Baxi, Indian. J. Chem., 1990, 
29B, 793-796. 
88. M.T.M., EI-Kiassimy, A.M. Rahman, G.A. El-Sarat and A.K. Mahmad, 
Pure. Appl. Sci. Bull, 1992, 8, 1-12. 
89. A.K. Dimri and S.S. Parmar, J. Heterocycl. Chem., 1978, 15, 335. 
90. O.A. El-Sayeed and H.Y.Aboue Enein, Arch. Pharm., 2001, 334(4), 
117-120. 
91. C. Dwivedi, T.K. Gupta and S.S. Parmar, J. Med. Chem., 1972, 15, 553. 
92. V. N. Chaubey and H. Singh, Bull. Chem. Soc. Jpn., 1970, 43, 2233. 
93. H.Y. Hasan, N.A. Al-Koussi and Z.S. Farghaly, Chem. Pharm. Bull., 
1998, 46(5), 863-866. 
105 
94. Shamsuzzaman, A. Salim and M. K. Akram, Indian J. Chem., 1999, 
38B, 1218-1220. 
95. (a) J. Mohan, Anupama, A. Kumar, A. Kumar and D. Khetar, Indian J. 
Heterocycl. Chem., 2000, 9(4), 251-254; (b) J. Mohan, G.S.R. 
Anjanayelu and D. Madan, Indian Chem. Soc., 1991, 68, 252. 
96. R. Sharma, S. Kumar and H.K. Pujari, Indian J. Chem., 1990, 29B, 
440-442. 
97. V. Peesapati and G. Rupavani, Indian J. Chem., 1998, 37B, 468-472. 
98. Rampal, R.N. Handa and H.K. Pujari, Indian J. Chem., 1994, 33B, 
520-525. 
99. M. A. Salama and S.A. El-Essa, Indian J. Chem., 2001, 40B, 678-681. 
100. V. Peesapati and G. Rupavani, 1998, 37B, 468-472. 
101. A.F. Minka, Farm. Zh., 19, 47 (1964), Chem. Abstr., 1966, 64, 3514c. 
102. S.C. Mahukar, M.R Aslam, S.B. Ambhaikar, Indian. J. Chem., 2000, 
39B, 603-609. 
103. A.N. Arakelian, H. Dunn, L.L. Grieshammer and L.E. Cokman, J. Org. 
Chem., 1960, 25, 465. 
104. R. Deghengi and G. Daneault, Can. J. Chem., 1960, 38, 1255. 
105. J.R Trivedi, S.J. Contractor and I.D. Shah, J. Indian. Chem. Soc., 1966, 
43, 265. 
106. V. Kishore, N.K. Narain, S. Kumar and S.S. Parmar, Pharmacol. Res. 
Commun., 1976, 8, 43. 
107. (a) H. Nagase, Chem. Pharm. Bull, 1973, 21, 270; (b) ibid, 1973, 
21, 279. 
106 
108. (a) N.P. Buu-Hoi and D. Lavit, J. Org. Chem., 1955, 20, 1191. (b) N.P. 
Buu-Hoi and D. Lavit, J. Chem. Soc., 1958, 1721. (c) N.P. Buu-Hoi, 
T.B. Loc and N.D. Xyong, J. Org. Chem., 1958, 21, 1458; (d) N.P Buu-
Hoi and N.D. Xyong, Bull. Soc. Chem. France, 1958, 758; (e) N.P. 
Buu-Hoi, N.D. Xuong and F. Binon, J. Chem. Soc., 1956, 713. 
109. (a) VS. Ingle, A.R. Sawale, R.D. Ingle, R.A. Mani, Indian J. Chem., 
2001, 40B(2), 124-128; (b) K.C. Joshi, V.N. Pathak and R.K. 
Chaturvedi, Pharmazie, 1986, 41, 634. 
110. H. Tamiyama, Y. Tanaka and H. Uchida, J. Pharm. Soc. Japan, 1956, 
76, 147-149. 
111. A.H. Siddiqui, K. V Rao and D. Ramesh, Indian J. Chem., 1989, 28B, 
762-763. 
112. Y. Tomita, T. Ohkawara, T.Yamasaki and M. Furukawa, Heterocycles, 
1990, 31(12), 2139-2145. 
113. M. Tisler, S. Vestnik, Kemi. Drustva 4, 91 (1957), Chem. Abstr, 1960, 
54, 12111. 
114. S. Mukhtar, M. Rahman VP, W.H. Ansari, G. Lemiere, A. De Groot and 
R. Dommisse, Molecules, 1994, 4, 232-237. 
115. A. Levai, Monatshefte fur Chemie, 1991, 122, 127-129 and references 
therein. 
116. G. Solati, J. Pharm. Sci., 1975, 64, 355. 
117. A. Xichena, J.E. Ombetta, J. Navarro, J. F. Robert, J.J. Panouse, Eur. J. 
Med Chem., 1979, 523. 
118. Basic Terminology of Stereochemistry (lUPAC Recommendations 
1996) http.V/www.chem.qmw.ac.uk.iupac/stereo/. 
107 
119. The relative configuration of (3) is depicted according to a proposal of 
H. Maehr[120]. 
120. H. Maehr, J. Chem. Ed. 1985, 62, 114. 
121. M. Karplus, J. Chem. Phys. 1959, 30, 11. 
122. W. Davey, J.R. Gwilt, J. Chem. Soc., 1957, 1017. 
123. A.I. Vogel "A Text Book of Practical Organic Chemistry", Longman 
London, edition, 1978. 
Chapter - 2 
3y5'Disubstituted''2''Pyrazolinyl-
Thiocarboxamides 
Theoretical 
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THEORETICAL 
Pyrazolines belong to an important class of biologically active five 
membered heterocyclic compounds containing two nitrogen atoms at 1,2 
positions and one double bond in the ring. There are three isomeric forms of 
pyrazolines as A^-(I), A^-(II), A^-(III) depending upon the positions of double 
bond. 
R4 R3 
R4'-
Rs-
OD 
N 
R4'-
Rs-
Rs' 
1 
R3 R4, 
Ri 
N Rs-
(m m 
t 
NR, 
Ri = R2 = R3 = R3' = R4 = R4' = R5 = R5' = H or alkyl or aryl. 
Pyrazoline derivatives have been studied extensively because of their 
ready accessibility, diverse chemical reactivity, broad spectrum of biological 
activity and variety of industrial applications'"^. A study on pyrazolines still 
is an intriguing subject because of their varied bioactive nature. Pyrazoline 
derivatives are known to possess various biological activities, such as 
antibacterial^-'antifungal'insecticidal^' '-^^ pesticidal '^^ -^^ herbicidal''3-^^ 
acaricidal^^ antiinflammatory'''^-^^, analgesic'^ ®'^ ^, arthropodicidal^®"^'', 
antiallergic^^, anti-histaminic^^, diuretic^'', mildewicidal^^, antiviral^^, 
antitumor and anti-HIV activity''®-^', anti-depressant'^^-'^^ hypoglycemic 
activity^"*-^ .^ It has been reported that introduction of 1-acetyl group at 
1-position enhances the molluscidal a c t i v i t y a s well as increases the 
stability of 2-pyrazolines and substitution at 3-position in indole nucleus with 
different moieties markedly affects the hypotensive activity^®'^ ^. A number of 
pyrazoline derivatives has also been found to exhibit highly potent as 
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cerebroprotective action^ '^® .^ Pyrazoline derivatives substituted at 1-position 
are reported to be cardiovascular agents^^"^''. Also, l-aryl-2-pyrazolines are 
found to be useful as antioxidant composition in polymer^^ and in the 
treatment of cerebral edema® .^ Pyrazoline nucleus attached to indole ring 
systems have been shown to exhibit monoamine oxidase inhibitor activity^®. 
Several haloanilido pyrazolines are used in textile and cinematographic film 
industry. ^ ^ 
Different methods are reported in literature for the preparation of 
pyrazoline derivatives. Mannich and Heilner^^ have prepared pyrazoline 
derivative (IV) by the cyclization of p-hydrazino carbonyl in acetic acid and 
methanol in presence of Zn. 
\ / -COCH2CH2NHCH3 ^ d - \ ^COCH^CH^NCHs 
i) Zn NO 
ii) AcOH 
iii) MeOH 
T / \ 
I 
CH3 
N 
(IV) 
Curtius et have reported the synthesis of pyrazoline derivative (V) 
by the cyclization of azine of methyl ketone with maleic acid. 
CH3 
C2H5 C2H5 
maleic acid 
H3 
C2H/ 
A 
C2H5 
H 
N 
(V) 
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F. Kallay et al.^'^ have synthesized 3-(o-hydroxyphenyl)-5-
phenylpyrazoline (VI) by heating flavanone with hydrazine hydrate in ethanol. 
ONHiNHj-HjO 
ii)aOH/A 
+ 
(V?) 
Some new 4-aroyl-substituted pyrazolines^^ (VII) have been synthesized 
by the condensation of hydrazine hydrate or phenylhydrazine hydrochloride 
with 3-aroylflavanones in pyridine. 
a R I = R 2 = H 
b R, = H, R2 = OCH3 
c R, = 0CH3,R2 = H 
ONH2NH2H2O/ 
PhNHNHjJia 
. ii^  Pyridine/Reflux 
(yH) 
a 
b 
c 
d 
e 
f 
R, = R2 = R = H 
R, = R = H,R2 = 0CH3 
R, = 0CH3,R2 = R = H 
R, = R2 = H,R = Ph 
R, = H,R2 = OCH3,R = Ph 
R, = OCH3,R2 = H,R = Ph 
Ill 
M.G. Joshi et al.^^ have synthesized 3,S-diaryl-l-phenyl pyrazolines (VIII) 
from chalcones or a,p-dibromochalcones by reacting with phenyl hydrazine 
hydrochloride in DMF. 
Ph.NHNH2.Ha 
inDMF/A 
PhNHNH2.Ha 
inDMF/A 
R2 
(VIII) 
^^  / \ -R5 
Ri R2 R3 R4 Rs 
a OH H H CH3 H 
b OH H H CH3 OCH3 
c OH Br H CH3 H 
(1 OH Br H CH3 OCH3 
e OH H H H H 
f OH H H H OCH3 
g OH H CH3 H OCH3 
h OH H CH3 H OCH3 
i H H H H H 
j H H H H OCH3 
Kirpa Shanker and co-workers^^ have synthesized l-acetyl-5-aryl-3-[o-
(indol-S-yl-methyleneamino) phenyl]-2-pyrazolines (IX) by the cyclisation of 
substituted-2'-(indole-3-yl-methyleneamino)chalcones with hdyrazine hydrate 
in presence of glacial acetic acid. 
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H 
ONHZNHzHJO 
ii)AcOH 
iii)aOH/A 
COCH=CH- / \ 
R 
a R = 2-For3-Cl 
b R = H,2-0CH3 
R.J. Cremlyn et al}^^ prepared 3-phenyl-5-(4-N-methylhydrazino-
sulfonyl-a-naphthyl)pyrazoline (X) and 3-phenyl-5-(4'-hydrazinosulfonyl-a-
naphtyl) pyrazoline (XI) from 4-chlorosulphonyl-a-naphthyl chalcone by 
reaction with hydrazine hydrate and //-methyl hydrazine in methanol at room 
temperature.-
/ \ -CH—CHOOPh QQ^g—^ X^—cH=CHOOPh 
\ / 
dSOjH 
Ice-bath (24 h) 
0 N2H4.H2O/ 
iOMeOH 
\ / 
i) MeNHNHz/ 
ii)MeOH 
MeNHNHOzS 
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Thiazolyl-pyrazoline derivatives^®' (XII) were prepared by the reaction 
of 2-arylamino-5-(3'-aryl/heteroaryl-acrylo)-4-methylthiazoles with 
hydrazine hydrate in ethanol in presence of acetic acid. 
CH, 
R, / \ CXXH=CH—Rj 
i) NHjNHJ-HJO 
iO ROH/AcOH/A 
R. / \ 
N—NH 
poi) 
Ri = H or Br or CI or Me or 
OMe or OEt 
R2 = Substituted phenyl or 
2-Furyl or 2-Pyridyl or 
2-Thienyl 
V.G. Thakare et have synthesized 5-aryl-3-(2-hydroxyphenyl)-A^-
pyrazolines (XIII) by heating 2'-hydroxy chalcones with hydrazine hydrate in 
ethanol while in acetic acid the corresponding 5-aryl-l-acetyl-3-(2-
hydroxyphenyl)-A^-pyrazolines (XIV) were obtained. However, 2'-
hydroxychalcones react with hydrazine hydrochloride in DMF to give the 
isomeric 3-aryl-5-(2-hydroxyphenyl)-A^-pyrazolines (XV). 
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M. Ahmad and have prepared pyrazoline derivatives 
(XVI) by heating methyl 4-oxooctadec-2(£)-enoates with phenyl hydrazine in 
benzene and acetic acid, which were screened for their antibacterial and 
antifungal potential. 
OCH3 
i) Y—NHNHj 
ii) Ben2Bne/AcOH/A 
OCH, 
R = CH3(CH2)I2. 
Y = H, Ph, CHsPh 
3-aryl-5-aryl/heteroaryl-4-arylsulphonyl pyrazolines (XVII) and 3-aryl-
5-aryl/heteroaryl-4-aryl sulphonyl-1-phenyl pyrazolines (XVIII) have been 
synthesized by the condensation of chalcones with hydrazine hydrate and 
phenyl hydrazine in ethanol and these compounds have been tested for their 
different biological activities.'®^ 
R, 
X r - ^ J W \ -c—CH2—s-
II II 
o o 
-R' 
i)R"CHO 
ii)EtOH/A 
Rv R"CH 
\ c—c- / \ -R 
O O 
ONHJNHZ.HZO 
ii)EtOH/A 
OPhNHNHz 
ii)AcOH/EtOH/A 
7 
N. 
R =H,CH3 
R' =H,CH3andCl 
R" = Substituted phenyl and 
heteroaryl 
Ph 
(XVII5 
O 
II 
-s- / \ -R 
R' „ O 
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A number of pyrazoline d e r i v a t i v e s ^ ^ ' ^ 5 . 7 7 . 7 9 , 8 7 , i 0 6 - i i i (XIX, XX) have 
been prepared from different chalcones using hydrazine hydrate or phenyl 
hydrazine and acetic acid. Some of these compounds showed potential 
biocidal activities. 
V n 
i)NH2NH2H20 
u)HOH/A 
a R=2'-0H 
b R = 2'-OH-5'-Cl 
c R=2'-OH-5'-Br 
d R = 2'-0H-4'-CH3-5'-C1 
e R=2'-OH-3',5'-Cl2 
\ 
i)HiNHNH2 
O 
Rv 
V n 
(XK) 
, a R = 2'-0H 
' b R = 2'-0H-5'-CH3 
c R = 2'-OH-5'-Cl 
d R = 2'-OH-5'-Br 
e R = 2'-0H-4'-CH3-5'-C1 
f R = 2'-OH-3',5'-Cl2 
I ~Ai 
CfiHs 
A.R. Parikh and co-workers^have synthesized different pyrazoline 
derivatives (XXI-XXIII) by heating chalcones and hydrazine hydrate or 
phenyl hydrazine in ethanol. 
f \ C—CH=CH—R 
SO2.NH- / \ 
(xxn) N Ph 
// \ ^ ~ CfiHs, S-Br-CfiRi, 
^ \ 2/4-CI-C6H4, 
(XxnQ 
2-OCH3-C6H4, 
3,4,5-(0CH3)3-C6H2, 
4-OCH3-C6H4 
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B.S. Holla et al} have synthesized aryl furyl pyrazolines (XXIV) by 
heating arylfuryl propenones with hydrazine hydrate in dioxane and were 
tested for antibacterial activity. 
i) NH2NH2H2O 
ii) Diojane/A 
R 
\ T 
/ \ 
H ' ^ a-
(XXIV) 
-a a 
b 
c 
(1 
e 
R 
/7-NO2 
p-Br 
p-Cl 
m-NOj 
0-NO2 
V. Auwers et a/.^^^ have synthesized pyrazoline derivatives (XXV-
XXVIII) from a,P unsaturated esters and diazomethane. 
HJXOzCH, 
CH3O2CCH + CH2N2 
H H 
CH3O2C- \ -OO2CH3 
N 
(XXV) 
rearrangement 
t 
H 
CH3O2C-
1 
CO2CH3 
.N 
H 
(XXVI) 
117 
H3aX02CH3 
HCC02CH3 
+ CH2N2 HbCOZC-
H3C02C 
H CH3 
CX)2CH3 
f^  (xxvn) 
C02CH3 
CH.B. Rao et aO'^^ have prepared 3-aroyl-4-aryl-A2-pyrazolines (XXIX) 
through cycloaddition of diazomethane with chalcones. These compounds 
exhibit mild local anaesthetic, CNS depressant, and anticonvulsant activities. 
R Ri R2 R3 
a H H H H 
b H H H OCH3 
c H OCH3 H H 
d H NO2 H H 
e H H NO2 H 
f NMez H H OCH3 
g NMcz H H H 
h OCH3 H H H 
i NO2 H H H 
j OCH3 H H OCH3 
k NO2 H H OCH3 
1 -OCH2O- -OCH2O- H H 
m H H H NO2 
H 
i) CH2N2 
ii) CHa3/®C 
(XXK) 
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A.K. Fateen et al}^^ have synthesized A'-spiropyrazoline derivatives (XXX) 
by heating 2-arylidene-tetralones with diazomethane or diazoethane in 
benzene. 
O 
R'v 
Ben2Bne/A 
+ R"CHN2 »-
R R 
R R' Ar 
a H CH3 Ph (XXX) 
b H CH3 p-MeOC6H4 R R' R" Ar 
c H CH3 PhCH=CH a H CH3 H Ph 
d H CH3 /j-NOjCfiHt b H CH3 CH3 ;j-MeOC6H4 
e H CH3 2-furyl' c H CH3 CH3 PhCH=CH 
f CH3 CH3 Ph d H CH3 CH3 2-Furyl 
g CH3 CH3 PhCH=CH e CH3 CH3 H Ph 
h CHj CH3 /j-MeOCsEj f CH3 CH3 H PhCH=CH 
i CH3 CH3 ;?-N02C6H4 g CH3 CH3 H ;7-MeOC6H4 
j CHj CH3 2-furyl2 h CH3 CH3 CH3 2-Furyl 
k H Ph Ph i H Ph CH3 Ph 
1 H Ph /)-MeOC6H4 j H Ph H ;?-MeOC6H4 
m H OMe Ph k CH3 CH3 CH3 PhCH=CH 
1 CH3 CH3 CH3 /?-MeOC6H4 
m H CH3 CH3 Ph 
n CH3 CH3 CH3 Ph 
Recently, R. Raghunathan and c o - w o r k e r s ^ h a v e prepared a series of 
novel spiropyrazolines [5.9^] anthrones (XXXI, XXXII) by regioselective 
1,3-dipolar cycloaddition of diphenylnitrilimine with 9-methyleneanthrone or 
9-arylideneanthrone in chloroform. 
0 
a 
i) ajN 
-NH—QHs 
ii) CHaj/RDomTenp. 
N—QH5 
5 (XXX^ 
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+ QHs^^N—NH—QHj 
a 
OB3N 
iO CHas/RoomTenp 
R = HorMeorNMez 
a,a'-Bis[spiro(4-aryl-l-pyrazoline)]cycloalkanones^'^'^^® (XXXIII) have 
been synthesized through cycloaddition of diazomethane with 
a,a'-diarylidenecycloalkanones in chloroform 
.(CH2)„ 
RHC= 
0 
n R 
a 3 C6H5 
b 3 3-NO2-C6H4 
c 3 3,4-(0CH3)2.C6H3 
d 3 2,4-{0CH3)2.C6H3 
e 3 3,4-(02CH2).C6H3 
f 3 4-C1.C6H4 
g 3 2-C1.C6H4 
h 3 4-(CH3)2N.C6H4 
i 3 2-Furyl 
j 2 CfiHs 
k 2 3,4-(0CH3)2.C6H3 
1 2 2-Furyl 
m 2 2-CI.C6H4 
0CHa3/°c 
Hm--
pcxxn^ 
F. Al-Omran et have also synthesized bis(2-pyrazoline) 
derivatives (XXXIV) by 2,6-dicinnamoyl pyridines or 1,3-dicinnamoyl-
benzenes with phenyl hydrazine. 
120 
X = CH,N 
a Ar = Ph 
b Ar = 2-C1C6H4 
c Ar = 4-MeC6H4 
d Ar = 4-MeOC6H4 
e Ar = 2,4-(MeO)2C6H3 
f Ar = C4H3S(2-Thienyl) 
g Ar=C4H30(2-Fuiyl) 
Ar 
i)PhNHNH2 
ii) AcOH/A 
Pyridine/A 
(XXXIV) 
A.H.M. Elwahy'^^ have prepared bis(4,5-dihydropyrazolyl) ethers (XXXV) 
by condensation of bis(chalcones) with hydrazine hydrate/phenyl hydrazine in 
acetic acid. 
q / i) NH2NH2.H2O 
X 
\ 
Ph-
'N OPhNjHs N. iOAcOH/A ] 
Ph 
Ph 
O 
X = CH2 or (CH2)2 or (^2)4 
X 
(XXXV) 
(XXXV^ 
CXXHj 
-Ph 
N" 
I 
Ph 
N 
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Cyclization of coumarines with N2CHCH (0Me)2 give corresponding 
diastereo fused pyrazolines'^^ (XXXVII). 
CH(MeO)2 
+ N2CHCH(OMe)2 
R=H 
R' = cx)2a (XXXV15 
G. Toth and co-workers'^'' have synthesized several fused benzopyrano 
[4.3-c] pyrazolines (XXXVIII) by the condensation of the appropriate a,P-
unsaturated ketones with methyl or phenyl hydrazines in pyridine. 
i)R2NHNH2 • 
if) Pyridine/A 
(xxxvno 
X Ri 
a CH2 H -
b s H -
c 0 H -
d 0 Ph -
e CH2 H Ph 
f CH2 H Ph 
g s H Me 
h s H Ph 
i 0 H Me 
j 0 H Ph 
k 0 Ph Me 
I 0 Ph Ph 
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Archana et al^^"^ have synthesized l-acetyl-5-substituted aryl-3-(3'-
amino-2'-methyl-6'-monosubstitutedquinazoline-4'(3'H)-onyl]-2-pyrazolines 
(XXXIX) by heating l-[3'-amino-2'-methyl-6'-monosubstitutedquinazolin-
4'(3'H)-onyl]-3-(arylidenyl)chalcones by cycloaddition of hyrazine hydrate in 
methanol and these were tested for anticonvulsant activity. 
N—NHCXXH=CH 
NHiNHj-HjO/gl-acetic acid/ 
nethanol/A 
R X 
1 H H 
2 /j-OMe H 
3 /J-OH H 
4 p-N(Me)2 H 
5 m-OMe, p-OU H 
6 H 6-Br 
7 p-OMe 6-Br 
8 p-on 6-Br 
9 p-N(Me)2 6-Br 
10 m-OMe, p-Q\i 6-Br 
(XXXK) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
R 
H 
p-OMe 
p-OH 
p-N(Me)2 
/w-0Me,/7-0H 
H 
p-OH 
m-OMe, /p-OH 
H 
H 
H 
H 
H 
6-Br 
6-Br 
6-Br 
6-Br 
6-Br 
123 
S.P. Hiremath et a/J^^ ^ave prepared l-(10-substituted-7H-indolo[2,3-
c]isoquinolin-5-yl)-3,5-disubstituted pyrazolines (XXXX) by refluxing 
5-hydrazino-10-substituted-7H-indolo[2,3-c] isoquiolines with appropriate 
arylideneacetophenones in ethanol. 
R R' 
a a CfiHj 
b Me C A 
c Br CfiHs 
discussion 
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DISCUSSION 
SUMMARY 
The work described in this chapter includes the reaction of 
thiosemicarbazide with -
(i) l,5-Bis(3,4-dimethoxyphenyl)pent-l,4-dien-2-one (4) which afforded 
a novel compound, 2-[3-{(3,4-dimethoxyphenyl)ethenyl}-5-{(S,4-
dimethoxyphenyl)}-2-pyrazolin-l-yl]thiocarboxamide SDs (12). The 
thiosemicarbazone (11) formed as intermediate being minor could 
only be detected on TLC (Rf value, shade). 
(ii) l,5-Bis(4-chlorophenyl)pent-l,4-dien-3-one (8) which yielded an 
analogous compound, 2-[3-{2-(4-chlorophenyl)ethenyl}-5-{(4-
chlorophenyl)}-2-pyrazolin-l-yl]thiocarboxamide .SZ)^^ (14) and 
thiosemicarbazone, N^-[l,5-bis(4-chlorophenyl)pent-l,4-dien-3-
ylidene]thiosemicarbazide SD4 (13) as intermediate, both (i & ii) in 
the presence of hydrochloric acid and 
(Hi) l,5-Bis(4-methylphenyl)pent-l,4'dien-3-one (15) in the presence of 
acetic acid which yielded the thiosemicarbazone, N^-[l,5-bis(4-
methylphenyl)pent-l,4-dien-3-ylidene]thiosemicarbazide SD2 (16) as 
the sole product. When this reaction failed to cyclise in acetic acid, 
the above reactions (i) and (ii) have then been carried out in HCl. 
Structures are established on the basis of IR, Mass, ^H-NMR and '^C-
NMR spectral studies. The compounds (12) and (14) have been evaluated 
for anticancer activity and compound (12) for antibacterial activity 
INTRODUCTION 
The synthesis of 2-pyrazolines has received considerable attention 
because of their wide range of applications as antibacterial^"'^, antifungal 
insecticidaP^'^^, antiinflammatory'^^"^^, analgesic"* '^^ ^ antipyretic, 
antiallergic^^, antihistaminic^^, diuretic^"^, antiviral^^, (antitumor activity and 
anti-HIV)'^°''^^ antidepressant"^^""^ ,^ hypoglycemic activity '^'"'^ ^, hypotensive^®'^ ^ 
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and cerebroprotective agents^^'^^, anticonvulsant^^'' and local anesthetic' 
and also industrial applications as activators for polymerization'^^, dyes for 
wool, nylon'^^, electrophotographic photoconductors'^^, wavelength shifters 
in liquid, polymer scintillation'^^ and optical brightners'^°. The reactions of a 
number of a,P-unsaturated ketones with hydrazines forming pyrazolines are 
r e p o r t e d . R e c e n t l y , two groups of researchers, M.E. Elba'^' and Bela 
Rezessy et have also carried out reactions of chalcones with 
thiosemicarbazide to form pyrazolines. However, the analogous reactions with 
a,p-unsaturated dienones have not yet been described. Keeping in view of the 
above findings and as part of our work in search of biologically active sulphur 
and nitrogen containing heterocycles, we have undertaken this problem. It 
consists of the reactions of dienones (i) l,5-bis(3,4-dimethoxyphenyl)pent-
],4-dien-3-one (4) and (ii) l,5-bis(4-chlorophenyl)pent-l,4-dien-3-one{S) 
with thiosemicarbazide in the presence of hydrochloric acid which yielded 
novel compounds, 2-[3-{2-(3,4-dimethoxyphenyl)ethenyl}-5-{(3,4-di-
methoxyphenyl)}-2-pyrazolin-l-yl]thiocarboxamide (12), and 2-[3-{2-(4-
chlorophenyl)ethenyl}-5-{(4-chlorophenyl)}-2-pyrazolm-l-yl]thiocarboxamide 
(14). In the former, the thiosemicarbazone (11) formed as intermediate being 
minor could not be isolated while in the latter, the thiosemicarbazone, N^-
[l,5-bis(4-chlorophenyl)pent-1,4-dien-3-ylidene] thiosemicarbazide 
(13) was isolated in 10% yield, (iii) The reaction of the dienone, l,5-bis(4-
methylphenyl)pent-l,4-dien-3-one (15) with thiosemi-carbazide has been 
carried out in the presence of acetic acid in which the corresponding 
thiosemicarbazone, 1,5-bis(4-methylphenyl)pent-1,4-dien-3-yl idenej 
thiosemicarbazide (16) formed could not cyclize to give the desired product. 
Due to the failure of this reaction in acetic acid medium, the above two 
reactions (i & ii) have then been carried out in the presence of hydrochloric 
126 
acid. The dienones (4), (8) and (15) have been prepared following a reported 
method'^^ by condensing acetone with benzaldehydes (molar ratio, 1:2) in the 
presence of 2.5 equivalents of sodium hydroxide. 
Structural assignments, stereochemistry and biological assay are 
discussed. Screening results of compounds (12) and (14) are summarized for 
anticancer activity against 3-cell lines of three types of human cancers : lung, 
breast and CNS. Screening results of (12) are also summarized for 
antibacterial activity against four bacteria Escherichia coli, Bascillus 
subtilis, Staphylococcus epidermatis and Streptococcus viridans (DETAILS 
IN CHAPTER-6) 
MeQ OMe 
(4) 
CI- / \ 
O 
(8) 
/ \ •CI 
MeQ 
(12) 
MeO 
OMe 
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a-
H, H / V a 
N 
(14) 
Me- -Me 
0 
(15) 
Me-
(12) 
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RESULTS AND DISCUSSION 
The syntheses of compounds (12) and (14) were carried out from the 
corresponding dienones (4) and (8) by reaction with thiosemicarbazide (molar 
ratio, 1:3) in the presence of catalytic amount of conc, hydrochloric acid 
refluxing in ethanol for 10 h. In the former reaction, the uncyclized 
thiosemicarbazone (11)* was so minor that it could only be detected on TLC 
while in the latter, the uncyclized thiosemicarbazone (13) was obtained in 
10% yield. The reaction of dienone (15) was performed in AcOH medium 
where the thiosemicarbazone (16) formed could not cyclize (SCHEME - III). 
R, 
Ri-
o 
(15)R,=Me,R2=H 
NH2CNHNH2 
S O H / A c O i reflux, 10 h. 
(4)Ri=R2 = CMe 
^)Ri=a,R2=H 
3 
I 
NH2CNHNH2 
e Q H « a reflux, 10 h. 
Rr / 
(ll)»[R,=R2=avIe] 
(13)Ri=C1,R2=H 
*not isolated 
+ 
R2 
(12)R,=R2=CMe 
S ^ N H 2 (14)Ri=a,R2=H 
SCHEME - III 
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Mechanism of the above reactions : 
A plausible mechanism for the above reactions may be depicted as 
shown in SCHEME-IV. The 2-pyrazolines (12) and (14) are believed to be 
formed via condensation of the thiosemicarbazide with the carbonyl group of 
dienones (4) and (8) and subsequent cyclization of the so formed 
thiosemicarzones (11) and (13). 
(12), (14) 
SCHEME-IV 
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(i) Reaction of l,5-bis(3,4-dimethoxyphenyl)pent-l,4-dien-3-one 
(4) with thiosemicarbazide in the presence of catalytic amount of 
conc. HCl. [Synthesis of 2-[3-{(3,4-dimethoxyphenyl)ethenyl}-5-{(3,4-
dimethoxyphenyl)}-2-pyrazolin-l-yl]thiocarboxamide S D S A (12)] 
A mixture of 1,5-bis (S,4-dimethoxyphenyl)pent-l,4-dien-S-one (4) 
and thiosemicarbazide (molar ratio, 1:3) in ethanol in the presence of a few 
drops of concentrated hydrochloric acid was refluxed with stirring for 10 h. 
TLC examination (silica gel 'G', benzene-ethylacetate, 8:2 v/v) of the reaction 
mixture showed the formation of two components, one very minor (upper) 
and other major (lower) which was labelled as SDs .^. After usual work up, the 
residue was subjected to column chromatography over silica gel using 
benzene-ethyl acetate (8:2 v/v) as eluent. Elution of the column first 
furnished a minor orange-coloured product which was detected by TLC 
examination to be expected thiosemicarbazone (11) by comparing with the 
thiosemicarbazone SD4 (13) (Rf and shade). The minor product (11) could not 
be recovered. Further elution of the column yielded a dark brown solid which 
on crystallization from benzene-acetone furnished SDs^ as brown crystalline 
needles in 65% yield. 
the reaction sequence is given below -
MeO OMe 
M e O -
o 
(4) 
+ NH,!!;) - O M e  N H j C N H N H j 
(molar ratio, 13) 
E t O H m a , reflux, lOh 
MeO 
M e O - / % 
OMe 
/ \ -OMe 
S^ NHi 
(11)« 
' cou ld not be isolated 
(12) SD 5 A 
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Structure Elucidation of S D J A (12) 
It is a brown needle shaped crystalline solid, m.p. 130 °C and appears 
dark brown on exposure to iodine vapours (TLC). The structure of SD^ A has 
been elucidated by FT-IR, DCI-MS, ^H-NMR and ^^C-NMR spectra. The IR 
spectrum (KBr) displayed characteristic bands at 3447, 3338 (NH), 2934, 
2834 (CH), 1659 (C=C), 1589 (C=N), 1513, 1465 (phenyl), 1345 (C=S), 
1261, 1136 (C-O-C), 1020 (C-N), 961, 805, 759, 612 cm"'. The DCI-MS 
(NH3 as reagent gas) of SD5A(12) (FIG. 25) showed [M+H]"" peak as the base 
peak at m/z 428 (100.0) confirming its molecular weight as 427 
[C22H25O4N3S] which is equal to the sum of molecular weights of l,5-bis(S,4-
dimethoxyphenyl)pent-1,4-dien-3-one (4) (354) and thiosemicarbazide (91) 
minus one molecule of water (18). This indicated that the condensation has 
occurred between l,5-bis(3,4-dimethoxyphenyl)pent-l-4-dien-3-one (4) and 
thiosemicarbazide. A peak at m/z 394 was obtained by the loss of one 
molecule of H2S [(M+1) - HsS]"" and a peak at m/z 368 by the loss of CSNH2 
[(M+1) - CSNHj]^. The peak at m/z 352 [(M+1) - NHjCSNHj]^ arised by the 
cleavage of 1-2 and 1-5 bonds, appeared to be the diagnostic peak of 
pyrazoline ring and a peak at m/z 237 [(M+1) - CiiH]3N02]^ all supported the 
deduced structure. The mode of fragmentation is presented in CHART-8. The 
iH-NMR (FIG. 26) and ^^C-NMR (FIG. 27) spectra of S D J A dissolved in 
acetone-i/g showed signals as assigned (TABLE-9). The assignments of all 
'H-NMR and '^C-NMR signals to individual H- and C-atoms have been 
performed on the basis of typical chemical shift values, multiplicity, relative 
integrations and by comparing spectral data with similar compound SD4A 
(TABLE-10). The ^H-NMR spectrum of compound 805^(12) revealed the 
presence of three double doublets represented by a typical ABX splitting 
pattern due to geminal and vicinal coupling of the two diastereotopic protons 
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(magnetically non-equivalent methylene proton H^, He) at C-4 with the 
methine proton Hx at C-5 of pyrazoline ring.^^^ The two double doublets 
appeared at 53.08 and 3.76 with coupling constants (Jgen,= 17.55 Hz, 
Jvic=3.21Hz) in the former and (Jgem= 17.55 Hz, Jvic= 11.29 Hz) in the latter 
due to the coupling with axial proton at C-5 were assigned to equatorial and 
axial protons of C-4 respectively. The third double doublet at 55.91 with 
coupling constants (J=3.21Hz, J=11.29Hz) due to vicinal coupling with two 
magnetically non-equivalent protons of methylene group at C-4 of pyrazoline 
ring was assigned to axial methine proton of C-5. The large coupling constant 
(J= 11.29 Hz) of protons at C-4 and C-5 showed that they are trans-oriented 
(diaxial, antiperiplanar) to each other. The two trans oriented doublets at 
67.01 (J=16.48 Hz) and 7.04 (J=16.48 Hz) were attributed to ethylenic 
protons at C-T and C-2' respectively. Thus, coupling constant of ethylenic 
protons (J=16.48 Hz) indicated their trans geometry. The signals 63.76, 3.77, 
3.84, 3.87 were assigned to four methoxy groups protons. 'H-NMR spectrum 
also showed significant aromatic signals at 5 6.84 and 6.86 as two doublets 
with J = 2.14 Hz and J = 8.24 Hz for Ar-2 and Ar-5 protons respectively and 
a double doublet at 66.69 with J = 2.14 Hz, J = 8.24 Hz corresponding to Ar-
6. Another aromatic signals at 6 7.26 and 6.96 as two doublets with J = 2.14 
and J = 8.24 Hz were assigned for Ar'-2, Ar'-5 protons respectively and a 
double doublet at 67.12 with J = 2.14 Hz and J = 8.24 was attributed to Ar'-6. 
The '^C-NMR spectrum of S D S A showed the ring carbon signals at 5 136.69 
(C-Ar-1), 111.31 (C-Ar-2), 151.79 (C-Ar-3), 150.52 (C-Ar-4), 113.90 
(C-Ar-5), 118.92 (C-Ar-6) and 5 129.97 (C-Ar'-l), 110.88 (C-Ar'-2), 150.77 
(C-Ar'-3), 149.69 (C-Ar'-4), 112.81 (C-Ar'-5), 118.49 (C-Ar'-6), 56.25 
(4 X C-Ar-0CH3). The '^C-NMR spectral data are thus in agreement with the 
assigned structure. The ^H-NMR and ^^C-NMR spectral data are also in 
agreement with that of similar functional system. 
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On the basis of above evidence, S D S A was characterized as 2-[3-{(3,4-
dimethoxyphenyl)ethenyl}-5-{(3,4-dimethoxyphenyl)}-2-pyrazolin-l-
yljthiocarboxamide (12). 
OMe 
MeO 
S ^ N H , 
(ii) Reaction of l,5-bis(4-chlorophenyl)pent-l,4-dien-3-one (8) 
with thiosemicarbazide in the presence of hydrochloric acid 
[Synthesis of 2-[3-{2-(4-chlorophenyl)ethenyl}-5-{(4-chlorophenyl)}-2-
pyrazolin-l-yl]thiocarboxamide SD4A (14). The uncyclized thio-
semicarbazone, N^-[l,5-bis(4-chlorophenyl)pent-l,4-dien-3-ylidene] 
thiosemicarbazide SD4 (13) was also obtained in poor yield] 
A mixture of l,5-bis(4-chlorophenyl)pent-l,4-dien-3-one (8) and 
thiosemicarbazide (molar ratio, 1:3) in ethanol in the presence of catalytic 
amount of conc. HCl was refluxed for 10 h. TLC examination (silica gel 'G' 
benzene-ethylacetate, 8:2 v/v) of the reaction mixture showed the presence of 
two components, one minor (upper) and the other major (lower), labelled as 
SD4 and SD4A. These were separated and purified by column chromatography 
over silica gel using benzene-ethylacetate (8:2 v/v) as an eluent followed by 
crystallization (benzene - acetone) to give SD4 as orange crystalline globules 
in 10% yield and SD4A as brown crystalline needles in 60% yield. 
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The reaction sequence is given below -
a _ y / \ _ A A ^ / V a + NH2CNHNH2 
0 
(8) 
/ V - ^ 
S ^ N H , 
(13) 
(nDlariatio, 1:3) 
aOH«a,ieflu3^10h 
a 
a . 
/ w N 
+ 
s ^ m 
(14) 
\ - a 
structure Elucidation of SD4 (13) 
It is an orange crystalline globules solid, m.p. 130 °C and appears brown 
on exposure to iodine vapours (TLC). The structure of SD4A has been 
established by FT-IR, DCI-MS, 'H-NMR and ^^C-NMR spectra. The IR 
spectrum (KBr) displayed characteristic bands 3423, 3247(NH), 1595(C=N), 
1497 (Phenyl), 1197 (C=S), 1086 (C-N), 1008, 957, 812 and 708 cm"'. The 
DCI-MS (NH3 as reagent gas) spectrum (FIG. 28) of SD4 showed a set of 
peaks at m/z 376/378/380 (100.0/67.1/13.6) corresponding with [M+l]+, 
confirming its molecular weights 375/377/379 [C18H15CI2N3S] which is equal 
to the sum of molecular weights of the dienone (8) (302) and 
thiosemicarbazide (91) minus one molecule of water (18). This indicated that 
the formation of thiosemicarbazone has occurred by the condensation of (8) 
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with thiosemicarbazide. The fragment ions corresponding with sets of peaks 
at m/z 342/344/346 (7.0/4.5/1.6) [(M+O-HjSr, m/z 317/319/321 (95.9/ 
51.0/7.5) [(M+1) - CSNHf and at m/z 302/304/306 (13.6/6.5/1.6) [(M+1)-
NHCSNH]"^ supported the thiosemicarbazone structure. The mode of 
fragmentations is presented in CHART-9. The ^H- and ^^C-NMR spectra of 
SD4 dissolved in acetone-c/6 showed signals as assigned (TABLE-10). The 
assignments of all ^H-NMR (FIG. 29) and ^^C-NMR (FIG. 30) signals to 
individual H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity, relative integrations and by comparison 
with the spectral data of its precursor (8). The 'H-NMR spectrum of SD4 
exhibited two doublets at 5 7.32 and 5 7.46 with large coupling constants 
(J= 16.48 Hz) assigned to protons at C-2 and C-1 and other two doublets at 
57.18 and 57.38 with coupling constants (J=16.48 Hz) attributed to protons 
at C-4, C-5 respectively. The large coupling constants (J= 16.48 Hz) of vicinal 
protons confirmed their trans dispositions. The protons at C-1 and C-5 
appeared at lower fields (67.46 and 67.38) as compared to protons at C-2 and 
C-4 (67.32 and 67.18) as a consequence of deshielding effect of the aryl 
groups attached to them. A singlet at 69.87 was assigned to NH protons. The 
two singlets appeared at 67.54 and 7.90 were attributed to NH2 protons. The 
'^C-NMR signals also confirmed the thiosemicarbazone structure as the 
chemical shifts (TABLE-10) are fully in agreement with the assigned 
structure. The assignments are also in consistent with the reported values of 
similar thiosemicarbazones^^^. A peak at 6180.86 was attributed to C=S 
carbon. 
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Based on the above spectral evidence, the product SD4 was characterised 
as N^-[l,5-bis(4-chlorophenyl)pent-l,4-dien-3-ylidene]thioseinicarbazide 
(13). 
Structure Elucidation of SD4A (14) 
It is an orange coloured needle shaped crystalline solid, m.p. 260°C and 
appears brown on exposure to iodine vapours (TLC). The structure of SD4A 
has been elucidated by FT-IR, DCI-MS, ^H-NMR and ^^C-NMR spectra. The 
IR spectrum (KBr) of SD4A displayed characteristic bands at 3471, 3355 
(NH), 2817 (C-H), 1584 (C=N), 1475 (Phenyl), 1351 (C=S), 1088 (C-N), 
1007, 957, 829 and 774 cm'^ The DCI-MS spectrum of SD4A (14) (FIG. 31) 
showed a set of [(M+l)^ peak at m/z 376/378/380 (100.0/70.2/14.7), 
confirming its molecular weight 375/377/379 [C18H15N3CI2S], which is equal 
to the sum of the molecular weights of compound (8) (302) and 
thiosemicarbazide (91) minus one molecule of water (18). This suggested 
that condensation of dienone (8) with thiosemicarbazide has occurred. A set 
of peaks at m/z 342/344/346 (6.3/4.2/1.2) [(M+1)-H2S]+ and an another set 
of peaks at m/z 316/318/320 (11.7/9.2/1.4) [(M+1) - CSNHjr observed in 
the spectrum are the common feature of exocyclic thiosemicarbazone moiety. 
The sets of peaks at m/z 211/213/215 (8.3/4.1/3.8) [(M+1) - CgHgNClJ^and 
I •l'> ». fe > »«• I i «. 
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m/z 163/165/(2.0/1.0) [(M+1) - CgHioNzClS]^ were obtained by the cleavage 
of 1-2 and 3-4 bonds of pyrazoline ring. The mode of fragmentations is 
shown in CHART-10. The 'H-NMR (FIG. 32) and '^C-NMR (FIG. 33) 
spectra of SD4A dissolved in acetone-c/g showed signals as assinged 
(TABLE-11). The assignments of all 'H-NMR and ^^C-NMR signals to 
individual H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity, relative integrations and by a comparison 
with the spectra of the isomeric thiosemicarbazone (13). The ^H-NMR 
spectrum of SD4A revealed the presence of three double doublets as in SD5 
represented by a typical ABX splitting pattern due to geminal and vicinal 
coupling of the two diastereotopic protons (megnetically non-equivalent 
methylene protons H^, HB) at C-4 and the methine proton (H^) at C-5 of 
pyrazoline ring^^^ The two double doublets appeared at 53.10 and 53.84 with 
coupling constants Jgeni=17.55 Hz, Jvic=3.81 Hz in the former and 
Jgeni=17.55 Hz, Jvic = 11.60 Hz in the latter due to the coupling with axial 
proton at C-5, were assigned to equatorial and axial protons of C-4 
respectively. The third double doublet at 55.98 with coupling constants 
(J=3.81 Hz, J=11.60 Hz) due to vicinal coupling with two magnetically non 
equivalent protons of methylene group at C-4 of pyrazoline ring, was assigned 
to axial methine proton at C-5. The large coupling constants (J=11.60 Hz) of 
protons at C-4 and C-5 showed that they are trans oriented (diaxial, 
antiperiplanar) to each other. These signals are not present in the isomeric 
thiosemicarbazone (13). The two trans oriented doublets at 57.09 (J= 16.48 Hz) 
and 57.15 (J=16.48 Hz) were attributed to ethylenic protons at C-1' and C-2' 
respectively. The coupling constant of ethylenic protons J= 16.48 Hz indicated 
their trans geometry. In the 'H-NMR spectrum of SD4A, there were two sets 
of ethylenic protons whereas in this case only one set of ethylenic protons 
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was observed due to the formation of pyrazoline ring. The aromatic protons 
signals appeared as two sets of A2B2 systems, one set at 57.34 and 67.21 
(J=8.55 Hz) assigned to Ar-2,6 and Ar-3,5 protons and the other at 67.63 and 
67.43 (J=8.55 Hz) to Ar'-2,6 and Ar'-3,5-protons. The '^C-NMR spectrum of 
SD4A showed signals which are in strong agreement with the formation of the 
ring. The C-3 signal at 5146.33 in the isomeric SD4 shifted to downfield at 
5156.87 due to the formation of pyrazoline ring. The chemical shifts of other 
signals were found comparable with that of the isomeric thiosemicarbazone 
SD4 
Based on these facts, the structure of SD4A was formulated as 2-[3-{2-
(4-chlorophenyl)ethenyl}-5-{(4-chlorophenyl) }-2-pyrazolin-1-
yljthiocarboxamide (14). 
2 3 
(iii) Reaction of l,5-bis(4-methylphenyl)pent-l,4-dien-3-one (15) 
with thiosemicarbazide in the presence of acetic acid which 
yielded the thiosemicarbazone, N^-[l,5-bis(4-methylphenyl)pent-
l,4-dien-3-ylideneIthiosemicarbazide SD2 (16) as the sole 
product. The desired product (pyrazoline) could not be obtained 
here. 
A mixture of l,5-bis(4-methylphenyl)pent-l,4-dien-3-one (15) with 
thiosemicarbazide (molar ratio, 1:3) in ethanol in the presence of glacial 
acetic acid was refluxed for 10 h. TLC examination (silica gel 'G' benzene-
ethyl acetate, 8:2 v/v) of reaction mixture showed the formation of only one 
1 5 4 
component labelled as SD2. It was purified by column chromatography over 
silica gel using benzene-ethylacetate (8:2 v/v) as eluent followed by 
crystallization to give SD2 (16) as orange crystalline needles in 65% yield. 
The reaction sequence is given below : 
Me i \ ( \ — M e + NH2CNHNH2 
i 
Y ^^  r —Me : 
0 \ = / 
(15) 
aOH/AcOH,iefluj^  lOh 
Me-
Structure Elucidation of SDj (16) 
It is an orange crystalline needle, m.p. 160 °C and appears brown on 
exposure to iodine vapours (TLC). The constitution of SD2 has been 
established by FT-IR, DCI-MS, ^H-NMR and ^^C-NMR spectra and also by a 
comparison with the spectra of SD4. The DCI-MS (NH3 as reagent gas) 
spectrum (FIG. 34) of SD2 showed a peak at m/z 336 (100), corresponding 
with [M+1]"^ [C20H21N3SJ, confirming its molecular weight (335) which is 
equal to the sum of the molecular weights of 1,5-bis (4-methylphenyl)pent-
1,4-dien-S-one (14) (262) and thiosemicarbazide (91) minus one molecule 
of water (18). This indicated that the formation of thiosemicarbazone has 
occurred by the condensation of the dienone (14) with thiosemicarbazide. The 
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mass fragmentation pattern was found to be similar to that of SD4. A peak at 
m/z 319 was arised by the loss of ammonia molecule from molecular ion 
[(M+1)-NH3]'^. The corresponding [(M+l)-CSNH2r peak was observed at m/z 
276 by the cleavage of N-C bond of the thiocarboxamide moiety. A 
characteristic peak for thiosemicarbazone moiety appeared at m/z 262 
[(M+1)-NHCS NH]^. The mode of fragmentations is showed in CHART-11. 
The iR-NMR (FIG. 35) and '^C-NMR (FIG. 36) spectra of SDj dissolved in 
acetone-c/g showed signals as assigned in TABLE-12. The assignments of all 
'H-NMR and '^C-NMR signals to individual H- and C-atoms have been 
performed on the basis of typical chemical shift values, multiplicity, relative 
integrations and by a comparison with the 'H-NMR and ^^C-NMR spectra of 
previously established compound SD4 (13). The ^H-NMR spectrum of SD2A 
showed two doublets at 57.23 and 57.31 with large coupling constants 
(J=l 6.02Hz) assigned to protons at C-2 andC-1 and other two doublets at 
57.08 and 57.30 with coupling constants (J=16.00 Hz) attributed to protons 
at C-4 and C-5 respectively. The large coupling constant (J=16.02 Hz) of 
vicinal protons confirmed their trans disposition. The protons at C-1 and C-5 
appeared at lower field (57.31 and 57.30) as compared to protons at C-2 and 
C-4 (57.23 and 57.08) as a consequence of deshielding effect of the aryl 
groups attached to them. A singlet at 59.80 was assigned to NH proton. The 
two singlets appeared at 57.53 and 57.86 were attributed to NH2 protons. The 
^H-NMR spectrum also showed significant aromatic proton peaks in the form 
of A2B2 pattern at 57.62 and 57.24 as two doublets with J=8.08 Hz each for 
Ar-2,6, Ar-3,5 and another two doublets at 5 7.49 and 57.20 with J=8.24 Hz 
corresponding to Ar'-2,6 and Ar'-3,5 respectively. The '^C-NMR signals of 
SD2 (TABLE-12) were also found comparable with that of SD4 (13) 
TABLE-10. The '^C-NMR signals were fully in agreement with the assigned 
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Structure. These assignments were also in consistent with the reported values 
of similar thiosemicarbazones^^^. A peak at 5180.64 was attributed to C=S 
carbon. The methyl carbons appeared at 521.26 (C-Ar'-CHj) and 21.32 
(C-Ar-CHs). The ring carbons were observed at 5128.54 (C-Ar-2,6), 130.25 
(C-Ar-3,5), 134.90 (C-Ar-1), 140.23 (C-Ar-4) and 5127.94 (C-Ar'-2,6), 
130.23 (C-Ar'-3,5) 134.15 (C-Ar'-l), 139.30 (C-Ar'-4). 
On the basis of the above facts the product SD2 was characterized as 
N^-[l,5-bis(4-methylphenyl)pent-l,4-dieri-3-ylidene]thiosemicarbazide (16). 
3 2 
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EXPERIMENTAL 
l,5-Bis(3,4-dimethoxyphenyl)pent-l,4-dien-3-one (4) 
The compound (4) was prepared exactly as described in CHAPTER-1. 
2-[3-{3,4-Dimethoxyphenyl)ethenyl}-5-{3,4-dimethoxyphenyI)}-2-
pyrazoIin-l-yl]thiocarboxamide SDs^ (12) 
A mixture of l,5-bis(3,4-dimethoxyphenyl)pent-l,4-dien-3-one (4) 
(950 mg, 2.68 mmol) and thiosemicarbazide (732 mg 8.05 mmol) in ethanol 
in presence of a few drops of conc. HCl was refluxed with stirring at 80 °C 
on an oil bath for 10 h. The reaction mixture on TLC examination (silica gel 
'G', benzene-ethyl acetate, 8:2 v/v) showed two spots, one very minor (upper) 
and the other major (lower) labelled as SDs^. The residue was subjected to 
column chromatography over silica gel using benzene-ethyl acetate (8:2 v/v) 
as eluent. Elution first furnished the orange coloured showed as minor-
product, Rf 0.60 (benzene-ethyl acetate, 8:2 v/v), dark brown on TLC (I2). 
Further elution yielded a dark-brown solid which on crystallization (benzene-
acetone) furnished SDsa (12) as brown crystalline needles 1049 mg (65%)^ 
m.p. 130 °C, Rf 0.48 (benzene-ethyl acetate, 8:2 v/v). 
Spectral data of (12) 
IR (KBr pellet) : o^ax cm"^ 3447, 3338 (NH), 2934, 2834 (C-H), 1659 
(C=C), 1589 (C=N), 1513, 1465 (phenyl), 1345 (C=S), 1261, 1136 (-C-0-
C), 1020 (C-N), 961, 805, 759, 612, 575. 
^H-NMR (acetone-fi?6, 400 MHz) : 5h 7.01 (IH, d, J=16.48Hz, H-l'), 7.04 
(IH, d, J=16.48 Hz, H-2'), 3.08 (IH, dd, J=17.55 Hz, J=3.21 Hz, H-4eq), 
3.76(1H, dd, J=17.55 Hz, J=11.29 Hz, H-4ax), 5.91 (IH, dd, J=3.21 
1 6 3 
Hz,J=11.29 Hz, H-5ax), 3.76-3.88 (12H, s, 4 x OCH3), 6.84 (IH, d, 
J=2.14Hz, H-Ar-2), 6.86 (IH, d, J=8.24 Hz H-Ar-5), 6.69(1H, dd, J=2.14 Hz, 
J=8.24 Hz, H-Ar-6), 7.26 (IH, d, J=2.14 Hz, H-Ar'-2), 6.96 (IH, d, J=8.24 
Hz, H-Ar'-5), 7.12 (IH, dd, J=2.14 Hz, J=8.24 Hz, H-Ar'-6). 
i^C-NMR (acetone-f/fi, 100 MHz) : 5c 122.24 (C-1'), 139.72 (C-2'), 157.66 
(C-3), 42.42 (C-4), 63.78(C-5), 178.08 (C=S), 56.25(4 x OCH3), 136.69(C-
Ar-1), 111.31 (C-Ar-2), 151.79 (C-Ar-3), 150.52 (C-Ar-4), 113.90 (C-Ar-5), 
118.92 (C-Ar-6), 129.97 (C-Ar'-l), 110.88 (C-Ar'-2), 150.77 (C-Ar"-3), 
149.69 (C-Ar'-4), 112.81 (C-Ar'-5), 118.49 (C-Ar'-6). 
DCI-MS (NH3) : m/z 430(10.7), 429(34.3), 428(100.0), 427(6.8), 426(3.0), 
414(4.4), 412(2.4), 398(2.2), 397(7.4), 396(2.4), 395(2.0), 394(6.3), 
370(2.2), 369(10.7), 368(7.7), 367 (13.3), 355(2.2), 354(2.0), 353(2.2), 
352(5.1), 351(7.3), 238 (4.0), 237(6.4), 224 (2.0), 223(11.5), 203(6.7), 189 
(4.0), 165(4.0), 164(4.2), 163(4.6), 153(3.2), 153(2.4), 151(7.3), 79(2.2), 
78(2.2), 77(4), 76(2.2). 
l ,5-Bis(4-chlorophenyl)pent-l,4-dien-3-one (8) 
The compound (8) was prepared exactly as described in CHAPTER-1. 
2-[3-{2-(4-Chlorophenyl)etheiiyl}-5-{(4-chlorophenyl)}-2-pyrazolin-l-
yl]thiocarboxaiiiide SD4A (14) and N^-[l,5-bis(4-chlorophenyl) 
pent-l,4-dien-3-ylidene]thiosemicarbazide SD4 (13) 
A mixture of l,5-bis(4-chlorophenyl)pent-l,4-dien-3-one (8) (680 mg 
2.25 mmol) and thiosemicarbazide (614 mg, 6.75 mmol) in presence of a few 
drops of conc. HCl in ethanol (25 ml) was refluxed with stirring at 80 °C on 
an oil bath for 10 h. The progress of the reaction was monitored by TLC at 
every 30 minutes. After completion, the reaction mixture was concentrated 
under reduced pressure, extracted with ethyl acetate and washed with water 
1 6 4 
several times until the solution was neutral. The ethyl acetate solution was 
then dried over Na2S04. The solvent was evaporated and the orange-coloured 
oily residue left was examined by TLC (silica gel 'G', benzene-ethyl acetate, 
8:2 v/v). It was found to be a mixture of two components, one minor (upper) 
and the other major (lower), labelled as SD4 and SD4A. The oily residue was 
chromatographed over silica gel colunm using benzene-ethyl acetate, 8:2 v/v 
as an eluent. Elution of the column first furnished an orange coloured solid 
which on crystallization from benzene-acetone yielded SD4 (13) as light 
orange crystalline globules, 123 mg (10%), m.p. 130 °C, Rf 0.62 (benzene-
ethyl acetate, 8:2 v/v). 
Spectral data of SD4 (13) 
IR (KBr pellet) : o^ax cm'^ 3423, 3247 (NH) 1595 (C=N), 1595, 1497 
(phenyl), 1197 (C=S), 1086 (C-N), 1008 , 957, 812, 708 (C-Cl), 623, 
520, 480. 
^H-NMR (acetone-^/6, 400 MHz) : 5h 7.77 (2H, d, J=8.55Hz, H-Ar-2,6); 
7.46 (2H, d, J=8.55Hz, H-Ar-3,5), 7.64 (2H, d, J=8.40Hz, H-Ar'-2,6), 7.41 
(2H, d, J=8.40Hz, H-Ar'-3,5), 7.46 (IH, d, J=16.48Hz, H-1), 7.32 (IH, d, 
J=16.48Hz, H-2), 7.18 (IH, d, J=16.17Hz, H-4), 7.38 (IH, d, J=16.17Hz, 
H-5), 7.54, 7.90 (IH, s, NHj), 9.87 (IH, s, NH) 
i^C-NMR (acetone-rffi, 100 MHz,) : 5c 138.37 (C-1), 126.54 (C-2), 146.33 
(C-3), 118.88 (C-4), 134.46 (C-5), 129.50-136.54 (Ar+Ar'), 180.86 (C=S) 
DCI-MS (NH3) : m/z 376/378/380 [(M+l)/(M+3)/(M+5), 100/67.1/13.6], 
375 (7.0), 346 (1.6), 344 (4.5), 342 (7.0); 321(7.5); 320(11.6), 319(51.0); 
318(30.8); 317(95.9), 316(28.7), 315(30.3), 306(1.5); 304(6.5); 302(13.6); 
300(5.5), 217(2.0), 216(3.2); 215(4.5), 214(2.2), 213(4.4), 212(5.5), 
1 6 5 
211(8.0), 
197(5.0) 
172(1.4) 
154(1.7) 
142(4.2) 
127(5.5) 
102(7.0) 
77(10.6) 
207(2.2), 205(5.0), 203(1.6), 202(2.0), 199(2.2), 198(1.2), 
180(2.0), 179(2.6), 178(2.8); 177(2.2), 176(2.0), 173(2.4); 
171(6.5); 166(1.6); 165(1.8); 164(2.1); 163(2); 155(1.8); 
153(1.6); 152(1.5); 151(2.0); 150(1.9); 149(5.5); 144(2.2); 
140(6.0); 139(4); 138(5.0); 137(3.8); 136(2.4); 128(4.5), 
126(2.2); 125(10.6); 117(3.4); 116(3.6), 115(7.0); 103(2.2); 
101(2.4); 94(1.4); 93(2.2), 92(1.6); 91(3); 89(4.2); 78(2.2); 
76(7.5); 75(3.4); 74(3.2); 73(2). 
Further elution of the column yielded a dark brown solid which on 
crystallization from benzene-acetone afforded SD4A as brown needles shaped 
crystalline solid 740 mg (59.96%), m.p. 260 °C, Rf 0.58 (benzene : ethyl 
acetate, 8:2 v/v). 
Spectral data of SD4a(14) 
IR (KBr pellet) : u^ax cm"' 3471. 3355 (NH), 2817 (C-H) 1584 (C=N), 
1584, 1475.(phenyl) 1351 (C=S), 1088 (C-N), 1007, 957, 829, 774, 671 cm"'. 
iR-NMR (acetone-rffi, 400 MHz) : 5h : 7.09 (IH, d, J=16.48Hz, H-T), 7.15 
(IH, d, J=16.48Hz, H-2'), 3.10 (IH, dd, J=17.55Hz, J=3.81, H-4eq), 3.84 
(IH, dd, J=17.55Hz, J=11.60Hz, H-4ax), 5.98 (IH, dd, J=3.81Hz, J=11.60Hz, 
H-5ax). 7.34(2H, d, J=8.55Hz, H-Ar-2,6), 7.21(2H, d, J=8.55Hz, H-Ar-3,5), 
7.63 (2H, d, J=8.55Hz, H-Ar'-2,6), 7.43 (2H, d, J=8.55Hz, H-Ar'-3,5). 
i^C-NMR (acetone-^/g, lOOMHz) : 6c 121.82(C-1'), 138.22 (C-2'), 156.87 
(C-3). 42.24 (C-4) 63.67 (C-5), 142.96 (C-Ar-1), 129.88 (C-Ar-2,6), 129.42 
(C-Ar-3,5); 135.20 (C-Ar-4), 135.82 (C-Ar'-l), 129.65 (C-Ar'-2,6), 128.30 
(C-Ar'-3,5); 133.16 (C-Ar'-4), 178.37 (C=S) 
DCI-MS (NH3) : m/z 376/378/380 [(M+l)/(M+3)/(M+5)/100/70.2/14.7], 
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375/377/379 (8.7/28.1/16.0), 346 (1.2), 345(1.8), 344(4.2), 343 (1.6), 
342(6.3), 321(1.0), 320(1.4), 319(11.0), 318(9.2), 317(21.3), 316(11.7), 
315(9.6), 217(10), 216(2.2), 215 (3.8), 214(3.2), 213(4.1), 212(8.6), 
211(8.3), 207 (1.8), 205(3.8), 203(1.0), 202(1.1), 199(3), 198(1.8), 
197(6.7), 182(1.8), 181(1.8), 180(2), 179(2.2), 178(4.2), 177(3.6), 
176(2.1), 175(2.0), 173(3.6), 172(2.2), 171(8.2), 170(4.2), 165(1.0), 
163(2.0), 155(3.2), 153(4), 151(2.2), 149(4.1), 144(2.2), 143(3), 142(2.0), 
141(2.1), 140(3.6), 139(3.4), 138(3.4), 137(1), 129(1.6), 127(4.2), 
125(6.1), 117(2.0), 116(2.2), 115(4.7), 103(2.2), 102(2.4), 101(1.4), 
93(2.0), 91(2.4), 89(3), 77(2), 76(1.8), 75(3.8), 74(2.1), 73(2). 
l ,5-Bis(4-methylphenyl)pent-l,4-dien-3-one (15) 
It was prepared as described in (4)/(8) above by condensing acetone with 
p-tolualdehyde (commercially available). A mixture of p-tolualdehyde (5 gm, 
0.042 mol) and acetone (1.2 gm, 0.021 mol) in ethanol (20 ml) was kept on 
an ice bath and to this was added sodium hydroxide (4.17 gm, 0.104 mol) 
dropwise with stirring. A flocculent precipitate was formed during addition. It 
was stirred further for 1 h and then worked up as usual. The yellow solid thus 
obtained was recrystallized from benzene to give (15) as light yellow 
crystalline needles, 4.30 gm (71.27%), m.p. 175 °C, Rf 0.52 (pet. ether-
EtOAc, 8:2 v/v) 
Spectral data of (15) 
^H-NMR (acetone-^/fi, 400 MHz) : 5h 7.24 (2 x IH, d, J=16.17, H-2, H-4), 
7.75 (2 x IH, d, J=16.17, H-1, H-5), 7.27 (2 x 2H, d, J=8.85, 2 x Ar-3,5), 
7.64 (2 X 2H, d, J=8.85, 2 x Ar-2,6), 2.05 (6H, s, 2 x Ar-CHj). 
i^C-NMR (acetone-c?6, 100 MHz) : 5c 21.42 (C-Ar-CHj); 125.80 (C-2/C-4), 
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143.20 (C-l/C-5), 133.45 (2 x C - Ar - 1), 129.28 (2 x C-Ar-2,6), 130.51 (2 
X C-Ar-3,5), 141.53 (2 x C-Ar-4), 188.87 (C=0). 
DCI-Mass (NHj) : m/z 263 (100.0), 264 (23.9), 265 (3.3), 262 (3.1), 
145 (4.6). 
N^-[l,5-Bis(4-methylphenyl)pent-l,4-dien-3-ylidene]thiosemicarbazide 
SDj (16) 
A mixture of l,5-bis(4-methyl phenyl)pent-l,4-dien-3-one (600 mg, 2.2 
mmol) and thiosemicarbazide (625 mg, 6.87 mmol) in ethanol in the presence 
of glacial acetic acid (2 ml) was refluxed with stirring at 80°C on an oil bath 
for 10 h. Monitoring the progress of reaction by TLC (silica gel 'G', benzene-
ethyl acetate, 8:2 v/v) revealed the presence of a single spot, labelled as SD2. 
The reaction mixture was worked up as above and the yellow solid thus 
obtained was crystallized (benzene-acetone) to give (16) as an orange 
crystalline needles, 771 mg, (65%), m.p. 160°C, Rf 0.52 (pet. ether-ethyl 
acetate, 8:2 v/v). 
Spectral data of (16) 
iR-NMR (acetone-rffi, 400 MHz) : 5h 7.31 (IH, d, J=16.02 Hz, H-1), 7.23 
(IH, d, J=16.02 Hz, H-2), 7.08 (IH, d, J=16.0 Hz, H-4), 7.30 (IH, d, 
J=16.0 Hz, H-5), 2.35(3H, s, H-Ar-CH,), 2.33 (3H, s, H-Ar'-CHj), 
7.62(2H,d, J=8.08Hz, H-Ar-2,6), 7.24(2H, d, J=8.08Hz, H-Ar-3,5), 7.49 
(2H, d, J=8.24Hz, H-Ar'-2,6), 7.20(2H, d, J-8.24Hz, H-Ar'-3,5), 7.53, 
7.86(2H, s, NH2), 9.80(1H, s, NH). 
i^C-NMR (acetone-^/6, 100 MHz) : 5c 139.82 (C-1), 125.01(C-2), 
147.51(C-3), 117.07(C-4), 135.96 (C-5), 180.64(C=S), 21.32(C-Ar-CH3), 
21.26(C-Ar'-CH3), 128.54(C-Ar-2,6), 130.25(C-Ar,3,5), 134.90(C-Ar-l), 
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140.23(C-Ar-4), 134.15(C-Ar'-l), 127.94(C-Ar'-2,6), 130.23(C-Ar'-3,5), 
139.30(C-Ar'-4). 
DCI-MS (NH3) : m/z 338(9.2), 337(28.0), 336(100), 335(2.6), 321(3.6), 
319(5.8), 277(3.7), 276(2.0), 275(5.8), 262(3.2), 260(3.4), 217(3.2), 
192(1.8), 191(1.5), 185(2.4), 177(2.8), 162(2.0), 161(4.0), 160(3.8), 
151(1.8), 135(1.2), 134(1.4), 133(2.0), 132(1.9), 120(2.0), 119(1.4), 
118(1.5), 117(1.6), 116(1.9), 115(1.8), 106(2.2), 105(2.0), 78(1.8), 
77(13.7), 76(1.0). 
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Chapter - 3 
2-[3,5~Di-aryl substituted-!-
PyrazolinylJThiazolin-4-ones from 
Ch ale ones 
n^icorctical 
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THEORETICAL 
Thiazolin-4-ones belong to an important class of biologically active five 
membered heterocyclic compounds with a nitrogen and a sulphur atom at 1,3-
positions and a double bond in the ring. 
V . 
C 
(I) 
R'=R2 = NR2 = a]kyl = aiyl 
The compounds containing thiazolinone moiety are associated with 
diverse biological activities and are found to be very potent against a number 
of diseases^'^ such as antiulcer and cytoprotective"*, antimicrobial^'^, 
antiallergic^"^, antiinflammatory^, antitubercular'®, antiproliferative", 
antibone disorder^^ anti AIDS^^, cardiotonics'"^"'^, diabetes'^, fungicidal'^, 
herbicidal'^, fibrinogen receptor^®, insecticidal^' activity. Thiosemicarbazones 
of various aldehydes and ketones have been found to posses broad spectrum 
of medicinal properties^^. 
N.N. Khovratovich et al.^^ have reported the synthesis of 2-amino-4-
thiazolinone (II) and its derivatives. The spectral studies showed that in 
crystalline state it has an imino (II) and in solution an amino structure (III). 
BUU-HOI et al}"^'^^ have synthesized a number of thiosemicarbazones 
and their corresponding extra nuclear 4-oxo-A^-thiazolin-2-yl-hydrazones by 
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heating various aldehydes and ketones with thiosemicarbazide in dry ethanol 
in acidic medium followed by cyclocondensation of thiosemicarbazones 
formed with a-halogenated fatty acids to the corresponding 4-keto-2-
thiazolinyl hydrazones of the general formula. 
R—C^ 
O NH2NHCSNH2 
H EtOH/H /^A 
R = alkyl aryl, RN.H. or substituted and 
unsubstituted heterocyclic group. 
R-CH=NNH0=NH2 
SH 
a - habgenated fatty acid 
R—CH=NNH ^ 
N 
(IV) 
o 
BUU-HOI also reported a number of 4-oxo-A^-thiazolin-2-yl-
hydrazones (V) of aldehydes and ketones by heating a mixture of 
thiosemicarbazones and chloroacetic acid or the appropriate a-bromo-acid 
with sodium acetate. The synthesized compounds were found to be highly 
active in vitro against Mycobaterium tuberculosis and some of these also 
showed antiviral properties towards DNA and RNA viruses in tissue cultures. 
SH 
I 
CH=NNHC=NH 
R 
I 
+ BrCHCOOH 
R=H 
R' = H,alkyl 
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2-substituted A^-thiazolin-4-ones^'' (VI) were reported by condensing a -
haloacids and their derivatives with thioamides. 
L - C ^ O 
X-CH-R^ + 
L = OH,Oa 
R^  = alkyl, aiyl, NR2, OR, SR 
O. 
-N 
R^  
2-substituted 5-methoxy carbonylmethylene-A^-thiazolin-4-ones^'^(VII) 
were prepared from thioamides and thioureas with dimethylacetylene-
dicarboxylates. 
0=C—OMe 
i + 
NH2 
c 
COjMe 
O. 
H -N 
M& 02(/ 
R^  
S 
( v n ) 
r2= alkyl, NR2 
S. Gabrial et al^^ have synthesized A^-thiazolin-4-ones (VIII) from 
thiourea and phenyldithio carbamate (R^=NR2, SPh) with glycidic esters. 
a o — c = o 
-.CH 
NH, 
R" 
R 
+ 
R^  
R =^NR2orSPh 
H O — C = 0 NH 
HO OL .C 
R^  
/ 
R 
0 
(vm) 
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J. Goesdeler et al.^^ have prepared A^-thiazolin-4-one derivatives (IX) 
from diazoalkanes by condensing with thiobenzoylisocynate. 
O 
@ 
-N2 
R' -N 
(K) 
2-arylamino-A^-thiazolin-4-ones^° (X) were prepared by the reaction of 
P-chloroethyl or acetyl isothiocyanates with aryl amines. 
0 
c — N = c = s 
a c H , 
+ ArNH2 
^.^C—NHAr 
g > c O s 
O 
\ - N 
NHAr 
(X) 
A.O. Gukasyan et a/.^^ have synthesized 2,5-di-substituted thiazolin-4-
ones (XI) from cyclocondensation of p-R-C^H^ CH(OH) CCI3 with R'C 
(:NH) SH in DMF in the presence of KOH. 
R- / \ DMF/KOH/A - CH(0H)Ca3 + R'C^ NHSH R- , V Y - N R' 
SDIA(19) 
R=H,Me,Cl,Br,F 
R'=Me,Ph 
186 
G.D. Krapivin et al?^ have prepared 2-(5-R-2-furyl) thiazolin-4-ones 
(XII) from cyanofuran with thioglycollic acid in pyridine. 
R H \ CN + HSCH2COOH pyridine/A 
R = H,Me,N02,2,4,6,a3-C6H2 
M.A.A. Elneairy et al.^^ have prepared 2-(l,3-benzothiazol-2-yl-
methyl)-l,3-thiazol-4-(5H)-one (XIII) from 2-(l,3-benzothiazol-2-yl) 
acetonitrile with HjS and chloroacetic acid. The same compound (XIII) was 
also obtained by using mercepto acetic acid. 
H2S N S 
HSCHjCXXDH aCH.OOOH 
Nadia H. Metwally^'^ have synthesized 5-arylidene-2-(arylazocyano-
methylene)--4,5-dihydrothiazol-4-ones (XIV) and 5-arylidene-2-(arylazo-
methylenebenzimidazolyl)-4,5-dihydrothiazol-4-ones (XI) by refluxing 3-
aryl-2-sulfanylacrylic acid with a-aryl hydrazononitriles and 2-
arylhydrazono-2-cyanomethylbenzimidazoles in acetic acid. 
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AcOH/reflux 
AcOH / reflux 
H 
CN 
CN 
a 
b 
Ar 
CfiH, 
4-MeOCgH4 
(XIV) 
Ar Ar' 
a C5H5 C A 
b CfiHs 4-MeCgH^ 
c CfiHs 4-MeOCgH^ 
(1 CfiH, 4-CIC5H4 
e 4-MeOC5H5 CaH, 
f 4-MeOCgH5 4-MeCgH4 
g 4-MeOCjH5 4-MeOCgH^ 
h 4-MeOC5H5 4-ClC,H, 
discussion 
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DISCUSSION 
SUMMARY 
The work described in this chapter consists of the synthesis of 
following two novel compounds -
(i) 2-[3,5-bis(2-thienyl)-2-pyrazolin-l-yl]thiazolin-4-one SDj^ (20) from 
l,S-bis(2-thienyl)-2-propen-l-one (17) via 2-[3,5-bis(2-thienyl)-2-
pyrazolin-l-yljthiocarboxamide SDj^ (19) and 
(ii) 2-[3-(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-yl]thiazolin-
4-one SDjg (24) from 4-bromophenyl-4-methylphenyl-2-propen-l-one 
(21) via 2-[3-(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-
yljthiocarboxamide SDj^ (23), both in (i) and (ii) using chloroacetic 
acid in the presence of sodium acetate 
Structures are established on the basis of IR, Mass, ^H-NMR and 
^^C-NMR spectral studies. The compounds (19) and (20) have been 
evaluated for anticancer activity and compounds (19) and (24) for 
antibacterial activity. 
INTRODUCTION 
In recent years, the synthesis of thiazolin-4-ones has received 
considerable attention because of their wide range of biological and 
pharmaceutical applications as antiulcer and cytoprotective"*, antimicrobial"^, 
antiallergic^"^, antiinflammatory^, antitubercular'®, antiproliferative", 
antibonedisorder^^, anti AIDS'^ cardiotonics^''"^^, diabetes'"', fungicidal'^ and 
fibrinogen receptor^®. Although a large number of thiosemicarbazones^"*"^^ of 
a variety of aldehydes and ketones (including indanone, flourenone, steroid, 
chromanone, chalcone and flavanone) have been prepared as intermediates for 
synthesis of various kinds of heterocyclic compounds^^"^' and for biological 
testing '^^ '^ '^^ ^, some of these possess potential antitubercular^'*'''^ and 
antiviral"*^ activities. The compounds containing thiophene ring have been 
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found to possess potent anthelmentic activity"^®. In recent past, reactions of 
thiosemicarbazones^'''^^'^^ of various aldehydes and ketones with 
a-chloroacetic acid and its functional derivatives in presence of sodium 
acetate have been investigated and found to give the corresponding 
hydrazono-thiazolin-4-ones. However, the analogous reactions of 3,5-
disubstituted-2-pyrazolin-l-yl-thiocarboxamides with chloroacetic acid have 
not yet been described. Keeping in view of the importance of above findings 
and as part of our programme in search of biologically active compounds with 
sulphur and nitrogen containing heterocycles, we have undertaken this 
problem. In continuation of our previous work described in CHAPTER - 2 on 
the reactions of thiosemicarbazide with different a,P-unsaturated dienones to 
form novel compounds, 3,5-diaryl substituted 2-pyrazolin-l-yl-
thiocarboxamides, we have extended the above reactions employing the 
substrates, 2-thienylchalcone and 4,4'-bromomethyl chalcone in place of 
dienones and condensing the thiocarboxamide moiety of 2-pyrazolinyl 
thiocarboxamides with chloroacetic acid in presence of sodium acetate in 
order to incorporate a thiazolin-4-one ring in the molecule with a view to 
enhance biological and pharmaceutical properties. The substrates, thienyl 
chalcone, l,3-bis(2-thienyl)-2-propen-l-one (17) and bromomethyl 
chalcone, l-(4-bromophenyl)-3-(4-methyl phenyl)-2-propen-l-one (21) 
have been prepared following a reported procedure'^^ by condensing 2-acetyl 
thiophene with thiophene-2-aldehyde (both prepared from reported method''^) 
and 4-bromoacetophenone with tolualdehyde in presence of sodium 
hydroxide. The reactions of these chalcones possessing a,P-unsaturated 
function are then proceeded in two steps. The chalcones (17) and (21) are 
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first reacted with thiosemicarbazide in the presence of conc. HCl to yield 
1,3-bis(2-thjenyl)-2-propen-l-ylidene] thiosemicarbazide (18) (15%) 
and 2-[3,5-bis(2-thienyl)-2-pyrazolin-l-yl]thiocarboxamide (65%) in the 
former while N^ - [ 1 -(4-bromophenyl)-3-(4-methylphenyl)-2-propen-1-
ylidenejthiosemicarbazide (22) (14%) and 2-[2-(4-bromophenyl)-5-(4-
methylphenyl)'2-pyrazolin-l-yl]thiocarbaxamide (23) (66%) in the later 
The pyrazolinyl thiocarboxamides (19) and (23) are then treated with 
chloroacetic acid in presence of sodium acetate to yield novel compounds, 
2-[3,5-bis(2-thienyl)'2-pyrazolin-l-yl]thiazolin-4-one (20) and 2-[3-(4-
bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-yl]thiazolin-4-one (24) 
respectively 
Structural assignments, stereochemistry and biological assay are 
discussed. Screening results of (19) and (20) are summarized for anticancer 
activity against 3-cell lines of three types of human cancers : lung, breast and 
CNS and compounds (19) and (24) for antibacterial activity. (DETAILS IN 
CHAPTER-6). 
// 
0 
(17) 
N. 
\ 
'/ W 
NH 
S ^ N H , 
SDi (18) 
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J 
N, 
N 
'I w 
SDIA(19) 
S - ^ N 
V 
0 
SD,b (20) 
(21) 
S ^ N H , 
SD7(22) 
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SD7A(23) 
Br- / \ 
S - ^ N 
V 
o 
SD7B (24) 
-CH, 
1 9 3 
RESULTS AND DISCUSSION 
The synthesis of target compounds (20) and (24) has been performed in 
two steps (SCHEME-V). 
Step 1 : The 2-pyrazolinyl-thiocarboxamide (19) and (23) were first 
prepared as described in CHAPTER-2 from chalcones (17) and (21) with 
thiosemicarbazide (molar ratio, 1:3) in absolute alcohol in presence of conc. 
HCl under reflux for 6-10 h in good yields (-65%, 66.%). The uncyclized 
thiosemicarbazones (18) and (22) formed as intermediate were also isolated 
in poor yields. 
Step 2 : The compounds (19) and (23) were then condensed with 
chloroacetic acid and sodium acetate (molar ratio, 1:1.25:1.5) by refluxing 
the reaction mixture in freshly distilled acetic acid for 35 h. The respective 
products obtained after usual work up and purification by column 
chromatography over silica gel using benzene-ethyl acetate (8:2 v/v) as eluent 
followed by crystallization yielded (20) and (24) as brown crystalline needles 
in 56% and 55% yields. 
Ri 
(17) R,=R2= l / \ 
(21) R, =p-Br-C6H4 
R2 =p-CH3 - CgH4 
NH2CSNHNH2 (molar ratio, 1:3), 
ethanol, HCl, reflux, lOh 
R, J 
+ N 
R, 
NHj 
= R , = / / V 
R, =R,= // \ (18) 
(22) R, =p-BT-C6K4 
R2 =p-CH3 - C6H4 
(19) R, 2 
(23) R, =;p-Br-C6H4 
R2 - p-Cti^ - C6H4 
R 
N. 
N 
S ^ N H j 
(19) R,=R2 = // 
(23) Ri=/j-Br-C6H4 
R2=;,-CH3-QH4 
aCHjCOOH, CHjCXWNa 
(molar ratio, 1:1.25:1.5), 
acetic acid, refluj^ 35h 
SCHEME - V 
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N 
S - ^ N 
V 
O 
(20)R,=R2=// V 
(24) R,=p-Br-QH4 
R2=p-CH3-C(iH4 
Synthesis of 2-[3,5-bis(2-thienyl)-2-pyrazolin-l-yl]thiazolin-4-one 
SDjg (20) from l,3-bis(2-thienyl)-2-propen-l-one (17) via 2-[3,5-
bis(2-thienyl)-2-pyrazolin-l-yl]thiocarboxamide SDj^ (19) using 
chloroacetic acid in the presence of sodium acetate 
The pyrazolinyl thiocarboxamide SDj^ (19) was first prepared by 
refluxing a solution of thiosemicarbazide and thienyl chalcone, l,3-bis(2-
thienyl)-2-propen-l-one (17) (molar ratio, 1:3) in absolute alcohol in 
presence of conc. HCl, for 10 h. After completion of the reaction, the 
reaction mixture on TLC examination (silica gel 'G' benzene-ethyl acetate, 
8:2 v/v) showed the presence of two spots, labelled as SDj and SD^^. On usual 
work up and purification by column chromatography (sihca gel, benzene-ethyl 
acetate, 8:2 v/v) followed by crystallization from benzene-acetone, it yielded 
SDj as orange crystalline needles and SDj^ as brown crystalline needles in 
15% and 65% yield respectively. The compound SDj^(19) was then 
condensed with chloroacetic acid and sodium acetate (molar ratio, 
1:1.25:1.5). The cyclocondensation was carried out by refluxing the reaction 
mixture in freshly distilled acetic acid for 35 h. TLC examination (silica gel 
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'G' benzene-ethyl acetate, 8:2 v/v) of the reaction mixture showed the 
presence of only one spot, labelled as SDjg. After usual work up and 
purification of the products by column chromatography over silica gel using 
benzene-ethyl acetate (8:2 v/v) as eluent followed by crystallization (benzene-
ethyl acetate, 9:1 v/v) yielded SDj3(20) as brown crystalline needles in 56% 
yield. 
The reaction sequence is given below -
0). 
^ OOO^ + O H C — ^ y 
^ Z5eq.NaOH ^ 
(nDbff ratio, 1:1) 
// 'I w 
(17) 
-H2O 
NH2CSNHNH2 (nolar ratio, 1:3), 
ethanol, HO, refluj; lOh 
II \\ 
"S 
'/ w 
w 
\ 
NH 
S ^ N H , 
SDi (18) 
+ N' 
'I w 
SDIA(19) 
(iix / / V 
N 
MHz 
y \\ aCHzGOOH, a^OOONa 
y (rrolarratio, 1:1.25:1.5), 
S acetic acid, lefliD^ 35h 
-HQ 
( w 
K. N 
'/ w 
S - ^ N 
V 
SDIA(19) 
0 
SD,B(20) 
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Mechanism of the above reactions : 
A plausible mechanism for the above reactions may be offered 
(SCHEME-VI). The 4-thiazolinone ring in (20) and SD^^ (24) is 
believed to be formed by the cyclocondensation of the chloroacetic acid with 
thiocarboxamide moiety of 2-pyrazolines SDj^(19) and SD.^^(23). 
(17) , (21) 
Ri 
eO 
+ NHj C NH NH^/EtOH/HCl 
II S 
R 
^ R . 
J4H2NHCNH2 
S 
T N. 
'N 
Ri- © T 
NH2 
(19), (23) 
@H 
S ^ N H , 
R r T 
N 
HS '^^ ^NH 
T 
'N 
p- < AcOH/NaOAc -HCl S^'^NH -OH 
-R2 
H NH 
NHj 
-H,0 
NH—C—NH2 
S 
(18), (22) 
Rl- T N. 
N 
o 
9 
H" transfer N 
. - A OH 
HjO 
I'o-rH 
N 
S - ^ N 
R2 
V 
(20) , (24) 
SCHEME - VI 
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Structure Elucidation of SD^ (18) 
It is an orange crystalline solid,m.p. 130 °C and appears brown on 
exposure to iodine vapours (TLC). The structure of SDj has been established 
by FT-IR, DCI-MS, 'H-NMR and '^C-NMR spectra. IR spectrum (KBr 
* 
pellets) of SDj showed characteristic signals at 3420, 3240 (NH), 2915 
(CH), 1590 (C=N), 1495 (phenyl), 1180 (C=S), 1070 (C-N), 950, 816, 
715 cm-^ The DCI-MS (NH3 as reagent gas) spectrum (FIG. 37) of SDj (18) 
showed [M+H]"^ peak at m/z 294 as the base peak, confirming its molecular 
weight 293. This is equal to the sum of the molecular weights of l,3-bis(2-
thienyl)-2-propen-l-one (17) (220) and thiosemicarbazide (91) minus one 
molecule of water (18) indicating that condensation has occurred between the 
carbonyl group of the chalcone and amino group of semicarbazide forming 
thiosemicarbazone. A peak appeared at m/z 260 [(M+H)-H2S]"^ was due to the 
loss of HjS and another peak at m/z 277 [(M+H)-NH3]"^ observed by the loss 
of ammonia from parent ion. The other important fragment ion peaks were 
observed at m/z 233, 183, 112 and 77. These supported the thiosemi-
carbazone structure (CHART-12). The ^H-NMR (FIG. 38) and '^C-NMR 
(FIG. 39) spectra of SDj dissolved in acetone-c/^ showed signals as assinged 
(TABLE-13). The assignments of all ^H-NMR and ^^C-NMR signals to 
specific H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity, relative integrations and also by 
comparison of the spectral data with that of l,3-bis(2-thienyl)-2-propen-l-
one (Experimental). The 'H-NMR of SDj showed two doublets at 57.21 
(J=16.02 Hz) and 57.44 (J=16.02 Hz) which were attributed to C-2 and C-3 
protons. The proton at C-3 appeared at lower field (57.44) as compared to 
proton at C-2 (67.21) as a consequence of deshielding effect of 2-thienyl 
group attached to it. The coupling constant (J=16.02 Hz) suggested that the 
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ethylenic protons were trans to each other. A broad singlet at 59.98 was 
observed for NH proton and two singlets at 57.53 and 57.63 were also 
appeared for NHj protons. The aromatic protons signals as broad multiplet at 
57.11 - 7.60 for two 2-thienyl rings were accounted for six protons. The 
'^C-NMR spectrum also confirmed the formation of thiosemicarbazone as 
C-1 signal of carbonyl carbon has shifted to higher field from 5181.80 to 
143.69 due to disappearance of C=0 group and formation of C=N group. Two 
signals at 5116.99 and 5134.34 were assigned to C-2 and C-3 carbons. The 
signal at 5180.90 was attributed to C=S carbon. The aromatic carbons signals 
were assigned as shown in TABLE-13. 
On the basis of these facts, SD^ was characterized as N^-[l,3-bis(2-
thienyl)-2-propen-l-ylidene]thiosemicarbazide (18). 
" 3 3 4 
5 ^ . i 3 / 
N 
\ 
NH 
S ^ N H , 
SDi (18) 
Structure Elucidation of SDj^ (19) 
It is a brown needle shaped crystalline solid, m.p. 138 °C and appears 
brown on exposure to iodine vapours (TLC). The structure of SDj^ has been 
established by FT-IR, DCI-MS, ^H-NMR and ^^C-NMR spectra. The IR 
spectrum (KBr) displayed characteristic absorption bands at 3436 (NH), 
2945 (CH), 1576 (C=N), 1463 (phenyl), 1339, 1171 (C=S), 1079 (C-N), 
906, 818, 721, 609 cm'^ The DCI-MS spectrum (FIG. 40) of SD^^ showed a 
2 0 4 
[M+l]"^ peak at m/z 294 as the base peak, confirming its molecular weight 
293 [CjjHjjNjSj]. This is equal to the sum of the molecular weights of (17) 
(220) and thiosemicarbazide (91) minus one molecule of water (18) which 
indicated that the condensation has occurred between the thienylchalcone and 
thiosemicarbazide. The peak at m/z 260 [(M+1) - HjS]"^ was arised due to the 
loss of HjS from the parent ion and an another peak at m/z 234 [(M+1) -
CSNHj]"^ appeared by the cleavage of N-C bond. The peak observed at m/z 218 
[(M+1) - NH2CSNH2]"^ was due to the cleavage of 1-2 and 1-5 bonds, showing 
the location of the ring. The peak at m/z 183 [(M+1) - CjHjNS]^ and m/z 109 
[(M+1) - C^H^NjSj]"^ arised due to fragmenting of the ring at 
1-2 and 3-4 bonds which further confirmed the formation of ring. The other 
important fragement ions were observed at m/z 171, 169, 151, 109, all these 
supported the formation of pyrazoline ring (CHART-13). The ^H-NMR 
(FIG. 41) and '^C-NMR (FIG. 42) dissolved in acetone-t/g showed signals as 
assigned (TABLE-14). The assignments of all ^H- and ^^C-NMR signals to 
individual H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity and relative integrations and also by 
comparison with the spectral data of SDj (18) (TABLE-13). In ^H-NMR 
spectrum, the disappearance of the signals corresponding to olefmic protons 
at 57.21 (H-2) and 57.44 (H-3) in SDj (18) and in place the appearance of new 
signals as two doublets at 63.42 (J= 17.55 Hz, J=2.75 Hz) and 64.00 (J=17.55 
Hz, J=10.84 Hz) were attributed to H-4eq and H-4ax respectively. A double 
doublet at 66.37 (J=2.75 Hz, J=10.84 Hz) was assigned to H-5ax proton. 
Thus, the coupling constants showed that the two diastereotopic hydrogens at 
C-4 are anti and synperiplanar with C-5 hydrogen. The aromatic protons 
signals were accounted for six protons of two aromatic rings as shown in 
TABLE-14. The structure was further confirmed by '^C-NMR spectrum 
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which also showed the disappearance of the signals corresponding to the 
ethylenic carbons at 5116.99 (C-2) and 5134.34 (C-3) in SDj (18) and the 
appearance of new signals corresponding to methylene carbon at 543.90 
(C-4) and methine carbon at 560.12 (C-5). A signal at 5178.12 was assigned 
to C=S carbon and the signals for aromatic carbons appeared are shown in 
TABLE-14. 
Based on the above spectral evidence, SD^^ was characterized as 2-[3,5-
bis(2-thienyl)-2-pyrazoline-l-yl]thiocarboxamide (19). 
Structure Elucidation of SDjb(20) 
It is a dark brown needle shaped crystalline solid,m.p. 280 °C and 
appears brown on exposure to iodine vapours on TLC. The constitution of 
SDjb (20) has been established by FT-IR, DCI-MS, ^H-NMR and '^C-NMR 
spectra. The IR spectrum (KBr) of SDjg displayed characteristic absorption 
bands at 2818 (CH), 1680 (C=0), 1593 (C=N), 1550 (phenyl), 1470 (S-CHj), 
1385, 1351, 1291, 1224, 1101, 829, 714 cm"'. The DCI-MS (NH3 as a 
reagent gas) spectrum of SDjg (FIG. 43) showed [M+H]"^ peak at m/z 334 as 
the base peak, confirming its molecular weight 333. This is equal to the sum 
of the molecular weights of SDj^ (293) and chloroacetic acid (94) minus one 
molecule of water (18) as well as one molecule of HCl (36) which indicated 
that cyclocondensation has occurred between thiocarboxamide moiety of 
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SDj^ with chloroacetic acid thereby forming thiazolinone ring. The main 
fragment ion peaks observed at m/z 224 [(M+H) - CjH^NS]"^ and m/z 110 
[(M+1) - CgHgNjOSj]"^ were arised by the cleavage of 1-2 and 3-4 bonds of 
pyrazoline ring. The mode of fragmentation is shown in CHART-14. The ^H-
NMR (FIG. 44) and '^C-NMR (FIG. 45) spectra of dissolved in 
acetone-a?g showed signals as assigned in TABLE-15. The assignments of all 
^H-NMR and ^^C-NMR signals to individual H- and C-atoms have been 
performed on the basis of typical chemical shift values, multiplicity, relative 
integrations and by comparison of the spectral data of SD^^ (19) 
(TABLE-14). The two double doublets at 63.67 (J=17.85 Hz, J=3.51 Hz) and 
54.23 (J=17.85 Hz, J=10.84 Hz) were assigned to H-4eq and H-4ax protons 
respectively. A double doublet at 56.16 (J=3.51 Hz, J=10.84 Hz) was 
attributed to proton for H-5ax. Thus, the coupling constants showed that two 
diasterotopic hydrogens at C-4 are anti and synperiplanar with C-5 hydrogen. 
The signal corresponding to NHj protons at 67.12, 7.40 in SDj^ (19) 
(TABLE-14) has disappeared in the 'H-NMR spectrum of SD^g, showing that 
NHj group was involved in the formation of the thiazolinone ring. The 
formation of the ring has also been supported by the appearance of new signal 
at 53.85 corresponding to methylene protons of thiazolinone ring. The 
'^C-NMR spectrum showed a signal of 6187.01 (C-4') for carbonyl carbon. 
The signal corresponding to C=S group did not appear and in place other 
signals at 5178.64 (C-2'), 39.30 (C-5') appeared. The aromatic carbons 
signals were assigned as shown in the TABLE-15. 
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On the basis of these facts, SDjg was characterized as 2-[3,5-bis(2-
thienyl)-2-pyrazoline-l-yl]thiazolin-4-one (20). 
Synthesis of 2-[3-(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-
1-yl]thiazolm-4-one SD^g (24) from 4-bromophenyl-4-methylphenyl-2-
propen-l-one (21) via 2-[3-(4-bromophenyl)-5-(4-methylphenyl)-
2-pyrazolin-l-yl]thiocarboxamide SD^^ (23) using chloroacetic 
acid in the presence of sodium acetate 
The compound SD^g (24) was prepared as mentioned above. The 
pyrazolinyl thiacarboxamide SD^^ (23) was first prepared by refluxing a 
solution of bromomethyl chalcone (21) and thiosemicarbazide (molar ratio, 
1:3) in absolute alcohol in the presence of conc. HCl, for 10 h.. After 
completion of the reaction, the reaction mixture on TLC examination (silica 
gel 'G', benzene-ethyl acetate, 8:2 v/v) showed the presence of two spots, 
levelled as SD^ and SD^^. On usual work up and column chromatography 
followed by crystallization from benzene acetone, it yielded SD.^  as orange 
crystalline needles and SD^^as brown crystalline needles in 14% and 66% 
yields. SD^^ was then condensed with chloroacetic acid and sodium acetate 
(molar ratio, 1:1.25:1.5). The cyclocondensation was carried out by refluxing 
the reaction mixture in freshly distilled acetic acid for 35 h. TLC examination 
(silica gel 'G', benzene-ethyl acetate, 8:2 v/v) of the reaction mixture showed 
the presence of only one spot, levelled as SD^g. After usual work up and 
purification of the products by column chromatography over silica gel using 
2 1 8 
benzene-ethyl acetate (8:2 v/v) as eluent followed by crystallization (benzene-
acetone, 9:1 v/v) yielded SD^g (24) as dark brown crystalline needles in 55% 
yield. 
The reaction sequence is given below: 
Ci> 
ai) o 
-H20 NHzCSNHNHzCnular ratio, 1:3), ethanol. Ha, reflux, 10 h 
/ \ 
N + \ 
NH 
\ / 
NI^  
S"'' NH2 
SD,a2) 
SD7a(23) 
/ \ 
S^NH^ 
SDjaOS) 
acH200c*ia^ c0a>fa 
-CHj (ttclarratio, 1:125:1.5), 
acetic acid, refluj; 35 h 
-m 
w / 
-CH3 
N 
O 
SD^(24) 
Structure Elucidation of SD^ (21) 
It is an orange crystalline solid, m.p. 182 °C and appears brown on 
exposure to iodine vapours (TLC). The constitution of SD,^  has been 
established by FT-IR, FAB-Mass, 'H-NMR, '^C-NMR spectra. IR spectrum 
2 1 9 
(KBr) displayed characteristic absorption bands at 3464 (NH), 2930 (CH), 
1584 (C=N), 1478 (phenyl), 1386, 1326, 1250, 1117, 1072, 981, 867, 805, 
768, 712 cm-^ The FAB-MS spectrum (FIG. 46) SD, (22) showed [M]^ ion 
peaks at m/z 374/376 as the base peak confirming its molecular weight 374/ 
376. This is equal to the sum of the molecular weights of chalcone (301) and 
thiosemicarbazide (91) minus one molecule of water (18) which indicated the 
formation of thiosemicarazone by the condensation of chalcone with 
thiosemicarbazide. The sets of peaks were observed at m/z 340/342 [M-HjS]"^ 
and m/z 357/359 [M-NHj]"^. The mode of fragmentation is shown in 
CHART-15. The ^H-NMR (FIG. 47) and '^C-NMR (FIG. 48) spectra of SD^ 
dissolved in CDCI3 and DMSO respectively showed signals as assigned 
(TABLE-16). The assignments of all ^H-NMR and '^C-NMR signals to 
individual H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity, relative integrations and also by 
comparison with previously described thiosemicarbazone SD^ (18) 
(TABLE-13). The ^H-NMR of SD^ showed two doublets at 56.36 (J= 16.20 Hz) 
and 57.03 (J= 16.20 Hz) which were assigned to C-2 and C-3 protons. The 
large coupling constant (J= 16.20 Hz) of vicinal protons confirmed their trans 
dispositions. The proton at C-3 appeared at lower field (67.03) as compared 
to proton at C-2 (56.36) due to the deshielding effect of aryl group attached 
to it. A broad singlet at 610.57 appeared for NH proton. The singlet at 62.38 
was accounted for one methyl group protons. The aromatic protons signals 
were observed at 67.12-7.75. The '^C-NMR spectrum showed signals at 
6148.5 (C-1), 6115.70 (C-2) and 6135.50 (C-3). The signal at 6179.0 was 
attributed to C=S carbon. The signal at 621.10 was assigned for methyl 
carbon. The aromatic carbons signals were observed at 6123.50-141.50 
(TABLE-16). 
i I 1 1 1 L-- V - - I j * * 
T" b"! ' 
-i -L l . - i -i •3;,'. 
r 
220 
t- > 
u . 
i 
u". 
'Si 
• r* 
i v; 
•V I Li', r: 
•-1 i : . . 
ri 1-- a. •z _1 ilj 
LU 'Z i\i r> .V • •27. V<I. • .— - T-l )—I 
U.Gi 
•X iij Lfi •PZ^i) rtj<r Q 
:2 r. U.Cu O CKCQ a. >'X '-v 
u. in 
a: i c. t- O -U W Ui Lij jTi -cr 
a. C) i' Csj 
oi--
(fi G CE All- o szcoGitn 
CO 
I)'; 
•Si 
'SJ 
ff.-
U'J" 
u*i 
• u''. 
11. 
-
- U'i 
VO 
E 
Crl ^ I n c-n c J 
+ 
221 
iH m + 
If 
1 
§ ( ) § § 
§ 
:2 ^ ^ 
\ 
00 
ts 
I 
<s N 
IT) 
u 
222 
11 s. 
K S K i sssl L ! IIS risggg J i 1 
i l l « ID V s "5 O o o 
o o 1 S i S 
u a X a X a X 
X o o o g 
o — 
% -s O P-« 
H s i e l l l i ^ s i g s l i s g g s s o s s 
00 0 
fE z 
BE 3 
96 e 
cn 
- o 
9299 E 
6990 ; 
E902 0 
08 L 
^^B^es • 0 
Egl'I 6 
-^gegf 0 
-^9661 0 
zrTeeei o 
- O J 
r 
i 
d 
E 
- t o 
If 9 
9^ 01 - — 0000 
ludo tej6aiu[ Q. CL 
2 2 3 
t £ S S 3 5 
gSgS g 3S2iJ °SRiSS§ vin MO i n - o i x o — o s g o — 
F s^® f 
U E 
, g ~ g ~IS u CI X a X Q X 
« - " f e e JSS'V 
CTl 
C\J 
tn 
S 6 o et m f^ a " 
s 
o t 
rv 
i i in 
o I/) e •D 
cn 
o X ^ ^ % nj i 
M U H. U, lb u . ( 
I 12 
9 9^  
0 ^^  
^ zz > 
_ o 
IT) 
00 Tf 
O 
s 
o 
- o 
o -in 
0 
luaa Q. , O. 
262 
fS fS 
t-
Q 
o 
•d 
u 
u 0 a 
C/l 
ftj 
s 
u 
d CQ 
S 
z 
1 
I 
n 
H 
s 
a. a. w 
to 
b. 
e 
U 
N 
B 1-9 
3 « 
e D. 
i .2 
e es l-H 6£ 
a Q. & 
to 
s 
I 
a 
o >n 
o O o o >o o o V") 
00 >o in ON r-H rn rt cn O fS f-i^  <—> »—1 (S 
X 
CO U 
—I <s m U 
o fS o (N 
vo vo 
<N 
vo cn 1—1 in 00 fo o o fo vo od (N 
( N CO 
<s 
K 
2 
><i 
(N 
e 
l-c 
X X X X X X ^ <-1 fS ^ CO 00 
>o 
t--I 61 
m 
5 ^ 
2 2 5 
On the basis of above spectral evidence, the product SD^ (22) was 
characterized as N^ - [ 1 -(4-bromophenyl)-3-(4-methylphenyl)-2-propen-1 -
ylidene] thiosemicarbazide (22). 
SD? (22) 
Structure Elucidation of SD,^ (23) 
It is a brown needles shaped crystalline solid,m.p. 200 °C and appears 
brown on exposure to iodine vapours (TLC). The structure of SD^^ has been 
fully established by FT-IR, EI-MS, ^H-NMR and ^^C-NMR spectra. The IR 
spectrum (KBr) showed characteristic absorption bands at 3380 (NH), 2970 
(CH), 1590 (C=N), 1535, 1480 (phenyl), 1330, 1115 (C=S), 1075 (C-N) cm'^ 
The El-MS spectrum (FIG. 49) of SD^^ showed a set of peaks at m/z 374/ 
376 [M]"^ , confirming its molecular weight 374/376. This is equal to the sum 
of the molecular weights of the chalcone (21) (301) and thiosemicarbazide 
(91) minus one molecule of water (18) which indicated the condensation has 
occurred between the chalcone (21) and thiosemicarbazide. The set of peaks 
at m/z 357/359 [M-NHj]"^ appeared by the loss of anmionia and an another set 
of peaks at m/z 340/342 [M-HjS]"^ due to the loss of HjS from the molecular 
ion. The set of peaks at m/z 314/316 [M-CSNHj]"^ were observed by the 
cleavage of N-C bond. The mode of fragmentation is shown in (CHART-16). 
The 'H-NMR (FIG. 50) and '^C-NMR (FIG. 51) dessolved in CDCI3 showed 
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signals as assigned (TABLE-17). The assignments of all ^H- and ^^C-NMR 
signals to specific H- and C-atoms have been performed on the basis of 
typical chemical shift values, multiplicity, relative integrations and also by 
comparison with the spectral data of SD, (22) (TABLE-16) and SD,^(19) 
(TABLE-14). The two double doublets at 63.08 (J=17.10Hz, J=5.70Hz) and 
53.75 (J=17.10Hz, J=12.0Hz) were assigned to H-4eq and H-4ax 
respectively. The another double doublet at 55.57 (J=5.70Hz, J=12.0Hz) was 
attributed to the proton of H-5ax. These coupling constants showed that the 
two diastereotopic hydrogen atoms at C-4 are anti and synperiplanar with C-5 
hydrogen. A singlet was also observed at 67.36 for NHj protons. The 
aromatic protons signals at 57.09-7.62 for two benzene rings were accounted 
for eight protons (TABLE-17). The '^C-NMR spectrum showed signals at 
5159.90 (C-3), 42.80 (C-4), 61.60 (C-5), 23.70 (C-Ar-CHj) and the aromatic 
carbons signals at 6123.80-138.80. 
Based on the above spectral evidence, SD^^ was characterized as 2-[3-
(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-ylJthiocarboxamide (23). 
Ar V j - f . / , , 
2 
1 
SD7A(23) 
Structure Elucidation 8073(24) 
It is a dark brown needle shaped crystalline solid,m.p. 230 °C and 
appears brown on exposure to iodine vapours (TLC). The constitution of SD^g 
has been confirmed by FT-IR, EI-MS, 'H-NMR and '^C-NMR spectra. The IR 
2 3 2 
spectrum (KBr) of SD^g displayed characteristic absorption bands at 2964 
(CH), 1699 (C=0), 1593 (C=N), 1538 (phenyl), 1486 (-S-CHj), 1389, 1331, 
1211, 1111, 1067, 1006, 946, 867, 820, 707 cm''. The EI-MS spectrum 
(FIG. 52) showed a set of peaks [M+1]"^ at m/z 415/417, confirming its 
molecular weight 414/416. This is equal to the sum of the molecular weights 
of SD j^^  (374) and chloroacetic acid (94) minus one molecule each of 
water (18) and HCl (36). This indicated the formation of thiazolinone ring by 
the cyclocondensation of SD.^ ^ with chloroacetic acid. The mode of 
fragmentation is shown in CHART-17. The ^H-NMR (FIG. 53) and '^C-NMR 
(FIG. 54) spectra of SD^g dissolved in CDCI3 and DMSO showed signals as 
assigned in TABLE-18. The assignments of all ^H-NMR and '^C-NMR 
signals to specific H- and C-atoms have been performed on the basis of 
typical chemical shift values, multiplicity, relative integratitons and by 
comparison of spectral data with that of compounds SDjg (20) (TABLE-15) 
and SD,^ (23) (TABLE-17). The signal corresponding to NH^ protons at 
57.36 in SD^^ (TABLE-17) has disappeared in the ^H-NMR spectrum of 
SD^g and a new signal appeared at 53.83 corresponding to methylene protons, 
suggesting the formation of a thiazolinone ring. The aromatic protons signals 
for benzene rings containing eight protons were observed at 57.11-7.68 
(TABLE-18). The ^^C-NMR spectrum showed a new signal at 5187.42 for 
carbonyl carbon of the thiazolinone ring. The other carbons signals observed 
at 5158.52 (C-3), 43.21 (C-4), 63.88 (C-5), 178.27 (C-2'), 38.96 (C-5'), 
21.00 (C-Ar-CHj) and the aromatic carbons signals at 5125.69-138.14 were 
observed (TABLE-18). 
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Based on the above facts, SD^g was characterized as 2-[S-(4-
bromophenyl)-5-(4-methylphenyl)-2-pyrazolin-l-yl]thiazoliri-4-one (23). 
' ' H 
B r — ^ At J 
N, 
i S ^ N 
-CH, 
0 
SD7B (24) 
experimental 
2 3 9 
EXPERIMENTAL 
l,3-Bis(2-thienyl)-2-propen-l-one (17) 
It was prepared following a published procedure'^^ by condensing 
thiophene-2-aldehyde with 2-acetyl thiophene (prepared from thiophene 
according to reported procedure"''^) in equimolar ratio, in the presence of 2.5 
equivalents of sodium hydroxide. A mixture of thiophene-2-aldehyde 
(500 mg, 4.46 mmol) and 2-acetyl thiophene (562 mg, 4.46 mmol) in 
(20 ml) ethanol was kept on an ice bath and to this was added sodium 
hydroxide (446 mg, 11.15 mmol) dropwise with stirring. It was further stirred 
4 h and then worked up as usual. The yellow solid thus obtained was 
crystallized (acetone-benzene) to yield (17) as light yellow crystalline 
needles, 765 mg (78%), m.p. 89°C, Rj.0.63 (pet. ether - ethyl acetate, 8:2 v/v). 
Spectral data of (17) 
^H-NMR (acetone-rfg, 400 MHz) : 7.48 (IH, d, J==15.51 Hz, H-2), 7.94 
(IH, d, J=15.5I Hz, H-3), 7.67 (IH, dd, J=3.66 Hz, J=1.07 Hz, Ar'-3), 7.60 
(IH, dd, J=3.66, J=1.07 Hz, Ar-3), 7.27 (IH, dd, J=5.04hz, J=3.66 Hz, 
Ar'-4), 7.18 (IH, dd, J=5.04 Hz, J=3.66 Hz, H-Ar-4), 8.11 (IH, dd, J=5.04 
Hz, J=1.07 Hz, Ar'-5), 7.92 (IH, dd, J = 5.03 Hz, J=1.07Hz, Ar-5). 
i^C-NMR (acetone-^/g, 100 MH3) : 5c 181.80 (C-1), 121.36 (C-2), 133.06 
(C-3), 129-60-146.68 (C-Ar + Ar'). 
DCI-MS (NH3) : m/z 221/222/22.3 [(M+l)/(M+2)/(M+3), 100.0/20.4/11.8], 
220 (14.0), 191 (3.7), 137 (3.8), III (7.2). 
2 4 0 
2-[3,5-Bis(2-thienyl)-2-pyrazolin-l-yl]thiocarboxamide SD (19) 
along with thiosemicarbazone, N^-[l,3-bis(2-thienyl)-2-propen-l-
ylidene)thiosemicarbazide SDj(18) 
A mixture of l,3-bis(2-thienyl)-2-propen-l-one (17) (700 mg, 3.18 
mmol) and thiosemicarbazide (868 mg, 9.54 mmol) in absolute alcohol 
(25 ml) was refluxed for 10 h with stirring. The progress of the reaction was 
monitored by TLC at every 30 minute. After completion, the reaction mixture 
was concentrated under reduced pressure, extracted with diethyl ether and 
washed with water until the solution was neutral. The ethereal solution was 
then kept over Na2S04 overnight, then solvent evaporated and orange-coloured 
oily residue left was examined by TLC (silica gel 'G' benzene-ethyl acetate, 
8:2 v/v). It was found to be a mixture of two components, one minor (upper) 
and the other major (lower), labelled as SDj and SDj^. The oily residue was 
chromatographed over a silica gel column using benzene-ethyl acetate, 
(8:2 v/v) as an eluent. Elution of the column first furnished a light yellow 
coloured solid which on crystallization from benzene-acetone yielded 
SDj(18) as an orange crystalline needles, 221 mg (15%), m.p. 130 Rj.0.76 
(benzene-ethyl acetate, 8:2 v/v). 
Spectral data of SDj(18) 
IR (KBr pellet) : u^^^ cm*' 3420, 3240 (NH), 2915 (CH), 1590 (C=N), 1495 
(phenyl), 1180 (C=S), 1070(C-N), 950, 816, 715 cm"'. 
^H-NMR (acetone-^/g, 400 MHz) : 7.21 (IH, d, J=16.02 Hz, H-2), 7.44 
( I H , d, J = 16.02 Hz, H-3), 7.53, 7.63 (2H, s, N H j ) , 9.98 (IH, s, NH), 7.11-
7.60 (6H, br m, H-Ar + Ar'). 
^^C-NMR (acetone-c?6, 100 MHz) : 116.99 (C-2), 134.34 (C-3), 143.69 
(C-1), 180.90 (C=S), 127.60-143.91 (C-Ar + Ar'). 
2 4 1 
DCI-MS (NH3) : m/z 296/295/294 (15.4/21.2/100.0), 280/279/278/277 
(3.1/18.0/4.3/20.8), 260 (3.1), 235 (3.9), 233 (9.6), 218 (2.0), 185/184/183 
(3.1/4.3/32.4), 112 (3.9), 77 (8.7). 
Further elution of the column yielded a yellow coloured solid which on 
recrystallization from benzene-acetone afforded SD,^(19) as brown 
crystalline needles, 960 mg (65%), m.p. 138 °C, R^ 0.62 (benzene-ethyl 
acetate, 8:2 v/v). 
Spectral data of SD^^ (19) 
IR (KBr pellet) : u ^ ^ cm"^  3436, 3274 (NH), 2945 (CH), 1576 (C=N), 1463 
(phenyl), 1339, 1171 (C=S), 1079 (C-N), 906, 818, 721, 609 cm-'. 
^N-NMR (acetone-rfg, 400 MHz) : 3.42 (IH, dd, J=17.55 Hz, J=2.75 Hz, 
H-4eq), 4.00 (IH, dd, J=17.55 Hz, J=10.84 Hz, H-4ax), 6.37 (IH, dd, J=2.75, 
J=10.84, H-5ax), 7.12, 7.40 (2H, s, NHj), 7.05 (IH, ddd, J=3.66 Hz, J=1.22 
Hz, J=0.77 Hz, H-Ar-3), 6.94 (IH, dd, J=3.66 Hz, J=5.04 Hz, H-Ar-4), 7.30 
(IH, dd, J=5.04 Hz, J=1.22 Hz, H-Ar-5), 7.55 (IH, dd, J=3.66 Hz, J=1.07 Hz, 
H-Ar'-3), 7.17 (IH, dd, J=3.66 Hz, J=5.04 Hz, H-Ar'-4), 7.69 (IH, dd, 
J=5.04 Hz, J=1.07 Hz, H-Ar'-5). 
i^C-NMR (acetone-c/g, 100 MHz) : 5c 135.25 (C-3), 43.90 (C-4), 60.12 
(C-5), 178.12 (C=S), 152.28 (Ar-2), 131.42 (Ar-3), 128.87 (Ar-4), 125.57 
(Ar-5), 146.05 (Ar'-2), 130.62 (Ar'-3), 127.28 (Ar'-4), 125.19 (Ar'-5). 
DCI-MS (NH3) : m/z 296/295/294/293 (15.5/18.5/100.0/6.8), 260(6.0), 
237/236/235/234/233 (9.4/15.9/92.1/27.9/7.4), 218 (5.4), 183 (7.1), 171 
(4.1), 169 (12.9), 151 (5.3), 109 (4.6), 97 (7.6). 
2 4 2 
2-[3,5-Bis(2-thienyI)-2-pyrazolin-l-yIlthiazolin-4-one SD^g (20) 
A mixture of the pyrazolinyl thiocarboxamide SDj^ (19) (850 mg, 2.90 
mmol), chloroacetic acid (341 mg, 3.63 mmol) and sodium acetate (357 mg, 
4.35 mmol) in freshly distilled acetic acid (25 ml) was refluxed with stirring 
on an oil bath at 120 °C for 35 h. After the reaction was over, the reaction 
mixture was concentrated under reduced pressure, extracted with diethyl ether 
and washed with water until the solution became neutral. The ethereal solution 
was dried over Na2S04 and the solvent evaporated under reduced pressure. The 
yellow-coloured oily residue left was finally examined by TLC (silica gel 'G' 
benzene-ethyl acetate 8:2 v/v) which showed only one component, labelled as 
SDjg. The oily residue was chromatographed on a silica gel column using 
benzene-ethyl acetate (8:2 v/v) as an eluent. Elution of the column furnished 
a yellow-coloured solid which on crystallization from benzene-acetone 
(9:1 v/v) afforded SD^g (20) as dark brown crystalline needles, 573 mg (56%) 
m.p. 280 °C, Rf 0.58 (benzene-ethyl acetate, 8:2 v/v). 
Spectral data of SD^g (20) 
IR (KBr pellet) : u^^^ cm'^  2818 (CH), 1680 (C=0), 1593 (C=N), 1550 
(phenyl), 1470 (S-CH^), 1385, 1351, 1291, 1224, 1101, 829, 714. 
ifl-NMR (acetone-fifg, 400 MHz) : 3.67 (IH, dd, J = 17.85 Hz, J=3.51 Hz, 
H-4eq), 4.23 (IH, dd, J=17.85 Hz, J=10.84, H-4ax), 6.16 (IH, dd, J=3.51 Hz, 
J=10.84 Hz, H-5ax), 3.85 (2H, s, H-5'), 7.17 (IH, ddd, J = 3.66 Hz, J=1.22 
Hz, J=0.77 Hz, H-Ar-3), 6.99 (IH, dd, J=3.66 Hz, J=5.04 Hz, H-Ar-4), 7.39 
(IH, dd, J=1.22 Hz, 5.04 Hz, H-Ar-5), 7.65 (IH, dd, J=3.66 Hz, J=1.22 Hz, 
H-Ar'-3), 7.24 (IH, dd, J=3.66 Hz, J=5.04 Hz, H-Ar'-4), 7.79 (IH, dd, J=5.04 
Hz, J=1.22 Hz, H-Ar'-5). 
2 4 3 
"C-NMR (acetate-^/g, 100 MHz) : 156.18 (C-3), 44.54 (C-4), 60.67 
(C-5), 178.64 (C-2'), 187.01 (C-4'), 39.30 (C-5'), 126.36-143.38 (C-Ar + Ar'). 
DCI-MS (NH3) : m/z 336/335/334/333 (16.1/21.6/100.0/10.2), 236 (4.7), 
224 (6.1), 151(2.0), 110 (8.8), 109 (5.3). 
1-(4-Bromophenyl)-3-(4-methylphenyl)-2-propen-l-one (21) 
It was prepared as described above by condensing 4-methyl 
benzaldehyde with 4-bromoacetophenone in equimolar ratio in presence of 
2.5 equivalent of sodium hydroxide. A mixture of 4-methyIbenzaldehyde (700 
mg, 5.8 mmol) and 4-bromoacetophenone (1160mg, 5.8 mmol) dissolved in 
ethanol (25 ml) was kept on an ice bath in 500 ml flask. To this sodium 
hydroxide (583 mg, 14.6 mmol) was added dropwise with stirring. It was 
stirred further for 3 h. and then worked up as above. The yellow solid thus 
obtained was crystallized in ethanol to afforded (21) as yellow crystalline 
needles 1316 mg (75%), m.p. 138 °C, R^ 0.76 (hexane-ethyl acetate, 8:2 v/v). 
2 - [ 3 - ( 4 - b r o m o p h e n y l ) - 5 - ( 4 - m e t h y l p h e n y I ) - 2 - p y r a z o l i n - l - y l ] 
thiocarboxamide SD^^ (23) along with the adduct 
thiosemicarbazone, N^-[3-(4-bromophenyl)-5-(4-methylphenyl)-2-
propen-l-ylidene] thiosemicarbazide SD^ (22) 
A mixture of the chalcone (21) (1200 mg, 3.98 mmol) and 
thiosemicarbazide (1088 mg, 11.96 mmol) in absolute alcohol (50 ml) was 
refluxed with stirring at 80 °C on an oil bath for 10 h. The progress of the 
reaction was monitored by TLC at every 30 minute. After completion, the 
reaction mixture was concentrated under reduced pressure, extracted with 
diethyl ether and washed until the solution was neutral. The ethereal solution 
was then dried over sodium sulphate, solvent evaporated and the orange-
coloured oily residue left was examined by TLC (silica gel 'G', benzene-ethyl 
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acetate, 8:2 v/v). It was found to be a mixture of two compounds, one minor 
(upper) and the other major (lower), labelled as SD^ (22) and SD^^ (23). The 
oily residue was chromatographed over a silica gel column using benzene-
ethyl acetate (8:2 v/v) as an eluent. Elution of the column first furnished a 
yellow-coloured solid which on crystallization from benzene-acetone 
afforded SD^ (22) as an orange crystalline needles, 210 mg (14%), 
m.p. 182 °C, Rf 0.86 (benzene-ethyl acetate). 
Spectral data of SD^ (22) 
IR(KBr pellet) : o^^^ 3464 (NH), 2930 (CH), 1584 (C=N), 1478 (phenyl), 
1386, 1326, 1250, 1117, 1072, 981, 867, 805, 768, 712 cm'^ 
^H-NMR (CDCI3 + DMSO, 300 MHz) : 6.36 (IH, d, J=16.20 Hz, H-2, 
7.03 (IH, d, J=16.20Hz, H-3), 8.41 (2H, s, NH^), 10.57 (IH, s, NH), 2.38 
(3H, s, H-Ar-CHj), 7.12-7.75 (8H, br m, H-Ar). 
i^C-NMR (CDCI3 + DMSO, 75 MHz) : 148.50(C-1), 115.70(C-2), 
135.50 (C-3), 179.0) (C=S), 21.10 (C-Ar-CHg), 123.50-141.50 (2 x Ar - C). 
FAB-Mass (JEOL SX 102/DA-6000) : m/z 374/376 (100.0/93.75), 357/359 
(12.50/12.50), 340/342 (14.58/16.66), 315/317 (16.66/16.66), 298/300/ 
302 (41.66/45.83/10.42), 235/237(29.16/20.83), 218/220 (14.58/6.24), 
200/202/204/206 (2.08/8.33/8.33/4.16), 189/191 (8.33/20.83), 176/178 
(4.16/6.24), 165 (20.83), 162 (18.75), 154 (18.75), 136/134 (14.58/4.16), 
115/117 (18.75/20.83), 105 (6.24). 
Further elution of the column afforded a yellow solid which on 
crystallization from benzene-acetone yielded SD^^ (23) as brown crystalline 
needles, 989 mg (66%), m.p. 200°C, Rj.0.62 (benzene-ethyl acetate, 8:2 v/v). 
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Spectral data of SD^^ (23) 
IR (KBr pellet) : 3380 (NH), 2970 (CH), 1590 (C=N), 1535, 1480 (phenyl), 
1330, 1115, 1075, 960, 860, 810, 760 cm"'. 
^H-NMR (CDCI3, 300 MHj) : 3.08 (IH, dd, J=17.10 Hz, J=5.70 Hz, 
H-4eq), 3.75 (IH, dd, J=17.10Hz, J-12.0 Hz, H-4ax), 5.57 (IH, dd, 
J=5.70Hz, 12.0 Hz, H-5ax), 7.36(2H, s, NHj), 2.35 (3H, s, H-Ar-CHg), 7.09-
7.62 (8H, br m, H-Ar). 
"C-NMR (CDCI3, 75 MHz) : 159.90 (C-3), 42.80 (C-4), 61.60 (C-5), 
23.7 (C-Ar-CHj), 123.80-138.80 (2 x Ar- C). 
EI-MS : m/z 374/376 (6.06/2.27), 357/359 (9.10/10.60), 340/342 (9.85/ 
8.33), 314/316 (63.64/59.10), 299/301 (9.85/6.82), 284/286 (6.06/3.79), 
269/271/273 (7.5/9.85/1.52), 235 (7.5), 234 (13.64), 233 (6.82), 226 (3.0), 
225 (27.27), 224 (9.09), 223 (29.55), 205/207 (32.58/3.78), 197/199 
(20.45/18.18), 189/191 (49.24/100.0), 182/184 (25.76/22.73), 178/180 
(12.12/3.03), 169/171 (6.06/6.81), 165/167 (21.21/3.03), 155/157 (9.09/ 
10.60), 150/152 (4.54/8.33), 144/146 (17.42/12.12), 128/130 (17.42/4.55), 
115/117 (44.70/43.18), 102/104 (43.18/6.82), 91 (47.72), 88/90 (35.60/ 
15.15), 77/79 (20.45/7.58), 65 (14.77), 60 (78.03). 
2-[3-(4-bromophenyl)-5-(4-methylphenyl)-2-pyrazoliii-l-yl]thiazolin-4-
one SD^B (24) 
A mixture of the pyrazolinyl thiocarboxamide SD^^ (23) (900 mg, 
2.4 mmol), chloroacetic acid (283 mg, 3.0 mmol) and sodium acetate 
(296 mg, 3.6 mmol) in freshly distilled acetic acid (25 ml) was refluxed with 
stirring on an oil bath at 120 °C for 35 h. After the reaction was over, the 
reaction mixture was concentration under reduced pressure, extracted with 
diethyl ether and washed with water until the solution became neutral. The 
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ethereal solution was dried over NajSO^ and the solvent evaporated under 
reduced pressure. The yellow-coloured oily residue left was finally examined 
by TLC (silica gel 'G' benzene-ethyl acetate, 8:2 v/v) which showed only one 
component, labelled as SD^g. The oily residue was chromatographed on a 
silica gel column using benzene-ethyl acetate (8:2 v/v) as an eluent. Elution 
of the column furnished a yellow coloured solid which on crystallization from 
benzene-acetone (9:lv/v) yielded SD^g (24) as brown crystalline needles, 
548 mg (55%)^ m.p. 230 Rj.0.35 (benzene-ethyl acetate, 8:2 v/v). 
Spectral data of SD^g (24) 
IR (KBr pellet) : u^^^ 2964 (CH), 1699 (C=0), 1593 (C=N), 1538 (phenyl), 
1486 (S-CH^), 1389, 1331, 1211, 1111, 1006, 946, 867, 820, 707. 
iH-NMR (CDCI3 + DMSO, 300 MHz) : 3.35 (IH, dd, J=18.0 Hz, J=3.90 
Hz, H-4eq), 3.94 (IH, dd, J = 18.0 Hz, J=11.10 Hz, H-4ax), 5.76 (IH, dd, 
J=3.90, J=11.10 Hz, H-5ax), 3.83 (2H, s, H-5'), 2.30 (3H, s, H-Ar-CH3), 
7.11-7.68 (8H. br m, H-Ar). 
i^C-NMR (CDCI3, 75 MHz) : 5c 158.52 (C-3), 43.21 (C-4), 63.88 (C-5), 
178.27 (C-2'), 187.42 (C-4'), 38.96 (C-5'), 21.0 (C-Ar-CHj), 125.69-138.14 
(2 X Ar-C). 
EIMS : m/z 415/417 (28.78/2.27), 386/388 (3.03/1.52), 380/382 (2.27/ 
2.27), 366/368 (1.52/1.66), 338/340/342(1.52/2.27/1.0), 308/310 (9.84/ 
6.82), 311/313 (2.0/1.8), 298/300 (6.06/4.55), 284/286 (2.27/1.14), 269/ 
271 (2.27/0.90), 258/260 (1.52/1.52), 249/251 (0.75/1.52), 231/232/233 
(9.85/89.39/31.82), 217/218/219 (41.66/9.09/3.79), 202/204 (12.12/ 
34.85), 195/197 (13.64/9.09), 189/190/191 (12.12/21/21.21), 181/183 
(17.42/15.15), 155/157 (15.15/18.18), 152 (2.27), 151 (2.20), 150 (2.65), 
149 (8.71), 148 (10.60), 147 (3.03), 146 (1.51), 145 (4.54), 144 (9.85), 143 
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(6.06), 142 (5.30), 141 (9.09), 140 (7.57), 139 (4.54), 138 (7.57), 137 
(6.82), 119 (8.33), 118, (67.42), 117, 100.0), 116 (15.15), 115 (50.76), 106 
(5.30), 105 (15.53), 104 (3.78), 103 (16.28), 102 (20.15), 101 (5.30), 92 
(7.5), 91 (47.72), 86 (21.21), 79 (2.27), 78 (6.06), 77 (12.88), 76 (17.42), 
75 (11.36), 72 (11.06), 68 (7.58), 65 (9.09), 63 (4.55), 52 (5.30), 50 (3.78), 
46 (41.66). 
S e / , ermces 
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Chapter - 4 
1^3j3''Tris(p'Chlorophenyl)propene 
from Chalcone 
^Theoretical 
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THEORETICAL 
New synthetic insecticides are discovered in two ways. The first and 
most important, atleast until recent years, is discovery by accident, guided of 
course by past experience. The second is by exploration of groups of 
compounds related to logical method of synthesizing new insecticides is to 
combine certain chemical radicals of known value by linkage that may be 
expected to enhance toxic properties. Organophosphorus esters have played 
an extremly important part in insect control, and despite modern 
developments are still used on a wide scale. In contrast to the organochlorine 
insecticides, they degrade readily in the environment. In organochlorine 
insecticides of type II 'DDT' (dichlorodiphenyl trichloroethane) and BHC 
(benzene hexachloride) are most frequently used. DDT has been reported to 
effective against more than one hundred well-known insect^pests damaging 
crops and plants grown for man's benifit, e.g. bollworm, codlus moth, 
Colorado potatobeetle etc. DDT is not a cure-all. Some important pests not 
controlled by DDT include the mexican bee beetle, grass hoppers (various 
species), cotton leaf-worm, etc. The mode of action, which is now well 
authenticated and understood, involves the irreversible inhibition of the 
enzyme acetylcholinesterase, which is essential to nervous conduction in 
insects, by phosphorylation of a hydroxy group at the active site. 
Thiophosphoric ester are usually preferred because of their greater stability, 
but it is important to note that they are only poor inhibitors of the enzyme, 
and are rapidly oxidized in the insect to much more toxic phosphoric esters. 
Since acetylcholinesterase is a vital enzyme in vertebrates as well as insects, 
the mammalian toxicity of many organophosphorus insecticides is high. 
However, differences in distribution and metabolism in insects and mammals 
make some esters surprisingly safe. 
2 5 4 
The widespread usage of the organic insecticides has resulted in the 
appearance of resistance in mosquitoes, German cockroach, Cabbage worms, 
Leaf Hoppers, Thrips, Aphids, Mites and Ticks. However, it remained for the 
widespread development of resistance by the housefly, Musca domestica to 
provided a conclusive demonstration of the importance of the problems of 
insecticides resistance from agricultural and public health stand points has 
stimulated a large volume of useful research into the formulation of different 
insecticides and synthesis of their derivatives. Extensive series of organic 
compounds were surveyed for their general insecticides value, especially in 
the period from 1917-1928 by William Moore at the University of 
Minnesota, by C.H. Richardson, R.C. Roark and R.T. Cotton of the U.S. 
Department of Agriculture and F. Tafferfield of the Rothamsted Experimental 
Station in England. By means of such studies many of the chemical structure 
which would contribute to insecticide effectiveness became more and more 
evident. However, as Oilman et al} said "we are still at the emperical stage, 
and rather crude emperical stage in many respects, in correlating chemical 
constitution with physiological action on practically all type of living 
things". In general, this statement still holds true. 
Literature survey revealed that many attempts have been made for the 
synthesis of new organic insecticides from 4,4'-dichloro chalcone and using 
other substrates. Chalcones constitute an important group of natural products 
and some of them possess a wide range of biological activities such as 
antitumor^"^ antibacterial''"'^, an t i fungal^" 'an t i - inf lammatory ' 
antimicrobial'^"'^, anti-cancer'^, prostaglandin binding'^ and insect 
antifeedant'^. W.H. David et al}^ synthesized l,3-bis(4-chlorophenyl)-2-
propen-l-one (I) gauny hydrazone hydrochloride and analogs as antimalarial. 
NNHC(:NH)NH2Ha 
R = H , M e , / j - a QH, ^ 
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Mulder et al?^ reported the syr\thesis of insecticidal l-(phenyl 
carbamoyl)-2-pyrazolines (II) from substituted chalcones and tested against 
Laptinotarsa decemlineata. Pyrazoline derivatives of the chalcone were also 
reported as insecticides. A.S. Tomcufcik el al.^^ prepared tuberculostatic 
hydrazones (III) by treating chalcones with hydrazines. 
Ph 
N. 
n 
-H N 
I 
C0NHPhR4 
R4 = 3,4-02,4-0,4-iodo etc. 
R- / \ 
Ri R9 
I I I 
- C = C — C = N N H — 7 7 - N H 7 
N, 
(m) X 
R = a , 0 a , P h , C F 3 , B r e t c . 
R, = H, 4 - a QH4,2-naphthyl etc. 
R2 = H,Me 
R3 = substituted phenyl, 2-naphthyl 
X=(CH2),.3 
Some new class of insecticides^^, 1-phenyl carbamoyl-2-pyrazolines 
(IV-V) have been prepared and their insecticidal properties were evaluated on 
the larval stages of Aeedes aegypti, Pieris brassicae and Leptinotarsa 
decemlineata. Recently the substituted 2-amino-3,4-dihydropyridine 
derivatives were synthesized and they are used in drug. 
HN—CO 
R 
R=Horall9'lorhaIo 
(IV) 
R2 = H 
X = 0 
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Besides the synthesis of insecticidal compounds many workers 
synthesized the derivatives of chalcone. Bhasker et al?"^ synthesized 3-aroyl-
4-aryl-2-pyrazolines (VI). 
R- / \ / \ 
0 N, \ N 
H 
(VD 
R = Horalky lor halo 
V.D. Orlov et al ^^ carried out the arylation of a,P-unsaturated ketones 
and prepared a number of chalcones analogue beside the cycloalkanones. 
0 o 
(Ph)2HC- -CH(Ph)2 (Ph)2HC- -CH(Ph)2 
(Vn) (vni) 
O. Shimizu et al?^ have synthesized insecticidal l-carbamoyl-4-phenyl 
pyrazoline derivatives (IX). 
R / \ -R, 
N, 
R2 (K) 
R=alkylorhab 
Ri = hab oraDg^I 
R2 = CX)NHR3 
S. Nisaku et alP have synthesized benzopyranopyrazolines (X). These 
compounds were potential useful as insecticides and analgesic. 
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OMe 
R 
N 
OH 
Me 
(X) 
R= H, Me, CH2CH2OH, Ph, tolyl 
N. Harribert et al?^ have prepared diphenyl-2-pyrazoline-l-
carboxamides (XI) and were tested as insecticides, acaricides and 
ectoparasiticides. 
NCONH- / \ X = H,C1,F Y = C H 0 , a F , F 2 
Z = H, Cm allQ'l, CF3, Cm (halo) 
S. Thomas^^ reported the synthesis of insecticidal pyrazoline 
carboxamides (XII) and tested against Spodoptera frugiperda larvae. 
a 
N 
/ \ -a 
CONH ^ ^ \ CF3 
m 
2 5 8 
0 . Kiyomi et al.^^ have synthesized insecticidal 3-difluoromethoxy-
phenyl- l-phenyl(carbamoyl-2-pyrazoline) (XIII). 
CH;: CPhCOC6H4C)CHF2-;? + NH; - NH; ^^hanol/H^/A ^ ^ H F ^ Q . 
N 
H 
(Xffl) 
l-carbamoyl-4-halomethyl-4,5-dihydro pyrazoles^^ (XIV) have been 
synthesized and their insecticidal and acaricidal properties were evaluated for 
Heliothis virescens. 
Ri = R4 = substituted Ph 
CX2Y R2 = H, allg l^, alkojy caibony 1 etc. 
R3 = H.aDq'l, aklojy caibonyl etc. 
X = hato 
Y = H, halo, halo alkyl 
^ NR3R4 z = o , s 
(XIV) 
Some new dihydropyrazole (XV) compound^^ have been prepared and 
these were tested as insecticidal, acaricidal. These compounds gave 80-100% 
kill of Heliothis verscens, spodoptera exiguo and Diabrotica balteata, 40-
79% kill of Myzus persicae and <40% kill of Tetranychus urtica. 
X = O o r S 
A = (un) substituted aiyl 
Rj = H, (un) substituted aDq^ l or aiyl 
R2 = (un) substituted alkyl 
R3 = H, acyl, (un) substituted alkyl 
PCV) 
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S. Otto et al.^^ have prepared pyridylpyrazoles (XVI) and these 
compounds were evaluated as herbicides, insecticides and acaricides. 
m=0,1 
n = 1-3 
Ri = H, (substituted) allQ'l, alkenyl, allQ'nyl 
R2 = H, NO2, OH, SH, CN, halo etc. 
(R4)n Rj = H, cyano, halo etc. 
R, = NO2, cyano, CXDjH, OH, SH etc. 
(O)n, 
(XVI) 
M. Takeshi et al?'^ have synthesized hydrazono (tetrahydronaphthalenyl) 
benzamides (XVII) as an insecticides and acaricides. These compounds 
showed the potential activity against Spodoptera titura. 
A = CH2,CH2CH3etc. 
Q = H, C,.i2 alkyl, Ci.,2 haloaHcyletc. 
Wi = W2 = 0 , S 
X = Y = H , halo, cyano, SCN, SFj 
R, = H, Ci^ allQ'l, Ci^ hatoallg'l, cyclo allg'I etc. 
R2 = R3 = H,Ci^ aB^letc. 
m = l - 4 
n = l-5 
(XVI?) 
0. Itaru et aP^ have prepared N-thiadiazolyl cyclopropane carboxamides 
(XVIII) and these were evaluated as insecticides, acaricides. These 
compounds show decreased residual toxicity or cause little or no 
environmental pollution. 
Y X 
Li - L5 = H, (halo) alkyl, alkoj^', halo 
X = halo,H 
Y= halo aBg^ l 
(xvm) 
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M.L. Dean et al?^ have synthesized a novel heterocyclic nitroalkenes 
(XIX) which were found potential as acaricides and insecticides. 
(XK) 
R = halo oraDo'l 
C. Weygand et al}'^ have synthesized l-(4-methylphenyl)-3-(phenyl)-1-
propanol (XX) by the reduction of p-methyl chalcone with Pt. oxide and 
ferric chloride in presence of acetic acid. 
H,C 
^ Pt. ojdde, FeOs/AcOH 
(XX) 
B. Patro et al.^^ carried out the sodium borohydride reduction (or 
Grignard addition) of the cyclopropyl ketones to afford cyclopropyl carbinols 
(XXI). 
0 MeS MeS 
SMe 
NaBHior 
RjMgX 
(XX5 
SMe 
a 4-MeOC6H^ 
b C,H3 
^ R3 
H 
H 
Me 
Me 
c 4-MeOC6H4 Me Me 
discussion 
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DISCUSSION 
SUMMARY 
The work described in this chapter consists of the preparation of -
(i) 1,2,3-tris(4-chlorophenyl)propan-l-ol Q (25) from 1,3,3-tris(4-
chlorophenyljpropan-]-one P (2) obtained by the addition of 
chlorobenzene to 4,4'-dichlorochalcone (1). 
(ii) 1,3,3-tris (4-chlorophenyl)prop-l-ene R (26) by the dehydration of 
Q (25) in the presence of p-toluenesulphonic acid in dry benzene. 
Structures are established on the basis of IR, Mass, 'H-NMR and 
^^C-NMR spectral studies The compound (25) has been evaluated for 
anticancer activity. 
INTRODUCTION 
The toxicity of hydrocarbons is in general increased when the following 
elements or radicals are introduced into the molecule, CI, Br, I, OH, SH, SO2, 
NO2 and NHj. Organochlorine compounds are reported to be potent 
insecticidaP^'^^'^^, antitumor^'^, antimalarial^® and acaricidaP'"^^ Keepmg in 
view of the importance of organochlorine compounds, effort has been made 
for search of some new or improved organochlorine compounds as 
derivatives of chalcones, and we have prepared the following organochlorine 
compounds : 
(i) 1,3,3-tris(4-chlorophenyl)-propan-l-ol Q (25) from l,3.3-tns(4-
chlorophenyl)propan-]-one P (2) obtained by the addition of 
chlorobenzene to 4,4'-dichlorochalcone (1). 
(11) l,3,3-tris(4-chlorophenyl)prop-l-ene R (26) from Q (25) by dehydration 
in the presence of p-toluenesulphonic acid in dry benzene. 
Structural assignments, stereochemistry and biological assay are 
discussed. Screening results of compound Q (25) are summarized for 
2 6 2 
anticancer activity against 3-cell lines of three types of human cancers : lung, 
breast and CNS and then against 60-cell lines of nine types of human cancers: 
leukemia, lung, colon, CNS, melanoma, ovarian, renal, prostate and breast 
(DETAILS IN CHAPTER-6) 
a 
P(2) 
2 6 3 
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RESULTS AND DISCUSSION 
The synthesis of target compound R (26) was performed in three steps : 
Step 1 : The adduct P (2) was prepared from chalcone (1) using chlorobenzene 
in presence of anhydrous AICI3 exactly as described in CHAPTER-1. 
Step 2 : The carbonyl group of the l,3,3-tris(4-chlorophenyl)propan-l-one 
P (2) was reduced with sodium borohydride (molar ratio, 1:14.31) in THF 
with stirring for 18 h and the products purified by column chromatography 
over silica gel using pet. ether-benzene as eluent which afforded Q (25) in 
90.71% yield. 
Step 3 : The dehydration of l,3,3-tris(4-chlorophenyl)propan-l-ol Q (25) 
was carried out by refluxing it in dry benzene in the presence of 
j3-toluenesulphonic acid for 4 h with azeotropic removal of water. The product 
was crystallized from benzene-acetone (8:2 v/v) to yield the final product 
R (26) in 85% yield (SCHEME-VII). 
Ck 
.CI 
PhCl/anhyd.AlCl3 
(nolar ratio, 1: laige exiess: 3), 
stirred, 2 h 
NaHi, (molar ratio, 1:14.3), 
THF, stirred, reflu); 4 h 
a 
Dehydration in presence of 
p-TsOH, dry benzene, relufi; 8 h. 
a 
R(26) 
SCHEME - VII 
Q(25) 
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Preparation of l,3,3-tris(4-chlorophenyl)propan-l-one P (2) from 
4,4'-dichlorochalone (1) using excess of chlorobenzene in the 
presence of anhydrous aluminium chloride 
The preparation and structure of compound (2) were discussed in 
CHAPTER-1 
Reduction of P (2) with sodium borohydride (Preparation of 
l,3,3-tris(4-chlorophenyl)propan-l-ol Q (25) from l,3,3-tris(4-
chlorophenyl )propan- l -one P (2) by reduction with sodium 
borohydride in THF) 
The compound (25) was then prepared by refluxing a solution of sodium 
borohydride and l,3,3-tris(4-chlorophenyl)propan-l-one (2) (molar ratio, 
1:14.31) in tetrahydrofuran with stirring for 14 h. The tetrahydrofuran 
solvents was distilled off under reduced pressure and the residue extracted 
with ethyl acetate, washed with water to remove unreacted sodium 
borohydride and dried over sodium sulphate. On evaporation of solvent, an 
oily residue was obtained. The products on purification by column 
chromatography (silica gel, pet. ether-benzene, 8:2 v/v) afforded Q (25) as 
white semisolid mass in 90.71% yield. 
Structure Elucidation of Q (25) 
It is a white semisolid mass and appears brown on exposure to iodine 
vapours (TLC). The constitution of Q has been established by FT-IR, DCI-MS, 
'H-NMR, and ^^C-NMR spectra. The IR spectrum (KBr) displayed 
characteristic absorption bands at 3580 (-0H), 2939, 2923 (C-H), 1597, 
1576 (phenyl), 1517, 1490, 1404, 1344, 1293, 1180, 1091, 1013, 960, 898, 
832, 771, 754, 735, 722, 676, 568, 528 cm"'. The DCI-MS (NH3 as reagent 
gas) spectrum (FIG. 55) of Q (25) showed a set of [M+] peaks at m/z 390/ 
392/394 (17.07/14.63/2.44), confirming its molecular weights 390/392/394 
which is consistent with molecular formula [C2,Hj7Cl30]. The sets of peaks 
2 6 6 
i 
4 !•••• ( 
; iOy-i- 1 1 ;••, 1 
r-T!—!-!-*-m-rT-;—y-rr-r-rr-rr r—r-^~rrrmi-i—i-i-T-r-v: tt'I—rT-r-n rrT'i—r-rrTTTn 
! 
r . . - i . - . J . . ' i l i . * . ' . i i c .0 
I 
11 < I " T t f ' I I I 1 1 I I I I I ' l t J I J 1 I 1 I I " 
iiCl'-.^ f \jiil2} 
I 
I t 
I 
/ 
. H n I 
.:!vr :rQ!j ! 
• T ti' r • "lifj--' 
•r "c' 
• T ^ L -
--T-T-r^ TrT-r-r V-l;' 
-.h-i:-;! I fifi 
I ,ljl. .1] . 
Vn 
' M!!....!!... ''!• 'i' i!:J.. !i l.'lii.. ..'j !! i.... . i i ' 1»' i jtt t' i 111 cttiTii^ f ill I i ji i ii ^  lii ii • I't I li ip iinn » i'i'it'^ tt^ ' n ml 
'fP- i . I 1 n K'.'J loH ! ir.n ii-.n ! rr; i r.n :j;!in j i n :J;.3H 
! ! t I 
! !l 
L!!i_ 
.'II 
•ii 
iii. 
'•iii 
!l! 
!!l. 
mil 
25FI i'':-!:' cTfD 
G'JY? SCAN 12 
TTTi r aw:; n 
o'liw or"? o^C 
R .i, r If r: II n y inn ^ n n v = pi <5 7 pt a r> 
IT) 
IT) 
d 
S 
76 00 20 "7' 00 0 1 0 0 4 3 133 00 8 5 
n n g •i i 0 7 0 0 A y\ ^ -r A U. w'-T Q 0 t - . 6 • 2 3 S 00 100 ij 
32. nn w y r~ i 108 00 i i . i ~k7 A w .> . !oo S. y . 2 3 6 nn «• »/ 74 8 
00 i i ! 6 . 10? n n Ji 1 -'.p. n n 4 6 • 2 7 7 00 60 p . 
0 0 
J... 
•i i OO 1? 13?. 00 2 3 6 00 21 *7 
?3 0 0 l i b ' ! 00 6 1 0 ! 0 0 Q 0 0 < < 3 
?4 . 0 0 •4 7 . i 0 0 '"y i S i 00 •3 2-40 00 4 
2 6 7 
at m/z 155/157 (8.5/2.40) [M-(p-CIC6H4)2CH]-' and at m/z 235/237/239 
(100.0/60.5/11.3) [M-CgHgClO]"- were arised by the cleavage of 2-3 bond as 
shown in CHART-18. 
m'z 235/237/239 (100.0/60.5/11.3) 
a 
m/z 390/392/394 (17.07/14.6372.44) 
a - Y V - c ^ o 
+ 
a= =c=o 
miz 139/141 (22.5/2.44) 
-CH3 a-
/ \ 
OH 
nVz 155/157 (8.50/2.40) 
CHART-18 
The 'H-NMR (FIG. 56) and ^^C-NMR (FIG. 57) spectra of Q dissolved 
in acetone-c/g showed signals as assigned (TABLE-19). The assignments of all 
^H-NMR and '^C-NMR signals to individual H- and C-atoms have been 
performed on the basis of typical chemical shift values, multiplicity and 
relative integrations. The 'H-NMR spectrum of Q showed three triple 
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doublets due to geminal and vicinal coupling of the two diastereotopic 
protons at C-2 and the two methine adjacent protons at C-1, C-3 positions. 
The two triple double doublets appeared at 52.32 and 52.46 with coupling 
constants J=14.04 Hz, J=5.65Hz, J=8.85 Hz and J=14.04 Hz, J=10.07 Hz, 
J = 9.01 Hz to H-2up and H-2dn respectively. Especially according to 
carplus^^, the coupling constant Jjyp 3 and Jj^ ^^  3 indicate a synclinal position 
of H-3 relative to the diastereotopic hydrogen atoms H-2up and H-2dn. The 
third triple doublet at 54.42 with coupling constants J=8.85 Hz, J=9.01 Hz, 
J=4.28 Hz due to vicinal coupling with two magnetically non equivalent 
protons of methylene group at C-2 position. A double doublet at 64.32 with 
coupling constants J=5.65 Hz and J= 10.07 was assigned to methine proton at 
C-3. A doublet at 64.47 with coupling constant J=4.28 Hz was assigned to 
alcoholic group proton at C-1. The signals for aromatic protons appeared as 
AjBj pattern and were assigned for three aromatic rings as shown in 
TABLE-19. The '^C-NMR spectrum of Q (TABLE-19) showed signals which 
are in strong agreement with the assigned structure. The carbon signals at 
571.17 and 545.92 were attributed to C-1 and C-2 carbons. An another signal 
at 547.24 was assigned to C-3 carbon. The signals for aromatic carbons were 
observed at 6124.11-145.79. 
Based on the above spectral evidence, Q was characterized as 1,3,3-
tris(4-chlorophenyl)propan-l-ol (25). 
a 
Q(25) 
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Preparation of l ,3,3-tris(4-chlorophenyl)prop-l-ene R (26) from 
l,3,3-tris(4-chlorophenyl)propan-l-ol Q (25) by dehydration in 
the presence of /7-toluenesulphonic acid in dry benzene 
l,3,3-tris(4-chlorophenyl)propan-l-ol Q (25) was dissolved in dry 
benzene and allowed to reflux with stirring on an oil bath at 80 °C for 4 h in 
presence of a catalytic amount of /?-TsOH. TLC examination (silica gel, 
benzene-diethyl ether, 9:1 v/v) showed almost complete conversion of Q to a 
new compound labelled as R. The reaction mixture was concentrated, 
extracted with diethyl ether, washed with water to remove the acid and dried 
over sodium sulphate. On evaporation of the solvent, a white residue was 
obtained, which on recrystallization with benzene-acetone afforded white 
crystalline globules of R (26) in 85% yield. 
Structure Elucidation of R (26) 
It is a white crystalline globules, m.p. 220 °C and appears light brown 
colour on exposure to iodine vapours (TLC). The constitution of R has been 
established by FAB-MS, 'H-NMR, ^^C-NMR spectra and also by comparison 
with the spectra of Q (25). The FAB-MS spectrum (FIG. 58) showed a set of 
peaks at m/z 373/375/377/379 (27.08/9.75/1.0/0.8) corresponding with 
[M+1]^ [C2iH,5Cl3], which confirmed its molecular weight (372). This 
molecular weight corresponds with the molecular weight of Q (25) (390) 
minus one molecule of water. The set of peaks at m/z 337/339/341 (12.50/ 
7.29/9.08) was arised by the loss of HCl molecule from parent molecule 
[(M+l)]+. The set of peaks at m/z 235/237/239 (35.42/20.83/8.34) [(p-
ClCgH5)2CH]'^ was obtained by the cleavage of 2-3 bond. The mode of 
fragmentation is showed in CHART-19. The 'H-NMR (FIG. 59) and ^^C-
NMR (FIG. 60) spectra of R dissolved in CDCI3 showed signals as assigned 
(TABLE-20). The assignments of all 'H-NMR and '^C-NMR signals to 
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individual H- and C-atoms have been performed on the basis of typical 
chemical shift values, multiplicity, relative integrations and by comparing the 
spectral data with compound Q (25) (TABLE-19). The 'H-NMR spectrum of 
R exhibited a doublet at 57.16 (J=16.20 Hz) and double doublets 56.55 with 
large coupling constants (J= 16.20 Hz, J=7.20 Hz) assigned to protons at C-1 
and C-2. The large coupling constant (J= 16.20 Hz) of vicinal protons 
confirmed their trans geometry. The proton at C-1 appeared at lower field 
(57.16) as compared to proton at C-2 (56.55) because of deshielding effect 
of the aryl group attached to it. A doublet at 54.82 (J=7.20 Hz) was assigned 
to methine proton at C-3. The signals for aromatic protons appeared as 57.11-
57.84 and were accounted for 12 protons (three aromatic rings). The '^C-
NMR signals were fully in agreement with the assigned structure. A signal 
observed at 557.3 was assigned to C-3 carbon. The signals at 5129.70 and 
5130.60 were attributed to C-1 and C-2 carbons. 
On the basis of these facts the structure of R was formulated as 1,3,3-
tris(4-chlorophenyl)prop-l-ene (26). 
a 
R(26) 
Gxperimcntal 
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EXPERIMENTAL 
4,4'-Dichlorochalcone (1) 
Compound (1) was prepared exactly as reported in CHAPTER-1. 
l ,3,3-Tris(4-chlorophenyl)propan-l-one P (2) 
Compound (2) was also prepared exactly as reported in CHAPTER-1. 
1,3,3-Tris (4-chlorophenyl)propan-l-ol Q (25) (Reduction of P (2) 
with sodium borohydride) 
A mixture of l,3,3-tris(4-chlorophenyl)propan-l-one (2 gm, 0.0051 
mol) and sodium borohydride (2.70 gm, 0.073 mol), in tetrahydrofuran 
(80 ml) was refluxed with 8 ml of 5% sodium hydroxide for 18 h. The 
progress of the reaction was monitored by TLC at every 30 minutes. After 
completion, the reaction mixture was concentrated under reduced pressure, 
extracted with ethyl acetate and washed with water several times until the 
solution was neutral. The ethyl acetate solution was then dried over Na^SO^. 
The solvent was evaporated and the coloured oily residue left was examined 
by TLC (silica gel 'G' pet. ether-benzene, 8:2 v/v) which revealed the 
presence of a major spot labelled as Q. The oily residue was then 
chromatographed over silica gel column using pet. ether-benzene 8:2 v/v as 
an eluent. Elution of the column furnished a white semi solid mass 1.73 gm 
(90.71%), Rf 0.836 (pet. ether-benzene, 8:2 v/v) 
Spectral data of Q (25) 
IR (KBr pellet) : : 3580 (OH), 2939, 2923 (CH), 1597, 1576 (phenyl), 
1517, 1490, 1404, 1344, 1293, 1180, 1091, 1013, 960, 898, 832, 771, 754, 
535, 722, 676, 568, 528. 
2 8 0 
iH-NMR (acetone-^/g, 400 MHz) : :4.47 (IH, d, J=4.28 Hz, OH), 4.42 
( IH, ddd, JJUP.r^.SS Hz, J2DN,r9.01 Hz, J j oh^'^ ^S Hz, H-1), 2.32 ( IH , ddd, 
J 2 u p . 2 d n = 1 4 . 0 4 Hz, J 2 „ p . 3 = 5 . 6 5 H z , J^.p ,=8 .85Hz , H-2up), 2.46 (IH, ddd, 
J2UP.2DN=14.07 Hz, J 2 , „ 3 = 1 0 . 0 7 H z , J2DN.r9.01 Hz, H-2dn), 4.32 (IH, dd, 
Hz, ^z, H-3), 7.20-7.50 (12H, b rm, 3xH-Ar). 
i^C-NMR (acetone-rfg, 100 MHz) : : 71.17 (C-1), 45.92 (C-2), 47.24 
(C-3), 124.11-145.79 (3xC-Ar). 
DCI-MS (NH3 as reagent gas) : m/z 390/392/394 (17.07/14.63/2.44), 372/ 
374 (2.44/2.40), 337/339/341 (24.40/21.95/2.40), 235/237/239 (100.0/ 
60.5/11.3), 155/157 (8.5/2.40), 151 (8.5), 140 (8.3), 139 (22.5), 138 (4.6), 
137 (5.9), 134 (5.6), 128 (4.8), 125 (5.2), 118 (6.2), 117 (19.0), 109 (5.4), 
108 (13.6), 107 (4.8), 99 (7.0), 94 (4.7), 93 (6.2), 92 (5.7), 91 (15.6), 82 
(5.1), 77 (8.1), 76 (20.7). 
l ,3,3-Tris(4-chlorophenyl)prop-l-ene R (26) [Dehydration of 
Q (25) in the presence of /7-toluenesulphonic acid] 
To a solution of l,3,3-tris(4-chlorophenyl)propan-l-ol Q (25) (1.20 gm, 
0.0031 mol) in dry benzene (25ml) was added p-toluenesulphonic acid (10 
mg) and refluxed with stirring over an oil bath at 80 °C for 4 h. The progress 
of the reaction was monitored by TLC at every 30 minute. After completion, 
the reaction mixture was concentrated, extracted with diethyl ether, washed 
with water and the organic phase dried over NajSO^ overnight. Evaporation of 
solvent gave a white residue, which on TLC examination (silica gel 'G' 
benzene-diethyl ether, 9:1 v/v) showed the presence of a single spot, labelled 
as R. The product was recrystallized from benzene-acetone furnished R as 
white crystalline globules, 0.9723 gm (85%), m.p. 220 °C, Rj.0.56 (benzene-
diethyl ether, 9:1 v/v). 
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Spectral data of R (26) 
iR-NMR (CDCI3, 300 MHz) : : 7.16 (IH, d, J,_2=16.20Hz, H-1), 6.55 
(IH, dd, J , 2 = 1 6 . 2 0 Hz , J 2 , 3 = 7 . 2 0 Hz, H-2), 4.82 (IH, d, J J 3=7.20 Hz, H-3), 
7.11-7.84 (12H, br m, 3xH-Ar). 
i^C-NMR (CDCI3, 75 MHz) : : 129.70 (C-1), 130.60 (C-2), 57.3 (C-3), 
126.90-140.20 (3 xC-Ar) . 
FAB-MS (Argon/Xenon, 6KV, 10mA, as the FAB gas) : m/z 373/375/377/ 
379 (27.08/9.75/1.0/0.80), 337/339/341 (12.5/7.29/9.08), 307 (10.40), 289/ 
291/293 (15.26/3.12/1.0), 261/263/265 (12.49/8.33/7.80), 251/253 (33.30/ 
19.80), 247/249 (8.34/4.0), 235/237/239 (35.42/20.83/8.34), 226/228 
(20.83/8.34), 212/214 (10.42/4.0), 199/201 (16.66/8.34), 189/191 (12.50/ 
6.25), 176/178 (12.50/10.42), 165/167 (29.16/6.25), 154 (100), 141 
(20.83), 139 (60.42), 138 (31.25), 137 (54.16), 136 (85.42), 125 (16.66), 
120 (14.58), 115 (12.50), 113 (4.0), 111 (14.58), 107 (33.30). 
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Chapter - 5 
A Flavone from 1,3'Diketone (Baker-
Venkataraman Transformation of 
2-Benzoyloxyacetophenone) as an 
Undesiredproduct in the Synthesis of 
Dithiazolidin-4-one 
l^eoretical 
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THEORETICAL 
Flavonoids are widely distributed plant secondary metabolites and the 
field of flavonoids is one of the most fascinating area of plant chemistry. 
Their occurrence in nature, the chemical and biological relationship between 
them and the chemistry of their derivatives have been the subject of intensive 
study in recent past. These natural heterocyclic compounds possess a wide 
range of physiological and pharmacological properties, which have potential 
of being exploited for therapeutic purposes. Hundreds of new flavonoids and 
their derivatives are being discovered every year from natural sources and 
many of them have been synthesized. The study of their synthesis, 
stereochemistry and physiological activities continue to enhance the horizone 
of this field. Numerous physiological activities have been attributed to 
flavonoids^ Flavones and their derivatives have a variety of biological 
properties such as fish toxicity^, heart stimulant^, antiviral"*"^, antifungal^, 
antihemolytic activity"^, anthelmintic activity^, contraceptive drugs^, vitamin P 
activity'®, antihistaminic activity'^ antihypertensive'^, analgesic and 
bronchodilator effects'^. In addition, they inhibit lipid peroxidation^-'" 
platelet aggregation'^, antiinflammatory^''^, antial lergic^ 'antibacterial '^- '^ , 
antitumour'^ and coronary vasodilatory actions'^-'^-^® and the activity of 
enzyme systems including cyclooxygenases and lipooxygenases^'. Flavonoids 
having heterocyclic nucleus in place of one of the phenyl nucleus possess 
muscular relaxation effect^^, spasmolytic activity^'^'^^, flavonoids also exert 
effects as antioxidants, free radical scavengers and chelators of divalent 
cation^. 
Flavonoids play interesting role in arresting the growth of cancer and 
modulating cancer related process in cells. Protection against 
carcinogenecity of benzo[a]pyrene on the mouse skin has been observed with 
2 8 7 
quercetin and myricetin^^. Putin and Morin have also been shown to be 
antitumourigenic^^. Two important properties of flavonoids are their ability to 
inhibit cytochrome P450 monooxygenase activity and their selection 
induction of detoxification enzymes such as glutathione transferase, 
glucoronyl transferase, exposited hydrolase and quinone reductase^^. Flavone-
acetic acid, a synthetic flavonoid has been clinically evaluated for anticancer 
properties and found to be curative against a variety of transplantable murine 
tumours. Its action resembles that of tumour necrosis factor (TNF)^^. Brake 
et al.^^ have demonstrated inhibition of cancer cell invasion in vitro with a 
number of flavonoids. Several flavonoids inhibit the metabolic activation of 
the chemical carcinogenes benzo[a] pyrene and aflatoxin^^ Numerous other 
reports have shown that flavonoids exhibit protective effects against a number 
of chemical mutagens and carcinogens^^. 
Several methods for the preparation of naturally occurring flavonoids 
have been reported in the literature^®. 
A.C. Jain et alV'^^ have reported the synthesis of 6,7-dimethoxy-3',4'-
methylenedioxy flavone (I) by oxidation of 2'-hydroxy-4'5'-dimethoxy-3,4-
methylenedioxy chalcone with selenium dioxide 
MeO. 
MeO' 
an^'l alcohol/A j^eO^ 
0 
0) 
M. Krishnamurti et al}'^ have synthesized 4'-methoxyfurano[4",5" : 8,7] 
flavone (II) from 2'-hydroxy-4-methoxyfurano[4",5" : 3',4'] chalcone via 4'-
methoxyfurano [4",5" : 8,7] flavanone with DDQ in dry dioxan. 
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0. \ OH 
Q 
/ V ^ O M e 
5% elhanolic 
OMe 
sulphuric acid/A 
0 
DDQ/diy diojan/A 
0. 
OMe 
0 
(n) 
Also a number of substituted 2'-hydroxy chalcone have been converted 
into corresponding flavones by prolonged refluxing with Se02 in isoamyl 
alcohoP^ and is applicable in those chalcones which do not have free 
hydroxyl group other than at 2'-position. A.G. Doshi et al.^^ developed a new 
method, in which 2'-hydroxy chalcones or the isomeric flavones on refluxing 
in DMSO for 30 min. in presence of catalytic amount of iodine afforded the 
corresponding flavones (III). 
Ri R3 R4 
a H H Me H 
b H H Me OMe 
c Br H Me H 
d Br H Me OMe 
e H H H H 
f H H H OMe 
2 8 9 
RE. Kumar et. al.^^ have synthesized a series of four new flavones, 
3,6-diacetyl and 6-acetyl-7-hydroxy-3',4'-dimethoxy flavones (IV-V), 
3,6-diacetyl and 6-acetyl-7-hydroxy-4'-methoxy flavones (VI-VII) from 
5-acetyl-2-4-diaroyl-dioxyacetophenone derivatives by Baker-Venkatraman 
rearragnement followed by acid cyclisation and deacetylation reaction. 
(XKZH, 
KOH/Pyridine 
R2 
H s O D C r ^ ^ ^ ^ ^ ^ C O CH2 
NaOAc/AcOH/A 
R2 
a R, = R^ = - OCH3 
b R, = - OCH3, R^ = H 
c R, = R2 = -0CH3 
d R, = -0CH3,R2 = H 
IV R, = R2 = - OCH3, R3 = - COCH3 
V Ri = Rj = - OCH3, R3 = H 
/ \ VI R,=-0CH3.R^=H,R3 = -C0CH3 
^ X ^ K - l y j j 0CH3, R2= R3 = H 
0 
(IV-VIQ 
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Recently R.B. Palkar et al^^ have reported several naturally occurring 
flavones bearing a methoxy group at position 3 such as 4'-hydroxy-3-methoxy 
flavone for their antiviral activity and anti bacterial activity. Different 
6-acetamido-3-hydroxy flavones (VIII) and 6-acetamido-3-methoxyflavones 
(IX) were synthesized from 5'-acetamido-3-aryl-2'-hydroxy chalcones. 
Ri 
, 0 H 
H^CCOHN-
H.CCOHN-
ethanol/20%NaOH/ 
20%H2O2,stinied 
R. 
acetone/DMS, 
K2CO3, reflux 
H j C C D H N ^ ^ ^ ^ ^ ^ ^ V ' ' ^ OMe 
0 
(DQ 
Ri R3 
a H a H 
b H NCCHj)^  H 
c OMe OMe H 
(1 OMe OMe OMe 
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M. Amzad Hossain''^ have prepared 3,5-dihydroxy-3',4"-methylenedioxy-
6", 6"-dimethylpyrano [2",3" : 7,8] flavone (X) and 3-methoxy-5-hydroxy-3,4-
methylenedioxy-6", 6"-dimethylpyrano[2",3" : 7,8]flavone (XI) from 2', 6'-
di(methoxymethoxy)-3',4'-methylene dioxy-6",6"-dimethylpyrano [2",3" : 4,3'] 
chalcone. 
OR 0 
R = -CH20CH3 
DemethojQ'methylation > 
0CH3 
discussion 
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DISCUSSION 
SUMMARY 
The work described in this chapter consists of the synthesis of -
(i) 2-hydroxy-4'-chlorodibenzoylmethane K (28) by Baker-Venkataraman 
transformation of 2-(4'-chlorobenzoyloxy)acetophenone as 
intermediate obtained from o-hydroxyacetophenone and 
p-chlorobenzoic acid in the presence of POCly 
(ii) 4'-chloroflavone SD (29) from 2-hydroxy-4'-chlorodibenzoylmethane 
K (28) as an undesired product, when the reaction was carried out 
with thioglycollic acid and ammonium carbonate in benzene to get 
dithiazolidin-4-one. 
Structures are established on the basis of Mass, ^H-NMR and 
^^C-NMR spectral studies. 
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INTRODUCTION 
In previous chapters we have synthesized 2-substituted 4-thiazolidinones 
as novel compounds from chalcones via their monoketo adducts using 
thioglycollic acid in the presence of ammonium carbonate in dry benzene. The 
aim of the present problem is to synthesize dithiazolidin-4-ones from 
1,3-diketones using the same reagents. For this purpose, the precursor, 
1,3-diketone K (28) is first prepared by Baker-Venkataraman transformation 
of 2-(4'-chlorobenzoyloxy)acetophenone obtained by the reaction of 
o-hydroxyacetophenone with /)-chlorobenzoic acid in the presence of POCI3. 
It is then reacted with thioglycollic acid and ammonium carbonate in dry 
benzene which yielded a flavone K (29) instead of the target compound, 
dithiazolidin-4-one. The ring closure of 1,3-diketone in acid medium to form 
flavone molecule is a well known reaction'^ '^ ''^ ^ From 'H-NMR spectrum, it is 
found that the 1,3-diketone exists in the equilibrium mixture of keto-enol 
tautomeric forms. 
a . 0 K(28) 
0 0 
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RESULTS AND DISCUSSION 
The reaction was carried out in two steps as follows (SCHEME-VIII) : 
The 1,3-diketone, 2-hydroxy-4'-chlorodibenzoyl methane K (28) was 
first prepared by Baker-Venkataraman transformation of 2-(4'-chlorobenzoyloxy) 
acetophenone condensing o-hydroxyacetophenone with /?-chlorobenzoic acid 
(molar ratio, 1:1) in the presence of a catalytic amount of POCI3. The crude 
product was washed with 10% NaHCOj solution and then crystallized from 
ethanol to yield (28) in 60% yield. 
The 2-hydroxy-4'-chlorodibenzoyl methane K (28) was then condensed 
with thioglycollic acid and ammonium carbonate (molar ratio, 1:1.30:5.25) 
by refluxing in dry benzene for 30 h. The products on purification by column 
chromatography over silica gel using pet. ether-diethyl ether as eluent 
followed by crystallization afforded SD (29) as white crystalline needles in 
80% yield. The target compound dithiazolidin-4-one could not be obtained. 
The 1,3-diketone did not react with thioglycollic acid and ammonium 
carbonate, it simply cyclized to give a flavone which is a well known 
cyclization reaction in acidic medium. 
, 0 H 
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, 0 H 
X — C H 3 + HOOC-
II 
O 
-a 
POCI3, pyridine, 
stirred 
If 
, 0 — c — i V — a 
C - C H 3 
0 
(27) 
Baker - Venkataiaman 
transforantion 
a 
, 0 H 
O. . 0 
HSCH2OOOH+ (NH4)2C03 
(molar ratio, 1:1.3:5.25), dry 
benzene, reflux, 30h 
O 0 
K(28) 
SCHEME - VIII 
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Synthesis of 2-hydroxy-4'-chlorodibenzoyl methane K (28) [from 
o-hydroxyacetophenone and p-chlorobenzoic acid in the presence 
of POCI3 via 2-(4'-chlorobenzoyloxy)acetophenone by Baker-
Venkataraman transformation] 
A solution of o-hydroxyacetophenone and p-chlorobenzoic acid (molar 
ratio, 1:1) in pyridine in the presence of POCI3 was stirred at room 
temperature for 2 h. The reaction mixture on usual work up and 
recrystallization from ethanol, yielded 2-(4'-chlorobenzoyloxy)acetophenone 
as crystalline needles (65%) yield. 
Baker-Venkataraman transformation 
2-(4'-chlorobenzoyloxy)acetophenone was dissolved in pyridine and 
pulverized KOH (molar ratio, 1:2) was added to it with constant stirring. After 
completion, it was further stirred for 8 h. TLC examination (silica gel 'G' pet. 
ether-diethyl ether, 8:2 v/v) of the reaction mixture showed the presence of a 
brown spot labelled as K. After usual work up and crystallization from ethanol 
afforded K (28) as yellow crystalline needles in 60% yield. 
Structure Elucidation of K (28) 
It is a yellow needle shaped crystalline solid, m.p. 122 °C and appears 
dark brown on exposure to iodine vapours (TLC). The structure of K has been 
elucidated by DCI-MS, 'H-NMR and ^^C-NMR spectra. The DCl-MS (NH3 as 
reagent gas) of K (28) (FIG. 61) showed [M+H]+ peaks as the base peak at 
m/z 275/277 (100.0/35.4), confirming its molecular weight as 274/276 
[CijHjjOgCl]. A set of peaks observed at m/z 139/141 (14.8/4.8) was due to 
the 2-3 bond cleavage. The important fragement ions are shown in 
CHART-20. 
'J -jOMf ' r.i"-du ill I 11' " T , nu "DTii r ijQMr • r ircorn IDTC . 
•Ti t " . ' ~ ' r i T f r T n w t - - i " " " " " • - • - • - - - - . 
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• 1 .<.1 
lyw's- J JI i j> J 1 . G 
- n f—)—I—I—I I I I—r -I—n 1—I—I—1—1—I—r 
— -J u t j = ; > Lii I. (- t^  1 . 
VO 
•"M JU ' HH 1 1 H 
I 
I 
1 -'M i '4M ISM If-M l .H 1 hW 1 ^H 
TT n r n t r r 1 noj* • 
I 
J^ r.fl .^'M jiSM VMM .-'My 
K>T=n nn r(Ari<'r:n-ny< nn ino'^^ ^^r.^-jna 
121 0 0 
1 nn 
6 i 
1 A R 
141 0 0 
•^ •7A n fi 
3 2 7 5 0 0 
-7K on 
i 0 0 0 
or, 1 
2 7 7 0 0 
n ft 
3 5 -4 
A "K 
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0 0 
[M+H]^ nVz 275/277 (100.0/35.4) 
tec- / \ -a 
miz 139/141 (14.8/4,8) 
CHART - 20 
The 'H-NMR (FIG. 62) and ^^C-NMR (FIG. 63) spectra of K dissolved 
in acetone-^/g showed signals as assigned in TABLE-21. The assignments of 
all ^H-NMR and ^^C-NMR signals to individual H- and C-atoms have been 
performed on the basis of typical chemical shift values, multiplicity and 
relative integrations. The two singlets, one at 54.91 and another at 57.31 were 
attributed to the keto and enol forms. The other two singlets at 511.88 and 
511.83 were assigned to aromatic and enolic hydroxyl groups. The aromatic 
protons signals were assigned as shown in TABLE-21. The '^C-NMR 
spectrum showed signals as assigned (TABLE-21). The signals at 550.26 was 
assigned to carbon and at 594.01 to carbon. The '^C-NMR 
spectrum of K showed the ring carbons signals 133.25 (C-Ar'-l), 163.25 (C-
Ar'-2), 119.22 (C-Ar'-3), 137.09 (C-Ar'-4), 120.20 (C-Ar'-5), 130.51 (C-Ar'-
6), 131.24 (C-Ar-1), 129.92 (C-Ar-2,6), 129.61 (C-Ar-3,5), 139.13 (C-Ar-4). 
The ^^C-NMR spectral data are thus in agreement with the assigned structure. 
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On the basis of above facts, the structure of compound K was formulated 
as 2-hydroxy-4'-chlorodibenzoyl methane (28). 
AF AT 
a . 0 K(28) 
Ai- Ar 
0 0 
Synthesis of 4'-chloroflavone SD (29) [from 2-hydroxy-4'-
chlorodibenzoyl methane K (28) using thioglycollic acid and 
ammonium carbonate in dry benzene 
A mixture of 2-hydroxy-4'-chlorodibenzoylmethane K (28), thioglycollic 
acid and ammonium carbonate (molar ratio, 1:1.30 : 5.25) in dry benzene was 
refluxed for 30 h. The products were purified by column chromatography 
over silica gel column using pet. ether-diethyl ether as eluent (8:2 v/v) 
followed by crystallization from benzene-acetone which yielded SD (29) as 
white crystalline needles in 80% yield. 
0 . . 0 
HSCHjCOOH+(NH4)2(X)3 
(molar ratio, 1:1.3:5.25), diy 
b e n 2 E n e , refluj; 3 0 h 
O 0 
K(28) 
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Structure Elucidation of SD (29) 
It is a white crystalline solid, m.p. 150 °C and appears grey on exposure 
to iodine vapours (TLC). The constitution of SD has been established by DCI-
MS, ^H-NMR and '^C-NMR spectra. The DCI-MS (NHj as reagent gas) of 
SD (29) (FIG. 64) showed [M+Hf peaks at m/z 257/259 (100.0/36.3) 
confirming its molecular weights 256/258 which corresponds with the 
molecular formula [C^sHgOjCl]. The other significant peaks were observed at 
m/z 228 (3.9), 137 (6.1), 120 (11.5), 92 (16.7). The mode of fragmentation 
is shown in CHART-21. 
-h 
0 [M+H]" m'z 257/259 (100.0/36.3) 
retro Diels Alder fission 
of pytone ring 
0 
0 
mlz 120(11.5) 
+ 
/ \ -a 
CH 
n^z 137/139 (6.1) 
CHART - 22 
The ^H-NMR (FIG. 65) and '^C-NMR (FIG. 66) spectra of SD 
dissolved in acetone-taf^ showed signals as assigned in TABLE 22. The 
assignments of all 'H-NMR and '^C-NMR signals to individual H- and 
C-atoms have been performed on the basis of their typical chemical shift 
values, multiplicity and relative integrations. The ^H-NMR spectrum of 
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SD showed two triple doublets at 57.50 and 57.84 with coupling constant 
J=9.15 Hz, J=7.17 Hz, J=1.22 Hz and J=7.17 Hz; J=8.55 Hz, J=1.83 Hz 
which were assigned to Ar-6 and Ar-7. The two double doublets appeared at 
68.13 and 57.75 with coupling constant J=9.15 Hz, J=1.83 Hz and J=8.55 Hz, 
J=1.22 Hz were attributed to Ar-5 and Ar-8. The signal at 56.89 was assigned 
to H-3. The other aromatic signals appeared as AjBj system at 58.14 and 
57.64 as doublets with coupling constant J=8.85 Hz were attributed to H-Ar'-
2,6 and H-Ar'-3,5. The '^C-NMR spectrum showed signals as assigned 
(TABLE-22). The characteristic peak appeared at 5177.80 for carbonyl 
carbon and the other carbon signals are at 5162.78 (C-2) and 5108.33 (C-3). 
The ring carbon signals appeared at 5126.25 (C-Ar-5), 126.02(C-Ar-6), 
134.92(C-Ar-7), 119.27(C-Ar-8), 157.15 (C-Ar-9), 124.88 (C-Ar-10), 
131.68 (C-Ar'-l), 128.94 (C-Ar'-2,6), 130.16 (C-Ar'-3,5) and 138.06 (C-Ar'-4). 
The '^C-NMR spectral data are thus in agreement with the assigned structure. 
On the basis of above evidence, SD was characterized as 4'-chloro 
flavone (29). 
Gxycrimental 
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EXPERIMENTAL 
2-Hydroxy-4 ' - chIorod ibenzoy lmethane K (28) from 2-(4'-
chlorobenzoyloxy)acetophenone (27) by Baker-Venkataraman 
transformation 
2-(4'-chlorobenzoyloxy)acetophenone (27) was prepared following a 
reported procedure''^ by condensing o-hydroxyacetophenone with 
/7-chlorobenzoic acid in equimolar ratio in the presence of POCI3. To 
the solution of o-hydroxyocetophenone (1550 mg, 11.40 mmol) and 
p-chlorobenzoic acid (1778 mg, 11.40 mmol) in pyridine (25 ml) was added 
POCI3 (2ml) dropwise so as to maintain the temperature of the reaction 
mixture at 50 °C. The reaction mixture was further stirred for 2 h. The 
semisolid mass thus obtained was decomposed with ice cold 50% HCl (50 
ml) to give yellow solid product which was washed with 0.5% aqueous NaOH 
(5ml). It was then crystallized from ethanol to give (27) as yellow crystalline 
needles, 2029 mg (65%), m.p. 115 Rf 0.64 (pet. ether - diethyl ether, 
8:2 v/v). 
Baker-Venkataraman transformation 
2-(4'-chlorobenzoyloxy)acetophenone (1350 mg, 4.93 mmol) was 
dissolved in pyridine (20 ml) and pulverzid KOH (551mg, 9.85 mmol) added 
to it in several lots with constant stirring. After complete addition, the 
reaction mixture was stirred for 7.5 h. The resulting yellowish red mass 
obtained was decomposed with ice-cold 1:1 HCl (50 ml). The yellow solution 
was extracted with ethyl acetate and the organic phase washed with 10% 
NaHCOj solution and with water, dried over anhydrous NajSO^. The product 
obtained after distilling off the solvent on crystallization from ethanol 
yielded K (28) as yellow crystalline needles, 810 mg (60%), m.p. 122 
Rf 0.76 (pet. ether-diethyl ether, 8:2 v/v). 
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Spectral data of K (28) 
iH-NMR (acetone-^/g, 400 MHz) : 4.91 (2H, s, 7.31 (IH, s, 
11.83 (IH, s, enolic OH), 11.88 (IH, s, H-Ar-OH), 7.00-8.15 (4H, 
brm, H-Ar'), 8.14 (2H, d, J=8.55Hz, H-Ar-2,6), 7.68 (2H, d, J=8.55Hz, 
H-Ar-3,5). 
'^C-NMR (acetone-rfg, 100 MHz) : 50.26 94.01 
196.80 (C-1 177.43 133.25 (C-Ar'-l), 163.25 
(C-Ar'-2), 119.22 (C-Ar'-3), 137.09 (C-Ar'-4), 120.20 (C-Ar'-5), 130.51 
(C-Ar'-6), 131.24 (C-Ar-1), 129.92 (C-Ar-2,6), 129.61 (C-Ar-3,5), 139.13 
(C-Ar-4). 
DCI-MS (NH3) : m/z 278/277/276/275/274 (6.3/35.4/20.2/100.0/3.9), 141/ 
139 (4.8/14.8), 121 (6.1). 
4'-Chloroflavone SD (29) 
A mixture of 1,3-diketone K (28) (770 mg, 2.81 mmol), thioglycollic 
acid (336mg, 3.7 mmol) and ammonium carbonate (1416 mg, 14.75 mmol) in 
dry benzene (20 ml) was refluxed for 30 h with stirring at 80°C on an oil bath. 
The progress of the reaction was monitored by TLC at every 30 minutes. 
After the reaction was over, the reaction mixture was concentrated under 
reduced pressure, extracted with diethyl ether and washed with water until the 
solution became neutral. The ethereal solution was dried over NajSO^ and the 
solvent evaporated under reduced pressure. The residue left was finally 
examined by TLC (silica gel 'G' pet. ether diethyl ether, 8:2) which showed 
only one component, labelled as SD. The residue was chromatographed over 
silica gel column using pet. ether-diethyl ether as an eluent. Elution of the 
column furnished a solid mass which on crystallization from benzene-acetone 
afforded SD (29) as white crystalline needles, 616 mg (80%), m.p. 150 °C,Rf 
0.46 (pet. ether-diethyl ether, 8:2 v/v). 
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Spectral data of SD (29) 
iH-NMR (acetone-dg, 400 MHz) : 6.89 (IH, s, H-3), 8.13 (IH, dd, 
J5^=9.15 HZ, J5 7 = 1.83 Hz, H-Ar-5), 7.50 (IH, ddd, J5 6=9.15Hz, Jg,7=7.17 
Hz, J6,8=1-22 Hz, H-Ar-6), 7.84 (IH, ddd, J^ 8=8.55 Hz, 
J5 7=1.83 Hz, H-Ar-7). 7.75 (IH, dd, 173=8.55 Hz, Jg g=1.22Hz, H-Ar-8), 8.14 
(2H, d, JAr'-2.6=8.85 Hz, H-Ar-26), 7.64 (2H, d, JAr'.3.5=8.85 Hz,H-Ar-35). 
i^C-NMR (acetone-^/g, 100 MHz) : 162.78 (C-2), 108.33 (C-3), 177.80 
(C-4), 126.25 (C-Ar-5), 126.02 (C-Ar-6), 134.92 (C-Ar-7), 119.27 (C-Ar-8), 
157.15 (C-Ar-9), 124.88 (C-Ar-10), 131.68 (C-Ar'-l), 128.94 (C-Ar'-2,6), 
130.16 (C-Ar'3,5), 138.06 (C-Ar'-4). 
DCI-MS (NH3) : m/z 260/259/258/257/256 (7.0/36.3/25.5/100.0/19.3), 228 
(3.9), 137 (6.1), 120 (11.5), 92 (16.7). 
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Biological Screening : Study for Anticancer 
and Antibacterial Activities 
(A). ANTICANCER ACTIVITY AGAINST MALIGNANT HUMAN 
TUMOUR CELLS : 
INTRODUCTION 
The compounds are evaluated as a single dose primary anticancer assay 
in 3-cell lines panels consisting of three types of human cancers : Breast 
(MCF7), Lung (NCI-H460) and CNS(SF-268). In the screening protocol, each 
cell line is inoculated and preincubated for 24-28 h on a microtiter plate. Test 
agents are then added at a single concentration and the culture incubated for 
further 48 h. End-point determinations are made with alamar blue^ Results for 
each test agent are reported as the percent of growth of the treated cells when 
compared to the untreated control cells. Compounds which reduce the growth 
of anyone of the cell lines to 32% or less (negative number indicates cell kill) 
are then passed on for evaluation in the full panel of 60-cell lines over a 5-
log dose range^. 
In the full panel of 60-cell lines, 9 types of human cancers, namely, 
leukemia, lung cancer, colon cancer, central nervous system, melanoma, 
ovarian, renal, prostate and breast are used. These test agents are added in five 
10-fold dilutions and a 48 hours continuous drug exposure protocol is used. 
Sulphorhodamine B (SRB), a protein-binding dye assay, is used to estimate 
cell viability or growth. Results are expressed as logjQ GI50 which is the drug 
concentration (M) causing a 50% reduction in the net protein increase in 
control cells during the drug incubation. 
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Data Analysis 
The calculated Measurement of Effect: Percentage Growth (PG). 
The measured effect of the compound on a cell line is currently 
calculated according to one or the other of the following two expressions. 
If (Mean OD^ ^^ ^ - Mean OD^^J > 0. then 
PG = 100 X (Mean OD^ ^^ ^ - Mean OD^^^^^yMean OD^,^^ 
Where : 
Mean = The average optical density measurements of SRB-derived 
colour just before exposure of cell to the test compound. 
Mean = The average optical density measurements of SRB-derived 
colour after 48 hours exposure of cell to the test 
compound. 
Mean = The average optical density measurements of SRB-derived 
colour after 48 hours with no exposure of cell to the test 
compound. 
The results as obtained from experimental data are represented in three 
ways. 
(i) The Data Sheet: 
The first two columns of the Table describe the subpanel and cell lines 
involved. The next two columns list the Mean OD^^ gro Mean : the 
next five columns list the Mean for each five different concentrations. 
Each concentration is expressed as the logjo (molar or |ag/ml). The next five 
columns list the calculated PGs for each concentration. The response 
parameters G150, TGI, and LC50 are interpolated values representing the 
concentrations at which the PG is +50.0 and -50.0 respectively. 
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(ii) Dose-Response Curves : 
The dose-response curve plot of the data package is created by plotting 
the PGs against the logjg of the corresponding concentration for every cell 
line. The cell line curves are grouped by subpanel : horizontal lines are 
provided at the PG values of + 50.0 and -50. The concentrations 
corresponding to points where the curves cross these lines are the GI50, TGI 
and LC50 respectively. 
(iii) The Mean Graphs : 
The mean graphs show mean graphs at each of the principal response 
parameters : GI50, TGI and LC50. Bars extending to the right representing 
sensitivity of cell lines to the test agent in excess of the average sensitivity 
of all tested cell lines. Since the bar scale is logarithmic, a bar 2 units to the 
right implies the compound achieved the response parameters (eg. GI50) for 
the cell line at the concentration one-hundredth the mean concentration 
required over all cell lines, and thus the cell line is usually sensitive to that 
compound. Bar extending to the left correspondingly imply sensitivity less 
than the mean. 
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RESULTS AND DISCUSSION 
The compounds [P(2), Ei^(3), C1FD(9), ClFD,c(10), SDgCll), 
SD4^(14),SD,^(19), SDib(20), Q(25)] were evaluated as one dose primary 
anticancer assay in three cell line panel and the results are depicted in 
TABLE 23. Out of the nine compounds screened, only two compounds, 
Ej^ (3) and Q(25) were found to be active. These compounds were then 
screened for cytotoxic activity^ at five different concentrations against 60 
cell lines of nine types of human cancers : leukemia, lung, colon, CMS, 
melanoma, ovarian, renal, prostate and breast. A 48 h continuous drug 
exposure protocol was used and a sulphorhodamine B protein assay was used 
to estimate cell viability or growth. Results in TABLE-24 and TABLE-25 are 
expressed as logjoGISO which is the drug concentration (M) causing 50% 
reduction in the net protein increase in control cells during the drug 
incubation. These compounds showed activity only at higher concentration. 
Noteworthy results were obtained for the compounds Ej^(3) in the case of 
melanoma, colon, renal cancers where the reduction in growth is 52, 80 and 
91% respectively TABLE-26 and for the compound Q(25) in the case of 
melanoma and colon cancers where the reduction in growth is 48 and 83% 
respectively (TABLE-27). 
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TABLE-23 : Results of anticancer activity of the compounds against 
3-ceIl lines of human cancers 
Test Compounds Concentration Percent growth 
(Lung) (Breast) 
NCI-H460 MCF7 
(CNS) 
SF-268 Activity 
P(2) IxlO-^M 62 32 49 Inactive 
E I A ( 3 ) 1 X 10-^M -11 3 7 Active 
CIFD (9) 1 X 10-^M 75 91 74 Inactive 
ClFDjc(lO) 1 X lO-^'M 114 81 126 Inactive 
SD,^ (19) 1 X lO-^M 117 100 121 Inactive 
SD,^(14) 1 X lO-^'M 119 98 123 Inactive 
SDg (12) 1 X 10-^M 87 84 91 Inactive 
SDjb (20) 1 X 10-^M 82 96 78 Inactive 
Q(25) 1 X 10-^M -42 2 -1 Active 
The compound £^^(3) has shown some cytotoxic effect only in renal 
cancer [SN12C] at the concentration of 1 x 10'^  m of the compound. 
The dose response curves of the compound Ej^(3) and Q(26) treated 
with different malignant human tumour cell lines have been deciphered in 
FIG. 67 and FIG. 68. 
The overall anticancer effect of the compounds (3) and (25) on all the 
human tumour cell lines is illustrated in FIG. 69 and FIG. 70 respectively. 
Mean graphs of the compound (3) and (25) which facilitate visual 
scanning of data for potential patterns of selectivity for particular cell lines 
with respect to a selected response parameters are represented in FIG. 71 
and FIG. 72 respectively. 
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TABLE - 24 National Cancer Institute Developmental Therapeutics Program 
In-Vitro Testing Results 
NSC: 716408-N/I Experiment IP: 0004MD35-17 Test Type: 08 Units: Molar 
Report Date: May 22.2000 Test Date: QNS: MC: 
COMI: CODE-EIA Stain Reagent; SRB Dual-Pass SSPL: OGVG 
Pan*l/C«ll Line 
L^ukaiia 
CCRP-CEH 
HL-SO(TBI 
K-5t2 
MOLT-4 
KP>U-a22t SR 
T i m 
Z«ro Ctrl 
LofllO Concentration 
Mean Optical Densitiea Percent Growth 
-« 0 -7 0 -8 0 - S O - ' 0 - 8 0 - 7 0 - 6 0 - 5 0 -4 OISO TOI LC50 
212 
(02 
210 
23< 
(25 
289 
Non-Small Cell Luno Cancer 
798 
201 
531 
982 
912 
255 
789 
031 
535 
995 
941 
241 
0 750 
1 911 
1 5«7 
1 033 
1 937 
1 279 
705 
929 
532 
535 
906 
230 
408 
019 
(03 
312 
000 
500 
286 
413 280 
22« 
477 
202 
99 
89 
100 
102 102 
98 
92 82 84 83 
103 100 
107 94 
102 100 
102 97 
33 13 
26 -31 
30 
10 
29 
5 
-5 
34 
22 -30 
71E-06 >1 OOE-04 >1 OOE-04 
80E-06 2 84E-05 >1 OOE-04 
15E-C6 >1 OOr-04 >1 OOE-04 
32E-06 4 50E-05 >1 OOE-04 
05E-0« 3 5(E-0S >1 OOE-04 
24E-0( 2 (3E-05 >1 OOE-04 
A549/ATCC 0 219 1 280 1 306 1 309 1 214 0 (1( 0 400 102 103 94 37 17 5 9''E 06 >1 OOE-•04 >1 OOE--04 
EXVX 0 381 0 852 0 835 0 859 0 3(7 0 (60 0 4(8 96 101 103 59 18 1 69E-05 >1 OOE--04 >1 OOE-'04 
H0P-(2 0 ^20 1 089 1 069 1 096 1 101 0 862 0 491 9» 101 102 (0 -6 1 43E-0S 8 20E 05 >1 OOE 04 
NOP-92 0 799 1 280 1 280 1 316 I 289 1 104 0 727 100 107 102 (3 -9 1 53E-05 7 50E-•05 >1 OOE--04 
NCI-H22( 0 -.412 0 879 0 871 0 8(7 0 84( 0 659 0 311 98 97 92 50 -30 9 76E-0( 4 22E-05 >1 00E< •04 
w:i-H23 0 527 1 300 1 362 1 3(8 1 320 0 909 0 (63 108 109 103 49 17 9 7(E-06 >l OOE-04 >1 OOE-04 
NCI-H322K 0 262 0 842 0 865 0 856 0 845 0 708 0 470 104 103 100 77 36 4 50E-05 >1 OOE--04 >1 OOE 04 
NCI-H4eO 0 295 1 72( 1 718 1 (89 1 f79 0 982 0 309 99 8/ 97 48 1 9 09E-06 >1 OOE--04 >1 OOE 04 
NCI K532 0 (09 1 527 1 506 1 594 1 5 9 0 949 0 (33 98 107 101 37 2 6 28E-06 >1 OOE 04 >1 OOE-•04 
Colon Cancer 
rcio 205 0 20( 0 774 0 7(6 0 774 0 7(0 0 361 0 041 98 100 97 27 -80 4 75E 06 1 79C-•05 5 22E 05 
HCC 2993 0 330 1 130 1 094 1 113 1 114 0 8(2 0 408 95 48 98 ( ( 10 1 95E-05 >1 OOC 04 >1 OOE 04 
HCT 116 0 281 i 013 2 082 2 017 1 9(9 1 132 0 421 104 100 97 49 8 9 59E-06 >1 OOE 04 >1 OOE 04 
HCT-15 0 J04 1 ((9 1 727 1 77( 1 (41 1 002 0 54 3 104 108 98 51 17 1 08E-05 >1 OOE--04 >1 OOE-04 rfKS 0 19( 1 177 1 206 1 158 I 224 0 676 0 2(2 103 98 105 49 7 9 54E-0( >l OOE--04 >1 OOE-04 
m i ? 0 489 2 23C ^ 118 2 221 2 020 1 457 0 713 93 99 88 55 13 1 34E-05 >1 00E-04 >1 OOE-•04 
SH-62C 0 195 1 109 1 1?4 1 07( 1 05-< 0 735 0 418 102 96 94 59 24 1 83E-05 >1 OOE 04 >1 OOE-•04 
r u s Cancer 
sr 263 0 530 I 558 1 569 1 (09 1 (03 1 119 0 811 101 105 104 57 27 1 75E 05 >1 OOE--04 OOE 04 E' 295 0 563 1 227 1 218 1 249 1 261 0 743 0 490 99 103 105 27 -13 5 08E-06 4 75E 05 »1 OOP 04 
SF 0 328 1 029 I 145 0 971 1 098 0 95( 0 359 117 93 110 90 -31 3 28E-05 6 44E--05 >1 OOE 04 
SHB 19 0 369 1 268 1 232 1 238 1 198 0 959 0 (90 96 97 92 (6 36 3 32E-05 >1 OOE--04 >I OOE 04 
SCT 0 565 0 831 0 844 0 840 0 856 0 7(3 C (40 105 103 110 74 38 3 35F-05 >1 OOE 04 >1 OOE--04 
U751 0 28^  1 170 1 169 1 144 1 085 0 730 0 247 100 97 90 50 13 1 02E-05 6 31E 05 >1 OOE 04 
Kolaroma 
lO\ IKVI 0 295 1 64( 1 ((8 1 601 1 (20 0 923 0 264 10.' 101 98 46 11 B 54F 06 ( 54F 05 OOP 04 
MAJJfE an 0 604 1 189 1 20S 1 242 1 214 1 364 0 561 103 l')9 104 79 7 2 I6e 05 8 26K 05 >1 OOE 04 
>(14 0 288 1 2C1 1 232 1 151 1 1 0 0 (91 0 «57 97 119 93 52 28 1 18F Oi >1 nuK 04 >1 OOK 04 
SX KEL : 0 41i 0 959 0 998 0 973 0 943 u 804 0 393 107 103 11 72 4 1 93E 05 8 76E 05 >1 OOE 04 
TK KEl :9 0 338 0 345 0 834 0 C34 0 817 0 677 0 542 98 <18 94 (7 40 4 29E 05 >1 OOE 04 >1 OOE 04 
St MEL 5 0 450 1 821 1 815 1 825 1 828 1 292 0 21^  100 100 ino 61 52 1 ?(e 05 3 47E 05 9 54E 05 '-•ACC- 257 0 689 (04 1 5C9 1 5(0 1 548 1 324 0 722 98 95 94 58 1 1 4.E 05 >1 OOE 04 >1 OOE 04 WACt fi 0 503 I 594 I 582 I 542 I 49/ 1 )J5 0 43? 9" •>5 91 57 14 1 ••58 U5 6 31F 00 >1 OOE 04 
Cvatian Cancer 
lOKOVl 0 356 I 420 1 425 1 434 1 43; 1 061 0 653 100 101 101 66 2 04F 05 >l OOF 04 '1 OOE U4 CVCkR 1 0 579 ) 1(4 1 197 1 189 1 163 1) 796 0 424 106 104 ion 3/ 27 6 21E 06 3 80E 05 >1 OOE 04 
ovrAR 4 0 487 1 133 1 149 1 142 1 113 II 750 0 t52 102 101 67 41 10 6 82E Ob >1 IIOI- 04 »1 OUE 04 
OVr/K 5 0 55J 1 123 t 1<7 1 118 1 125 1 094 0 893 109 9S 100 94 51 >1 OOE-04 >1 OOE 04 >1 OOE 04 
OVC*P 8 0 189 0 943 0 92( 0 945 1) 919 0 ei6 0 317 98 100 97 57 1/ 1 4(E-05 ooe--04 >1 OOE-04 
SK OV J 0 524 0 938 0 940 0 S55 0 343 0 658 0 6(4 100 104 101 81 34 4 50E-05 >1 OOE--04 >1 OOE 04 
R«nal Career 7JC 0 0 211 1 05( 1 137 u 894 1 092 0 628 0 19'> 109 81 104 49 9 9 f7E 06 7 12E 05 >1 OOE 04 
A4''K 0 962 1 370 1 383 1 379 1 3/2 1 189 0 (88 103 102 100 56 -29 1 16E-05 4 58E--05 >1 OOE--04 ACrfM 0 443 1 387 1 479 1 399 1 375 0 941 0 431 104 101 99 53 -3 1 IJ^ 05 8 94E 05 >1 OOE 04 
OKI 1 0 665 i 483 2 500 2 5(0 2 479 1 833 0 918 101 104 100 i' 14 1 '12E-05 >1 OOE 04 >1 OOL 04 
RXF J9J 0 647 1 048 1 036 I 0S3 1 023 0 705 0 3(0 97 lUl 94 14 -44 3 56E 06 1 7(E->05 >1 OOE- 04 
SN12C 0 447 1 2^ 5 1 116 1 183 1 160 0 299 0 040 80 05 92 33 91 2 16E-06 5 42F- 06 1 95E 05 
rit 10 0 73- 1 380 1 390 1 349 1 404 1 315 0 954 10^  95 104 90 14 5. .I:E 05 '1 OOE 04 >1 OOC 04 
00 J1 0 280 1 013 1 037 I 005 1 002 0 833 0 165 103 09 98 75 12 2 51E-05 >1 OOE 04 >1 OOE 04 
ProttflLfc Career rc > 0 287 0 719 0 758 tl 701 0 704 0 404 0 270 109 9( 96 27 ( 4 e9E 06 6 55E 05 >1 OOE 04 nu lis 0 271 0 929 0 924 0 945 0 892 0 719 0 518 99 102 94 68 38 3 91E 05 >1 OOE 04 >1 OOE 04 
Blaise Cancer MfT 0 187 0 792 0 919 0 7(4 0 745 0 334 0 125 104 95 92 24 -33 4 18E-06 2 64E- 05 >1 OOE-04 
WCI/ADR-RFS 0 485 1 208 1 218 1 233 1 165 0 816 0 643 101 1U4 94 46 2? 8 l-'E-06 >1 OOE 04 >1 OOE-04 
hs 5/ST 0 7(0 1 3(» 1 3(4 1 427 I 367 1 192 0 971 100 110 103 71 35 3 82E-05 >1 OOE 04 >1 OOE-04 
MC^ MB-435 0 395 I 632 1 (57 1 625 1 617 1 092 0 556 102 99 99 56 13 1 40E-05 >1 OOE-04 >1 OOE 04 KDA-N 0 240 I 552 1 4 5( 1 381 1 4C8 0 845 0 338 93 87 89 46 7 8 12E-06 >1 OOF-04 >1 OOE-04 
E7 i49 0 (71 454 1 495 1 523 1 462 1 409 0 912 105 109 .01 94 31 4 97E-05 >1 OOE-04 >J OOE-04 
T 4/D 0 650 1 101 1 117 1 124 1 039 0 760 0 706 103 105 86 29 12 4 28E-06 >1 001 04 >1 OOE-04 
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TABLE - 25 /National Cancer Institute Developmental Therapeutics Program 
NSC: 716407 -M 1 Experiment ID: 0004MD35-1(3 Test Type: 08 Units: Molar 
Report Date: May'.?, 2000 Test Date: QNS: MC: 
COMI: CODE-Q Stain Reagent: SRB Dual-Pass SSPL: OGVG 
Par«l/C«ll U n » 
Lfukonia 
CCRy-CEM 
KL-COITB) 
K-S62 
!IOLT-4 
*PN7-82J« 
SR 
Tiipe 
Zero 
Mean Optical Densltiei 
Ctrl - t o -7 0 -6 0 - S O 
212 
210 218 
62'j 319 
Hon-Smoll Call Lunj cancer 
A549/ATCC 
EKVX 
HOP-62 « 
HCI H22« 
»C.:-H2> 
HCI-H4«0 
HCt-H522 
Colon Cancer 
COLO 205 
KCC-299S 
HCT-116 
HCT-15 HTJ9 KH12 
SH-e20 
CNS Cancer 
sr-26a 
SP-295 
SP-J3J 
SNa-19 
Shm-75 
0251 
Melanoma 
LOX IKVI 
KALHC-3H 
M14 
SX-KEL-2 SK-MtL-3t 
Slt-MEL-5 
UACC-257 
UACC-S2 
Ovarian Cancer 
IGROVl 
OVCAR-3 
OVCAR-4 
OVCAR 5 
OVCAR-a 
SX OV-3 
Renal Cancer Iti 0 
A498 
ACKH 
CAKI-1 
RXP 393 
8H12C 
TX-10 
00-31 
Prostate Cancer 
FC-3 
DO-145 
Breast Cancer 
MCF7 
NCI/XDR-RIS 
HS 57eT 
MI1A-MB-43S 
MDA-N 
BT-549 
T-47D 
219 
381 
520 799 
442 
527 2ej 
295 
SO 9 
206 
330 
281 
304 
196 
489 
195 
510 
563 
328 
369 
565 
282 
295 
604 
238 
411 
338 
450 
689 
503 
356 
579 
487 
653 
189 
524 
211 
962 
443 
665 
647 
447 
737 
280 
287 
271 
187 
485 
760 
395 
240 
671 
650 
LoalO Concentration 
percent Growth 
863 
294 
571 
048 
973 
252 
270 
722 
151 261 
859 
327 
735 
736 
308 
780 
140 
069 
688 
181 
139 
461 
415 
256 
277 
827 
231 
827 
350 
524 
034 
967 
212 
341 
738 
112 
270 
838 
358 
726 
731 
292 
777 
117 
153 
680 
123 
039 
183 
0 831 
2 305 
1 579 
1 007 
2 010 
1 23« 
1 393 
0 78: 
1 187 
^ 265 
0 864 
1 364 
0 742 
1 749 
1 213 
845 
242 
551 
068 
010 
299 
1 303 
0 750 
1 136 1 2^ S 
0 869 
1 310 
0 754 
1 748 
1 314 
847 
259 
517 
034 
999 
259 
32S 
764 
279 
283 
863 
123 
715 
628 
277 
1 457 
1 370 
1 013 
1 268 
0 846 1 1^7 
1 652 
1 181 
1 320 
1 053 
0 904 
1 851 
1 614 
1 614 
650 
190 
365 
075 
>13 
824 
583 
594 
384 
287 
105 
978 
911 
147 
401 
423 
551 
032 
350 
393 
106 
790 
907 
1 386 
1 334 
1 121 
0 956 
0 921 
0 981 
0 824 
1 201 
1 244 
1 556 
1 482 
1 451 
1 107 
177 
399 
398 
364 
039 
223 
409 
176 
821 
932 
815 
202 
228 
545 
463 
500 
131 
811 
113 
063 
702 
166 
050 
162 
446 
411 
013 
280 
845 
276 
685 
165 
311 
071 
937 
884 
583 
588 
366 
310 
095 
977 
924 
000 
110 
400 
418 
393 
037 
175 
273 
066 
807 
912 
802 211 
258 
487 
436 
472 
117 
769 
106 
lOS 
688 
145 
156 
118 
0 771 
1 157 
2 049 
1 693 
1 188 
1 991 
1 115 
1 435 
I 446 
1 074 
1 258 
0 845 
1 242 
435 
514 
010 
301 
834 
285 
644 
111 
334 
080 
917 
865 
565 
583 
342 
366 
070 
984 
910 
Oil 
1 656 
1 131 
1 339 
1 118 
0 <90 
1 954 
1 551 
1 517 
1 Olt 
1 405 
1 396 
2 405 
1 029 
1 150 
1 459 
1 058 
828 
960 
817 
253 
190 
506 
J47 
473 
1 153 
1 387 
1 416 
1 054 
0 969 
0 925 
1 104 
\ U1 
1 392 
1 397 
2 281 
1 019 
1 187 
1 407 
1 135 
0 820 
0 952 
0 805 
1 258 
1 261 
1 459 
1 340 
1 566 
1 149 
4 0 -8 0 •> 0 -6 0 - 5 0 - 4 0 OI50 TGI LC50 
0 301 94 9S 97 98 14 1 68E-05 >1 OOE-04 >1 OOE-04 
0 464 103 101 97 98 -23 2 49E-05 6 46E-05 >1 OOE-04 
0 289 97 501 99 96 6 3 24E OS >1 OOE-04 >1 OOE-04 
0 102 98 95 102 98 8 3 42E-05 >1 OOE-04 >1 OOE-04 0 508 100 103 105 102 -19 2 69E-05 7 OOE-05 >1 OOE-•04 
0 244 96 S8 105 101 -16 2 73E-05 7 35E-05 >1 OOE--04 
(1 120 107 li2 103 105 10 3 78E-05 >1 OOE-04 >1 OOE-04 
0 119 105 118 108 112 -16 3 O'E-05 7 47E-05 >1 OOE-•04 
0 495 94 106 98 120 5 3 64E 05 9 14E 05 >1 OOE-04 
D 600 102 101 94 105 -25 2 64E 05 6 43E-0S >1 001 04 
0 417 95 101 102 101 1 3 ISE 05 9 75E 05 >1 OOE 04 
0 496 104 105 100 100 -6 2 97E 05 8 79E-05 >1 OOE-•04 
0 110 98 101 104 96 14 3 66E 05 >1 OOE-04 >1 OOE 04 
u 149 100 101 101 93 4 3 OlE 05 >1 OOE-04 >1 OOE--04 
0 498 98 86 101 96 -18 2 51E-05 6 91E-05 >1 OOE 04 
0 034 99 105 98 98 -83 1 85E-05 3 48E-05 6 54E •05 
0 516 97 97 96 102 23 4 ssE-c-; >1 OOE-04 >1 OOE-•04 
0 287 105 100 102 99 0 3 13E-05 >1 OOE-04 >1 OOE-•04 0 363 99 101 100 100 4 3 34E-05 >1 OOE-04 >1 OOE--04 0 283 94 91 96 101 9 3 56E-0S >1 OOE-04 >1 OOE--04 
0 604 94 95 101 91 7 3 O8E-O; >1 OOE-04 >1 OOE--04 
0 196 103 100 96 96 21 4 07E-05 >1 OOE-04 >1 OOE--04 
0 664 99 98 97 97 14 3 71E 05 >1 OOX-04 >1 OOE-•04 
0 540 95 100 104 112 -4 3 41E-05 9 20E-05 >1 OOE--04 a J49 74 74 80 73 2 i 14E-05 >1 OOE-04 >1 OOE 04 
0 571 99 100 98 103 22 4 52E-05 >1 OOE-04 >1 OOE 04 
0 510 107 1117 107 103 -10 2 94E-05 8 18E 05 >1 OOE-04 
0 401 98 105 101 106 3 97E 05 >l OOE-04 >1 OOE 04 
0 258 100 102 99 100 -11 2 TIE 05 7 72E-05 >1 OOE 04 
0 542 102 97 88 91 10 2 55E 05 7 91E 05 >1 OOE 04 
0 404 104 09 101 102 11 J 73E 05 >1 OOE 04 >1 OOE 04 
0 215 103 103 104 110 -48 2 40r 05 4 9eE-0S >1 OOE 04 0 513 96 106 102 98 31 5 I7E OS >1 OOE 04 >1 OOE 04 
0 422 98 102 101 107 6 3 20E 05 8 81E-05 >1 OOE 04 
0 695 97 97 97 91 1 2 94E 05 >1 OOE 04 >1 COE 04 
0 564 98 98 97 91 5 3 03E 05 >1 OOE 04 >1 OOE 04 
0 454 100 >•8 96 100 9 3 C8E 05 >1 OOE 04 >1 OOE 04 
0 513 107 101 111 118 11 3 36E 05 8 16E 05 >1 OOF 04 
0 534 103 98 94 92 8 3 13E 05 >1 OOE 04 >1 OOE 04 
0 487 93 IDO 102 97 25 2 43E 05 6 20E 05 >1 OOE 04 
0 363 101 lil2 100 )02 10 3 tae oi >1 OOE 04 >1 ooe 04 
0 49/ 94 99 101 120 5 3 61E 05 9 l)9K 01 >1 oor 04 
0 299 101 98 80 9G 9 1 41^ 0 . >l OOE 04 >l ook- 04 
0 782 99 100 101 98 19 2 57E 05 6 91E 05 >1 OOE 04 
0 190 97 99 97 97 12 2 71E 05 7 76P 05 >1 OOE 04 
0 765 90 92 92 86 5 2 78E 05 >1 OOE-04 >1 OOE 04 
0 508 102 101 99 97 -21 2 48E-05 6 58E-05 >1 OOE-•04 
0 468 86 81 78 82 2 2 52E 05 >1 oor-04 >1 OOE-•04 
0 818 102 82 110 102 12 3 81E-05 »1 OOE-04 >1 OOE-•04 
0 291 108 95 94 103 1 3 34E-05 >1 OOE 04 >1 OOE-•04 
0 102 106 101 107 106 1 3 49E-05 >1 OOE-04 >1 OOS--04 
0 196 104 101 108 107 20 4 49E-05 >1 OOE-04 >1 OOE--04 
0 175 99 97 99 97 -7 2 84E-05 8 62E-05 >1 OOE-•04 
0 474 100 101 107 108 -2 3 35E-05 9 52E-05 >l OOE-•04 
0 881 97 i.03 89 104 25 4 81E-05 >1 OOE-04 >1 OOE-04 
0 381 99 94 96 92 -4 2 73E-05 9 15E-05 >1 OOE--04 
0 307 96 96 89 89 5 2 SlE-05 >1 OOE-04 >1 OOE->04 
0 896 106 103 103 115 29 5 66E-0S >1 OOE-04 >1 OOE--04 
0 610 105 102 110 109 -6 3 26E 05 8 84E-05 >1 OOE-•04 
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TABLE-26 : Anticancer Activity of E^^ againt 60 Cell Lines 
Type of c ance r CeU l ine l o g „ G I 5 0 R e t a r d a t i o n of 
g rowth ( % ) 
C o n c e n t r a t i o n (M) 
L e u k e m i a C C R F - C E M - 5 33 _ __ 
H L - 6 0 ( T B ) - 5 42 31 1 0 x 1 0 < 
K - 5 6 2 - 5 29 - -
M O L T - 4 - 5 4 8 5 1 0 x 1 0 * 
R P M I - 8 2 2 6 - 5 30 2 4 1 0x10 < 
SR - 5 3 7 3 0 1 0 x 1 0 < 
Non-small cell A 5 4 9 / A T C C - 5 2 2 - -
Lung cancer E K V X - 4 77 - -
H O P - 6 2 - 4 85 6 1 0 x 1 0 ' 
H O P - 9 2 - 4 82 9 1 0 x 1 0 •• 
N C I - H 2 2 6 - 5 01 3 0 1 0 x 1 0 < 
N C I - H 2 3 - 5 01 - -
N C I - H 3 2 2 M - 4 35 - -
N C I - H 4 6 0 - 5 04 - -
N C 1 - H 5 2 2 - 5 2 0 - -
Colon cancer COLO 205 - 5 32 80 1 0x10 < 
H C C - 2 9 9 8 - 4 71 - -
H C T - 1 1 6 - 5 0 2 - -
H C T - 1 5 - 4 97 - -
H T 2 9 - 5 02 -
K M 1 2 - 4 87 - -
S W . 6 2 0 - 4 74 - -
CNS cancer S F - 2 6 8 - 4 76 - -
S F - 2 9 5 - 5 29 13 1 0 x 1 0 ' 
S F - 5 3 9 - 4 64 2 1 1 0 x 1 0 < 
S N B - 1 9 - 4 4 8 - -
S N B - 7 5 - 4 4 7 - _ 
U 2 5 1 - 4 99 13 1 0 x 1 0 ^ 
M e l a n o m a LOX IMVI - 5 07 11 1 0 x 1 0 ' 
M A L M E - 3 M - 4 67 7 1 0x10 " 
M 1 4 - 4 93 - -
S K - M E L - 2 - 4 7 1 4 1 0 x 1 0 < 
S K - M E L - 2 8 - 4 37 - -
S K - M E L - 5 - 4 90 52 1 0 x 1 0 
U A C C - 2 5 7 - 4 85 - -
U A C C . 6 2 - 4 90 14 1 0 x 1 0 < 
Ovarian cancer IGROVI - 4 58 - -
O V C A R - 3 - 5 2 1 2 7 1 0 x 1 0 * 
O V C A R - 4 - 5 17 - -
O V C A R - 5 > - 4 00 _ 
O V C A R - 8 - 4 84 - _ 
SK-OV-3 - 4 35 - -
Renal cancer 7 8 6 - 0 - 5 01 9 1 0 x 1 0 * 
A 4 9 8 - 4 94 2 9 1 0 x 1 0 < 
A C H N - 4 95 3 1 0x10 < 
C A K l - I - 4 72 - -
R X F - 3 9 3 - 5 42 4 4 1 0 x 1 0 < 
SN12C - 5 67 3 3 , 9 1 1 0 x 1 0 ' , 1 0x10 < 
T K - 1 0 - 4 29 _ 
U O - 3 1 - 4 60 -
Prostate cancer P C - 3 - 5 33 6 1 0 x 1 0 < 
D U . 1 4 5 - 4 4 1 _ 
Breast cancer M C F 7 - 5 38 3 3 1 0 x 1 0 < 
N C I / A D R - R E S - 5 09 _ 
H S 5 7 8 T - 4 42 _ _ 
M D A - M B - 4 3 5 - 4 85 _ _ 
M D A - N - 5 09 _ _ 
B T - 5 4 9 - 4 30 _ 
T - 4 7 D - 5 37 _ 
TABLE-21 : Anticancer of Q(25) against 60 cell line 
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Type of c ance r Cell l ine R e t a r d a t i o n of 
g rowth ( % ) 
l o g „ G I 5 0 C o n c e n t r a t i o n 
( M ) 
L e u k e m i a C C R F - C E M - 4 43 1 0x10 ^ 
H L - 6 0 ( T B ) - 4 60 2 3 1 OxlO"' 
K - 5 6 2 - 4 49 - 1 0 x 1 0 - ' 
M O L T - 4 - 4 4 7 - 1 0x10 " 
R P M I - 8 2 2 6 - 4 57 19 1 0x10-" 
SR - 4 56 16 1 OxlO-" 
Non-small cell A 5 4 9 / A T C C - 4 42 - 1 QxlO-" 
Lung cancer E K V X - 4 52 16 1 0 x 1 0 ' 
H O P - 6 2 - 4 44 5 1 0 x 1 0 * 
H O P - 9 2 - 4 58 2 5 1 OxlO-< 
N C I - H 2 2 6 - 4 50 1 1 0 x 1 0 " 
N C I - H 2 3 - 4 53 6 1 OxlO-< 
N C I - H 3 2 2 M - 4 4 4 - 1 OxlO-" 
N C I - H 4 6 0 - 4 52 - 1 0 x 1 0 ' 
N C I - H 5 2 2 - 4 60 18 1 0x10 " 
Colon cancer COLO 205 - 4 73 83 1 OxlO-" 
H C C - 2 9 9 8 - 4 34 - 1 0 x 1 0 < 
H C T - M 6 - 4 50 - 1 OxlO-" 
H C T - 1 5 - 4 4 8 - 1 0 x 1 0 ^ 
H T 2 9 - 4 45 - 1 0 x 1 0 " 
K M 1 2 - 4 51 - 1 0x10-" 
S W . 6 2 0 - 4 . 3 9 - 1 0 x 1 0 " 
CNS cancer S F - 2 6 8 - 4 . 4 3 - 1 0x10-" 
S F - 2 9 5 - 4 4 7 4 1 0 x 1 0 " 
S F . 5 3 9 - 4 6 7 - 1 OxlO-" 
S N B - 1 9 - 4 3 4 - 1 0x10 
S N B - 7 5 - 4 53 10 1 0 x 1 0 " 
U 2 5 1 - 4 40 - 1 OxlO-" 
M e l a n o m a LOX IMVI - 4 55 13 1 0 x 1 0 " 
M A L M E - 3 M - 4 59 10 1 0x10 
M 1 4 - 4 43 - 1 0x10 " 
S K - M E L - 2 - 4 62 4 8 1 0x10-" 
S K - M E L - 2 8 - 4 29 - 1 0x10-" 
S K - M E L - 5 - 4 49 6 1 0x10-" 
U A C C - 2 5 7 - 4 53 - 1 0x10 " 
U A C C - 6 2 - 4 52 - 1 0 x 1 0 " 
Ovarian cancer IGROVI - 4 45 - 1 0 x 1 0 " 
O V C A R - 3 - 4 47 11 1 0 x 1 0 " 
O V C A R - 4 - 4 . 5 0 - 1 OxlO-" 
O V C A R - 5 - 4 6 1 2 5 1 OxlQ-" 
O V C A R - 8 - 4 43 - 1 0x10 " 
SK-OV-3 - 4 44 5 1 0x10 " 
Renal cancer 7 8 6 - 0 - 4 47 - 1 0x10 " 
A 4 9 8 - 4 59 19 1 0 x 1 0 " 
A C H N - 4 57 12 I 0x10-" 
C A K I - I - 4 56 - 1 0 x 1 0 " 
R X F - 3 9 3 - 4 61 2 1 1 0x10 
SN12C - 4 60 - I 0x10-" 
T K - 1 0 - 4 42 - 1 0 x 1 0 " 
U O - 3 1 - 4 4 8 - 1 0 x 1 0 " 
Prostate cancer P C - 3 - 4 46 - 1 0x10 " 
D U - 1 4 5 - 4 3 5 _ 1 0x10-" 
Breast cancer M C F 7 - 4 55 7 1 0x10-" 
N C I / A D R - R E S - 4 4 7 2 1 0x10-" 
H S 5 7 8 T - 4 32 - 1 0x10-" 
M D A - M B - 4 3 5 - 4 56 4 1 0 x 1 0 - ' 
M D A - N - 4 54 - 1 0x10-" 
B T - 5 4 9 - 4 2 5 - 1 0x10-" 
T - 4 7 D - 4 49 6 1 0x10-" 
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(B). ANTIBACTERIAL ACTIVITY 
INTRODUCTION 
The test organism used in the study included Escherichia coli UP2566 
(Central Drug Research Institute, Lucknow, India), Bacillus subtilis MTCC-
121 (Institute of Microbial Technology, Chandigarh, India) and clinical 
isolates of Streptococcus viridans and Staphylococcus epidermatis 
(Department of Microbiology, J.N. Medical College, AMU, Aligarh, India). 
Culture Media and Inoculum 
Sabour and Dextrose (SD), Nutrient broth and agar were obtained from 
Hi-Media Pvt. Ltd. (Bombay, India) and were used for test bacteria. Freshly 
grown microbial cultures at 37° C were appropriately diluted in sterile normal 
saline solution to obtain a cell suspension of 10^ CFU/ml. 
Antibacterial assay 
Each synthetic compound was dissolved in DMSO to obtain a stock 
solution of different concentrations ranging from 2000-5000 |i.g/ml. The agar 
well diffusion method (Perez et al}) as adopted by Ahmad and Arina'* was 
used for our assay. 0.1 ml of the diluted inoculum (10^ CFU/ml) of test 
organism was spread on NA/SDA (Nutrient Agar/Sabur and Dextrose Agar) 
plates. Wells of 8 mm diameter were punctured into the agar medium and 
filled with 100 )il of compound, solvent blank and an antibiotic 
(chloramphenicol, 100 |a.g/ml) to which the test bacteria were sensitive. The 
plates were incubated for 18 h at 37 °C. Antibacterial activity was evaluated 
by measuring the zone of inhibition against the test organism. 
3 3 2 
RESULT AND DISCUSSION 
A total of 5 compounds were tested against three Gram +ve bacteria 
{Streptococcus viridans. Staphylococcus epidermatis. Bacillus suhtilis) and 
one Gram -ve bacteria {Escherichia coli). The varying level of anti-bacterial 
activity was detected against one or more test organisms. 
Antibacterial activity of test compounds 
The results for the antibacterial study of the tested compounds detected 
against the test organisms Escherichia coli, Bacillus subtilis, 
Staphylococcus epidermatis, Streptococcus viridans are depicted in 
TABLE 26. Solvent control (DMSO) showed non-significant inhibition to 
test microorganisms. 
All the five compounds demonstrated activity against both Gram +ve 
and Gram -ve bacteria. The compounds exhibited antibacterial activity in the 
concentration range 200 )ig to 400 |j,g/100 |j,l. Overall broad spectrum 
antibacterial activity i.e. active against Gram +ve and Gram -ve was deduced 
in five compounds. These compounds may be directly explored in the 
preparation of topical antiinfective agents. However, further exploration 
requires detailed study on exact MIC values and least toxicity to host cell and 
system. 
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